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Abstract 
Microbial fermentation and whole cell biocatalysis have long been used in an industrial 
context for the generation of commercially valuable biomolecules. There is significant further 
potential if they can be made as economically attractive as competing chemical process 
routes. Improvements in genetic engineering techniques such as those pioneered in the area 
of synthetic biology, have provided access to novel products including therapeutic proteins 
and enzymes. In order to capitalise on these advances, there remains a requirement for rapid 
bioprocess development and scale up. Here, single use bioreactors are of interest due to the 
advantages over traditional stainless steel technologies. These include reduced need for 
validation and turnaround times, a reduction in capital expenditure and increased facility 
flexibility. To date, however, they have not been thoroughly investigated for use with microbial 
expression systems. 
The aim of this thesis is to; (i) evaluate the oxygen transfer capabilities of different single-
use bioreactors with a view to determining suitability for microbial fermentation, and (ii) to 
define appropriate scale-up bases from high throughput microwell to laboratory and pilot scale 
bioreactors. Initial work focused on the characterisation, optimisation and scale-up of a whole 
cell P450 monooxygenase bioconversion in Escherichia coli. Three rounds of optimisation 
using a Design of Experiments (DoE) methodology resulted in a 3.3 fold increase in the 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. Results from the 96 deep square 
well (DSW) plates were then scaled-up to a traditional, pilot scale stirred tank bioreactor, 
increasing titres 25 times over a 3000-fold scale increase. Peak oxygen demands of 25.8 
mmolL-1min-1 were shown, with clear differences in oxygen consumption as a result of feeding 
and bioconversion during fermentation. The inability of microwell systems to support high 
biomass concentrations and oxidative bioconversion was also demonstrated.  
In addition, these studies helped provide fundamental insights into the mechanism for 
oxygen utilisation during microbial whole cell bioconversions. Prioritisation of oxygen 
utilisation for biomass accumulation over supplementary cellular activities such as 
bioconversion was seen in all cases. In some cases, oxygen demand as a result of growth 
was approximately 4 times greater than other contributions. This had previously been 
hypothesised in literature but not demonstrated.   
In order to better characterise oxygen mass transfer in microwell plate geometries, an 
improved method for quantification of the volumetric oxygen mass transfer coefficient (kLa) 
and oxygen uptake rate (OUR), based on the dynamic gassing out method, was subsequently 
developed. This method determines oxygen mass transfer parameters (kLa and OUR) during 
a fermentation to provide more representative values for OUR. Models for OUR and kLa were 
built in 24 DSW plates with maximum values of over 600 mgO2L-1h-1 and 103.5 h-1 respectively. 
The established models enable equivalent operating conditions for the different plate 
geometries to be determined. 
The applicability of two commercially available single use bioreactors (the Ambr®250 and 
the XDR-10) for microbial fermentation was evaluated, using a traditional pilot scale STR for 
comparison. This included building models which consider a number of factors likely to 
influence oxygen mass transfer simultaneously, as opposed to the empirical correlations 
which have been developed traditionally. The Ambr®250 was demonstrated as having similar 
oxygen mass transfer capability to the STR across the majority of the experimental ranges, 
reaching maximum kLa values of > 600 h-1. Analysis of a large number of industrial microbial 
fermentations (approximately 300) demonstrated that the Ambr®250 is capable of supporting 
microbial fermentation and bioconversion (or recombinant protein expression) in each, where 
the XDR-10 would not be suitable. 
After demonstrating the applicability of the Ambr®250 system for industrial microbial 
fermentation, a modelling tool was developed in the Python programming language capable 
of evaluating the cost and resource requirements of an Ambr®250 bioprocess development 
run. Preliminary sensitivity analysis highlights labour as the main influence on cost, followed 
by the replacement of single use bioreactors, each responsible for more than one third of the 
total run cost.  
Overall this work has established original, quantitative insights into oxygen utilisation in 
microbial expression systems and established engineering criteria for the selection and use 
of single-use bioreactor technologies for microbial cultivation. The methodologies developed 
here are considered generic and applicable to other expression systems with high specific 
oxygen demands such as yeast and heterotrophically cultured microalgae. 
 
  
Impact Statement 
This thesis has focused on the characterisation of small and pilot scale single use 
bioreactor systems and their application in the culturing of microbial expression systems, 
particularly those undertaking whole cell oxidative bioconversions. As such, in an attempt to 
further understanding in industry and academia alike: a whole cell oxidative bioconversion has 
been optimised and characterised enabling greater understanding of oxygen utilisation; 
methods have been developed for more accurate quantification of oxygen mass transfer 
capabilities in single use bioreactor technologies; the applicability of commercially available 
single use bioreactor technologies to microbial fermentation has been evaluated; and a 
computational tool for the economic evaluation of the Ambr®250 system developed. 
Optimisation and scale up of a microbial whole cell oxidative bioconversion from 
microwells to a pilot scale bioreactor quantified the peak demand for oxygen during culture, 
offered novel insights into the utilisation of oxygen in microbial expression systems and 
demonstrated the need for small scale culturing systems with enhanced oxygen mass transfer 
capabilities. 
Methodologies developed for the quantification of oxygen mass transfer coefficients, both 
in small and pilot scale single use culture systems offer potential improvements to the 
traditional techniques used. This offers a means of quantifying the oxygen demand of a 
microbial expression system during culture and therefore a more representative way for 
academia to understand the responses of an aerobic fermentation to the environment, and for 
industry to develop culturing technologies to meet the demands of microbial expression 
systems. 
Use of a multifactorial approach has offered novel insights into quantification of oxygen 
mass transfer in commercially available single use bioreactors. The need for characterisation 
using DoE methods was highlighted by a number of observations wherein key influences on 
mass transfer were a result of interactions which would not have been observed using other 
methods. 
Finally, an economic evaluation tool has been developed in the Python programming 
language for determining the cost and resource demands of bioprocess runs undertaken in 
the Ambr®250 system. This tool has already been implemented in an industrial setting for 
project costing, and the remit has been expanded to include resource allocation, reporting and 
project scheduling. 
In summary, the research undertaken in this thesis provides novel insight into oxygen 
mass transfer and the methodologies for its characterisation including where, on the basis of 
oxygen mass transfer, single use bioreactors can be applied to the highly lucrative field of 
microbial fermentation.  
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1. Introduction and Literature Review 
1.1. Context of the Research 
Engineered biological systems have been used over the years to process 
chemicals, produce energy and food, construct materials and even to aid in the 
improvement of health or the environment (Endy 2005). In the late 1970s Szybalski & 
Skalka, (1978), highlighted that molecular biology was in a state whereby recombinant 
DNA could be easily constructed, making it a powerful tool in enhancing biological 
potential. More recently, the limitations of these traditional techniques has been 
realised and so new technologies have been developed, such as synthetic biology, 
which to date has been applied in the production of novel antibiotics and biofuels 
(Weber et al. 2011), vaccines (Wimmer et al. 2009) and the generation of a minimal 
free living cell (Hutchison et al. 2016). In short, synthetic biology aims to apply robust 
engineering principles and characterisation to genetic engineering with a strong focus 
on the biological context (Andrianantoandro et al. 2006). 
From a Biochemical Engineering standpoint, the major commercially applicable 
outputs are more productive expression systems (thus far particularly microbial), or 
indeed completely new molecules (Khalil & Collins 2010). This results in lower process 
cost and a large variety of enzymes being expressed. Significant challenges remain 
though as a result of greater oxygen demand, process characterisation at small scale 
and the issue of scaling up expression systems which place an increased burden on 
the culture environment (Cheng & Lu 2012). 
In addition, there is increased use of single use bioreactor (SUB) technologies in 
the biotechnology sector, particularly for mammalian bioprocessing, due to the 
advantages they offer with regards to flexibility, environmental impact, capital 
expenditure and turnaround times (Eibl et al. 2010; Galliher 2008). There is however, 
a lack of investigation and development for microbial SUBs, a disconnect which needs 
to be addressed. 
In this first chapter, a review of the literature is undertaken in order to gain an 
appreciation of the current state of the industry, with a particular focus on biocatalysis, 
oxygen utilisation by microbial microorganisms, and available bioreactor technologies 
and their ability for oxygen mass transfer.    
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1.2. Literature Review 
1.2.1. Biocatalysis 
Biocatalysis is the use of enzymes to perform chemical syntheses. Enzymes 
undertake highly specific transformation of a ‘substrate’ to a ‘product’ and enhance the 
rate at which a conversion takes place (Beilen & Li 2002). Enzymes are often highly 
substrate, product and reaction specific, and capable of replacing multiple steps from 
the manufacture of a given molecule (Pollard & Woodley 2007), particularly if the 
current process uses traditional chemical catalysts (Woodley 2008). Biocatalysts are 
capable of regio- and enantio- selective modifications, which may not be possible by 
chemical means and can be used to generate industrially relevant products with high 
efficiency and minimal by-product formation (Osbon & Kumar 2019, Nikolova & Ward 
1993).  
Biocatalysts therefore have the potential to be beneficial to a manufacturing 
process, particularly in terms of its economics and sustainability (Gavrilescu & Chisti 
2005; Wohlgemuth 2010; Thomas et al. 2002; Castro & Knubovets 2003). It is worth 
noting that there are many factors associated with biocatalysis that can impact on 
performance and suitability for a given process (Hatti-Kaul et al. 2007).  
The major disadvantages of biocatalysis, particularly compared with chemical 
synthesis, is the lack of understanding relative to traditional chemical process 
techniques and the time and cost of developing and manufacturing an enzyme 
(Thomas et al. 2002), although these costs are continually decreasing. 
1.2.1.1. Biocatalyst Forms 
Biocatalysts may be used as isolated enzymes (often immobilised) or contained 
within a whole cell. Each has its own advantages and disadvantages and areas of 
application which are explored below. 
Isolated enzymes are amenable to shorter development timelines, and are simpler 
to implementation than their whole cell counterparts (Cao 2005). Also, very few, if any 
side reactions take place during the bioconversion as there are no other enzymes 
present (Nikolova & Ward 1993). This makes the conversion process much more 
predictable (Ishige et al. 2005). If necessary, immobilisation of the enzyme onto or 
within a solid support can be used in order to enable reuse (Gupta et al. 2011). Isolated 
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enzymes though, have much higher upstream costs, even when used in small 
quantities (Gilleran et al. 2010) due to the economic burden of their manufacture and 
purification. This necessitates enzyme reuse in order to maintain manageable costs 
(Cao 2005). It has been noted though that due to increasingly efficient enzyme 
manufacture, using recombinant organisms, these costs are and will continue to 
decline (Lima-Ramos et al 2014).  
Whole cell biocatalysts are cheap to implement upstream as they do not require  
for processing and isolation (Pollard & Woodley 2007), with an additional benefit due 
to a lack of requirement for cofactor addition (Nikolova & Ward 1993). Whole cells also 
have the capacity to contain multiple enzymes, allowing for complex, multistep 
transformations to take place in a single process step (Leon et al. 1998). However, a 
potential difficulty resulting from this is the generation of unwanted side products (de 
Carvalho 2011). A major advantage of whole cell biocatalysis is the relative ease of 
process scale up due to the ability to use, well characterised fermentation technologies 
(Fukuda et al. 2008). Additionally, if fermentation and bioconversion steps are 
separated, then alterations to media and catalyst concentrations can optimise reaction 
conditions and simplify downstream processing (Wachtmeister & Rother 2016, Park & 
Geng 1992). 
Disadvantages of whole cell biocatalysis include the need for expensive 
fermentation facilities (Pollard & Woodley 2007), especially if these facilities are 
required on a large scale. Also, whole cells are generally subject to substrate and 
product inhibition (Edwards 1970), with concentrations greater than 1gL-1 noted as 
being potentially detrimental. Limited use of whole cells with organic solvents and ionic 
liquids has also been reported (Roberts et al. 1995). In addition, when compared with 
isolated enzyme, greater mass transfer resistances due to the need to transport 
substrates and products across the cell membrane result in overall reaction rates being 
up to two orders of magnitude slower (Ni & Chen 2004); if whole cells are immobilised 
then these already high resistances are increased further (Leon et al. 1998). 
1.2.1.2. Industrial Relevance and Application of Biocatalysis  
Biocatalysis has been applied in industry for around two centuries, beginning with 
the use of immobilised whole cells for the formation of acetic acid in 1815 (Wandrey et 
al. 2000). Isolated enzymes have been applied in industry since the late 1960s, 
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beginning with the industrial resolution of amino acids in Japan, 1969 (Chibata & Tosa 
1977). 
The majority of success for industrial biocatalysis to date has been seen in the 
areas of fine chemicals and pharmaceuticals (Choi et al. 2015). Increasing interest in 
the use of biocatalysts is being seen, with more than 100 industrial biotransformations 
in the fine chemicals industry in the early 2000s (Straathof et al. 2002). Since then, it 
has also been reported that around 10% of all drug synthesis is reliant on biocatalysis 
(Patel 2008).   
Biocatalysis is employed in large-scale processes in a number of industrial sectors, 
including those shown in Table 1.1. The industrial enzyme market in 2009 was 
estimated at $5.1 billion, and was predicted to reach $6.9 billion in 2017 (Sanchez & 
Demain 2016). This rise can be attributed to the increase in applications in various 
markets (including cosmetics, paper and detergents), growth in the bulk chemical 
industry and the increased performance and competition within the enzymes market 
(van Beilen & Li 2002). Some examples of commercial scale products in the chemical 
and pharmaceutical industries are semi-synthetic penicillins (Boesten et al. 1996) and 
acrylamide. Additionally, many industries are under increasing pressure to become 
more environmentally responsible, with biocatalysts a practical route to achieving this 
(Saibi et al. 2012). This suggests a shift towards biocatalysis in these large and 
lucrative markets (the chemicals market alone is projected to be worth in excess of $5 
trillion in 2020) (Clomberg et al, 2018). 
1.2.1.2.1. Pharmaceuticals 
More than half of all commercial scale processes which apply industrial 
biotransformations are in the pharmaceutical field (Straathof et al. 2002), though none 
are considered ‘bulk’ processes (>20,000 tons per annum). Examples include the 
manufacture of an anti-HIV agent (3TC, Lamiduvine by Glaxo) (Mahmoudian et al. 
1993), intermediates of Omapatrilat, an antihypertensive medication (Patel 2001) and 
semi synthetic penicillins using penicillin amidase (Boesten et al. 1996). In addition, it 
was recently reported that biocatalytic processes are used in the manufacture of some 
of the world’s highest grossing pharmaceutical products, including Simvastatin 
(Zocor®) (Xie & Tang 2007) and Atorvastatin (Lipitor®) (Greenberg et al. 2004), with 
these two products alone achieving annual sales of around $20 billion (Tao & Xu 2009).  
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Table 1.1. Examples of the industrial application of enzymes (adapted from van 
Beilen & Li, 2002). 
 
Taxol®, an anti-cancer therapeutic involves the use of a lipase catalysed step 
(Liese et al. 2000).  
 
1.2.1.2.2. Chemicals 
There is a gradual move towards selective catalysis within the chemical industry 
(Straathof et al. 2002). Peroxidases are used in the synthesis of phenolic resins 
Industry Field of Application Examples/Comments 
Agriculture Feed additives Positive effects on environment, animal 
health and efficiency  
Heterologous enzyme 
production  
Laccase and trypsin production in plants 
Chemicals Biocatalysis Preparative biotransformations  
Polymers Polymer synthesis by enzyme catalysis  
Bulk organic compounds Via pathway engineering 
Cleaning New detergent enzymes Results in lower prices and increased 
competition 
Energy Fuel alcohol from biomass Genencor and Novozymes work on 
conversion of biomass-to-ethanol 
Food Enzymes used in food Variety of new enzymes in food preparation  
Nutraceuticals Increased carotene in tomato 
Pharma Chiral compounds Enantioselective biocatalysis  
Glycoprotein engineering In vitro protein glycosylation  
Enzymes as pharmaceutical 
targets 
Numerous target examples 
Materials Paper, textile, leather New enzymes from extremophiles  
Biosteel (silk) Heterologous expression of spider silk 
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(Pokora & Cyrus 1987), while ChiPros™, a group of chiral intermediates are 
manufactured by BASF in Germany (Hieber & Ditrich 2001). Arguably though, the most 
notable commodity manufactured using biocatalysis is the production of acrylamide 
using nitrile hydratase (Liese & Filho 1999). Although examples remain rare, some 
companies have switched from a chemical process to a biocatalytic one for 
manufacture of a product (e.g. β-lactam antibiotic cephalexin by DSM) (Van De Sandt 
& De Vroom 2000). Examples of products manufactured in the chemical and 
pharmaceutical industries using biocatalysis are shown in Table 1.2. 
1.2.1.2.3. Additional Industrial Sectors 
Enzymes employed in the food industry are many and diverse, including the 
production of high fructose corn syrup using xylose isomerase (Jensen & Rugh 1987) 
as well as cheese flavouring (lipases) and use in the baking of biscuits (proteases) 
(Kirk et al. 2002). 
In the textiles industry laccases are used for bleaching materials, and there is a 
substantial market in pulp and paper, where enzymes are used for bleaching, pitch 
control and de-inking (Kirk et al. 2002). Also, enzymes are used widely to generate 
feed additives for agriculture and in detergents such as biological washing powder 
(DiCosimo et al 2013, Bhat 2000). Examples from additional industries are shown in 
Table 1.1. 
1.2.1.3. Challenges to Adoption of Industrial Biocatalysis 
There remain a number of challenges to adoption of biocatalysis for industrial 
application. For example, due to increased processing times at industrial scale, 
degradation of the catalyst, substrate or product can result in significantly affected 
activities, titres and product quality (Pollard & Woodley 2007). Strategies have been 
developed though, which require either the continual removal of product (in situ 
product removal – ISPR) (Lye & Woodley 1999), or controlled supply of substrate to 
the bioconversion process. The majority of commercially available enzymes are 
expensive for their application, meaning that a number of alternative technologies for 
enzyme production have had to be developed (Lagemaat & Pyle 2001; Fotheringham 
et al. 2006). Rapid development timelines are essential in the pharmaceutical industry 
so as to maximize on patent life (Straathof et al. 2002). Thus, inclusion of any 
biocatalytic steps at an early stage is key for adoption.  
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Straathof et al (2002) discuss the criteria for a successful chemical process as 
having greater than 80% yield, a minimum final product concentration of 50gL-1, but 
typically in excess of 100gL-1, and a volumetric productivity from 1gL-1h-1 (with 
examples reported up to 130gL-1h-1). This highlights the challenge for biocatalysis to 
be incorporated into an industrial process, and this must be achievable at a commercial 
scale.  
There are industries which have achieved this and integrated biocatalysis as 
previously shown in Table 1.1. However, challenges remain including ease of scale 
up, when and where to incorporate biocatalysis and the mode of enzyme. The impact 
of biocatalysis in these industries is growing and there is little to suggest that this will 
cease. With the value of biotechnology measured in the hundreds of billions of dollars, 
the financial potential of this market is not to be underestimated.   
Oxidative bioconversions (including cytochrome P450s) are a valuable but 
challenging subset of biocatalysts (Burton 2003), with widespread application (Gillam 
2008; Hasler et al. 1999). Thus, P450s are discussed here as a potential model system 
for investigating oxidative bioconversions of industrial relevance. 
 
Table 1.2. Examples of products manufactured in the chemical and pharmaceutical 
industries using biocatalysis (adapted from Schmid et al, 2001. Leise et al, 2000 and 
Ishige et al, 2005). 
Product Enzyme Scale (tons per yr) Company 
Enantiopure Alcohols Lipase Thousands BASF 
R-amide; S-amide Lipase Hundreds BASF 
L-Aspartic acid Ammonia Lyase Thousands DSM 
Semisynthetic 
Penicillins 
Acylase Low Hundreds DSM 
6-Hydroxy-S-nicotine Hydroxylase Low (Development) Lonza 
Taxol Lipase - Bristol Myers Squibb 
L-Tyrosine Aminoacylase - Degussa 
Vitamin B3 Nitrile hydratase - Lonza 
Acrylamide Nitrile hydratase - Mitsubishi Rayon 
L-DOPA Tyrosine phenol lyase - Ajinomoto 
Pravastatin sodium P450 - Sankyo 
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1.2.2. Cytochrome P450s 
The literature indicates that P450s are a widely investigated and promising group 
of enzymes, capable of a number of highly specific bioconversions of significant 
industrial potential (Burton 2003), and so they are investigated in this thesis. 
Cytochrome P450s (CYP) are a super family of heme-proteins which are responsible 
for catalysing mainly oxidative bioconversions (Shakunthala 2010). Most interestingly 
from a Biochemical Engineering standpoint are those of pharmacological and 
toxicological significance. 
Many P450s are characterised as monooxygenases, while others are capable of 
hydroxylations, dealkylations and oxidations (Gillam 2008) with the potential 
substrates measured in the thousands (Hasler et al. 1999). This breadth is 
unsurprising when the number of organisms acting as sources of P450s is considered, 
from mammalian to bacterial and plant species (Baboo 2012).  
The advent of recombinant DNA technology and increased titres in heterologous 
expression systems allowed the determination of high resolution structures of P450s 
involved in drug metabolism including P450s 3A4 and 2C8 (Yano et al. 2004) (Figure 
1.1.), P450 2C9 (Wester et al. 2004), P450 2D6 (Rowland et al. 2006) and P450 2A13 
(Smith et al. 2007), present in the lung and associated with causation of lung cancer. 
Additional important developments include the role of P450s in the metabolism of 
drugs and other xenobiotics (Zanger & Schwab 2013, Cooper et al. 1965),  and the 
first separation and purification of P450 enzymes (Guengerich 2008). 
  
Figure 1.1.  Ribbon structures of P450s 3A4 (A and B) and 2C8 (C) (adapted from 
Yano et al, 2004), showing that the structure in CYPs, even those of different classes, 
is highly conserved. 
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1.2.2.1. P450 Classifications 
The grouping of cytochrome P450 monooxygenase systems is based on the 
number of protein components they contain (Degtyarenko & Archakov 1993), with 
three well established classes, plus a less explored fourth class (Roberts et al. 2002). 
Diagrammatic representations of these are shown in Figure 1.2 and the details of each 
are briefly discussed. 
Class I P450 monooxygenases are three component systems (Figure 1.2.A). To 
date the majority of P450 systems characterised are Class I. They are found commonly 
in bacteria and mammalian mitochondrial cells (Bell et al. 2010). When found in 
bacteria, Class I systems have a number of uses, including production of secondary 
metabolites and xenobiotic metabolism (Bernhardt 2006). When found in mammalian 
mitochondria, the P450 is involved in steroid metabolism (Fulco 1991). Class I systems 
do not have a P450 reductase (Munro et al. 2007), meaning they are incapable of 
achieving commercially viable activities without addition of this reductase (Arinc et al. 
1999). 
Class II P450 monooxygenases are two component systems as shown in Figure 
1.2.B. When found in mammalian systems, Class II P450s have been shown to be 
responsible for the oxidative metabolism of steroids, fatty acids and prostaglandins 
(Hasler et al. 1999). In plants, they are known to be responsible for the synthesis of 
cutin and lignin barriers (Bak et al. 2011).  
Class III P450 monooxygenases are single component systems (Figure 1.2.C). 
Found in a variety of prokaryotes and eukaryotes, Class III systems are involved in the 
synthesis of signalling molecules including prostaglandins (in mammals) and 
jasmonate (in plants) (Werck-Reichart & Feyereisen 2000). Comparatively high 
catalytic activity as a result of utilising O2 containing substrates makes Class III P450s 
good candidates for industrial application. 
Class IV P450 systems are composed of three bound elements similar to those in 
Classes I to III but used differently (Roberts et al. 2002) as shown in Figure 1.2.D. 
P450RhF, is a self-sufficient monooxygenase system (Nodate et al. 2006) and has 
been cloned into E.coli where it is capable of carrying out the oxidative bioconversion 
of 7-ethoxycoumarin to 7-hydroxycoumarin (umbelliferone) (Roberts et al. 2002). 
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Fusing constitutive parts of a P450 system to enhance the stability or activity is a 
concept that has been worked on since the late 1980’s (Murakami et al. 1987). Hussain 
and Ward (2003 a; 2003 b), worked on the generation of P450SU1 and P450SU2, 
which are self-sufficient, single polypeptide systems. These studies in particular are 
highlighted as the E.coli BL21 Star strain, into which these systems were cloned at 
UCL, are the subject of the work in Chapter 3. Unfortunately, catalytic rates with fusion 
enzymes, while often greater than those achieved by reconstitution of isolated 
enzymes, remain suboptimal (Gillam 2008).  
Advantages offered by self-sufficient, single polypeptide P450 systems (Class III, 
IV and fused), may provide a route to P450s being applied more readily to the 
commercial bioconversion opportunities in the near future. As yet though, there are 
several obstacles to be overcome before P450s can reach their unrealised industrial 
potential (discussed in Section 1.2.2.5). 
 
Figure 1.2. Diagrammatic representation of the four main classes of cytochrome P450, 
classes I to IV (A to D respectively) (taken from Roberts et al, 2002), illustrating key 
structural and compositional differences. In this diagram, Heme represents the P450 
enzyme, FAD flavin adenine dinucleotide, FMN flavin mononucleotide and FeS 
ferredoxin. 
 
(A) (B) 
(D) (C) 
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1.2.2.2. Mechanism 
Cytochrome P450s use energy from the conversion of NADPH to NADP+ and the 
transport of the resulting electron to perform bioconversions (Baboo 2012), including 
hydroxylations, oxidations, dealkylations and oxidative C-C bond cleavage (Sono et al. 
1996). P450s though, are most commonly monooxygenases, which means that they 
incorporate a single atom of oxygen into a substrate (Guengerich 2002). This is shown 
in the following reaction scheme where R represents the  conserved region of the 
substrate undergoing bioconversion (Loew et al. 1981): 
!" + $% 	%'(,%*+, -./0⎯⎯⎯⎯⎯⎯⎯⎯⎯2 	!$" +"%$	 
Table 1.3. Functions of cytochrome P450 enzymes by host organism (adapted from 
Baboo, 2012. and Bernhardt, 2006). 
Host Organism Function of P450 
Prokaryotes detoxify xenobiotics, synthesise antibiotics, fatty acid metabolism 
Plants synthesis of fatty acids and cutins 
Fungi synthesis of membrane sterols and mycotoxins 
Bacteria degradation of natural substrates 
Animals biosynthesis of steroids and hormones, detoxification 
 
1.2.2.3. Functions of P450s 
The roles of naturally occurring P450 enzymes are diverse and vary depending on 
the host organism. These roles in non-human organisms are summarised in Table 1.3. 
In humans, P450s perform a number of roles including the metabolism of drugs, 
biosynthesis of steroids, oxidation of unsaturated fatty acids and stereo- and regio- 
specific metabolism of fat soluble vitamins (Hasler et al. 1999). In the body, some 
P450s act on therapeutics, preventing major side effects. It has been reported that 
P450 enzymes act on the majority of drugs available on the market (Sridhar et al. 
2012). Examples are given in Table 1.4. Considerable research is also addressing 
P450s as drug targets (Guengerich 2002), due to links with production of erythropoietin 
(Epo) (Fandrey et al. 1990) and the onset of Chron’s disease (Corcos et al. 2012). 
 
12 
Table 1.4. Action of selected P450s in the body on therapeutic drugs demonstrating 
the diversity of functions that P450s naturally undertake within the body (adapted from 
Wiseman 2005).   
CYP Drug (Substrate) Action 
2E1 Ethanol Conversion to Ethanal 
2C9 Warfarin Anti-coagulant biotransformation 
3A4 Saquinavir HIV protease inhibitor biotransformation 
19 Anastrozole Aromatisation 
19 4-Imidazolyl-flavans Aromatisation 
2C8 Morphine Morphine N-demethylation 
2D6 Tamoxifen Aromatic hydroxylation 
 
1.2.2.4. Industrial applications of P450s 
There is significant commercial interest in P450s from industries including food, 
pharmaceuticals and cosmetics (Sakaki 2012), with the majority of research focusing 
on the use of P450s in developing drugs (Nettleton & Einolf 2011). In addition, 
predicting how cytochrome P450s will interact with drugs in the body has been a 
significant area of research (Zhang et al. 2009). 
1.2.2.4.1. Pharmaceuticals 
Early examples of P450s in commercial drug manufacturing is the production of 
the steroid, cortisone from progesterone in bacterial fermentation (Rhizopus arrhizus 
and Rhizopus nigricans) (Peterson et al. 1952), and in immobilised Curvularia lunata 
(a fungus) for the manufacture of hydrocortisone (Suzuki et al. 1993). Arguably the 
most successful example of industrial scale P450 bioconversion is the production of 
the statin pravastatin by CYP105A3 (Watanabe et al. 1995), with millions of patients 
treated in more than 100 countries for high cholesterol related ailments (Tsujita et al. 
1997). It should be noted that some of the biggest selling blockbuster therapeutics are 
statins, including Lipitor®, which has cumulative sales of over $140 Billion through 2012 
(forbes.com), highlighting the potential commercial applicability of CYPs. 
Additional examples include conversion of Vitamin D3 to 1α,25-dihydroxyvitamin 
D3 (Rolcaltrol for treatment of hypothyroidism, osteoporosis and chronic renal failure) 
(Sakakis et al. 1992), and the production of leukotoxin B, indicated in a number of 
pathophysiologic responses in humans (Falck et al. 2001). 
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The full commercial potential of P450s has not yet been exploited (Kaluzna et al. 
2015, Sakaki & Inouye 2000). There are a number of areas including antibiotics such 
as erythromycin (Shafiee & Hutchinson 1988) and tetracenomycin (Shen & Hutchinson 
1994), and anti-cancer therapies, for example Taxol® (Cragg & Newman 2005; 
Jennewein & Croteau 2001; Croteau et al. 2006; Kirby & Keasling 2009), currently 
produced by culturing P450 synthesising plant cells (Roberts 2007), where P450s are 
being explored for industrial application (Guengerich 2002).   
1.2.2.4.2. Additional Industries 
There are a number of P450 bioconversions used in the manufacture of 
compounds for the food industry. Astaxanthin is highly valued as a colourant and food 
supplement synthesised by the cytochrome P450 CrtS (Alcaíno et al. 2012). Catalysis 
of β-carotene into xanthophylls by CYP175A1 (Urlacher & Eiben 2006) and production 
of the flavourant trans-carveol by CYP71D18 (Wüst & Croteau 2002) are also 
successful examples.  
Hydroxylation of terpenes by P450s are important processes in the flavour and 
fragrance industries (Sakaki 2012), such as the conversion of (+)-valencene from (+)-
nootkatone, a high value compound traditionally extracted from grapefruit (Girhard et 
al. 2009). Production of compounds for the cosmetic industry such as oxygenated fatty 
acids and diacids (aliphatic α,ω-dicarboxylic acids) are produced using microbial 
P450s (Li & Beisson 2009). One such example is the production of azelaic acid, an 
FDA approved treatment for rosacea and acne (Gupta & Gover 2007). 
An additional application of P450s is their use in the production of transgenic 
plants, particularly the production of blue roses (Gillam & Guengerich 2001; Katsumoto 
et al. 2007) and mulit-colored carnations using CYP75A (de Vetten et al. 1999; Fukui 
et al. 2003) both of which have been commercialised. 
Cytochrome P450s have practical application in biodegradation (Guengerich 
1995), notably of PCDDs (polychlorinated dibenzo-p-dioxins) and PAHs (polcyclic 
aromatic hydrocarbons), by-products of forest fires and various processes in the oil 
industry (Kumar 2010). 
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1.2.2.5. Challenges with use of P450s 
Despite examples where P450s are employed in an industrial context (Section 
1.2.2.4), there are undoubtedly issues that need to be resolved in order for P450s to 
reach their potential. Figure 1.3. summarises a number of suggested improvements to 
P450 systems needed for their successful uptake in the biotechnology sector. In 
particular process related issues, such as a tolerance to solvents and issues 
associated with oxygen demand and mass transfer when using whole cells (Wiseman 
2003), which are investigated in this thesis. 
Widely reported issues include enzyme instability (short half-life), complexity and 
low catalytic activities, as well as a common dependence on co-factors (Sakaki 2012) 
although research is on-going to improve the stability of P450 systems expressed in 
heterologous organisms (Wiseman et al. 2000).  
Oxygen transfer and substrate mass transfer rates can hinder the potential for 
P450 application in commercial bioconversions (van Beilen et al. 2003a). Interestingly, 
work has been carried out whereby reduced levels of dissolved oxygen in the medium 
resulted in increased expression of cytochrome P450s (but importantly not activity) in 
both E.coli (Vail et al. 2005) and yeast species (Stansfield et al. 1991). Thus, 
technologies to facilitate rapid determination of optimal conditions for the P450 
systems (production and bioconversion) would be an important advancement. 
Figure 1.3. Suggested improvements to P450s to make them more suitable for 
commercial biotechnological application (adapted from Bernhardt, 2006).  
P450
Activity
O2 demand and 
mass transfer
Substrate 
specificity
Solvent 
tolerance
Stability Cofactor 
replacement
Redox partner 
interaction
Stereo- and regio-
selectivity of 
bioconversion
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1.2.3. Oxygen Supply to Oxidoreductive Enzymes 
Sections 1.2.1.3. and 1.2.2.5. highlight a number of the key issues with biocatalysis 
and the use of P450s in particular. It has already been noted that whole cell systems 
are the preferred way to undertake P450 bioconversions, and that these have not been 
well characterised. One of the major limitations is oxygen mass transfer, particularly in 
whole cell systems due to the oxygen demand of both the organism and the 
bioconversion. Due to the mechanism of bioconversion, using oxygen as a substrate 
as well as for metabolism, oxidoreductive enzymes typically have a greater oxygen 
demand than equivalent microorganisms which are not undertaking these biocatalytic 
steps (van Beilen et al. 2003b). 
1.2.3.1. Observed Oxygen Demands for Cytochrome P450s 
Table 1.5. shows the oxygen demand reported for a number of P450 oxidative 
bioconversions. From this, conclusions can be drawn regarding the criticality of oxygen 
supply to CYP enzymes. 
In general, it appears that hydroxylations require up to three times greater amounts 
of oxygen than deethylations. In addition, it can be seen that mutations in the enzyme 
result in differing rates of oxygen and NADPH consumption. It seems that oxygen 
consumption rates are generally greater than the reaction stoichiometry would 
suggest.  This is most apparent where mutants of a single P450 are compared (Fang 
et al. 1997; Mayuzumi et al. 1993).  
No effect is observed when comparing prokaryotic and eukaryotic host strains. 
Oxygen demand of a whole cell P450 biocatalyst though is significantly greater than 
that of a purified enzyme due to the oxygen demand for metabolism in the cell in 
addition to the requirement for bioconversion (Li et al., 2002). This lends further weight 
to the argument that these systems require more extensive characterisation. No 
discernible pattern is seen as a result of P450 class (I and II). Fang et al (1997) 
demonstrate data of particular interest as the bioconversion of 7-ethoxycoumarin to 7-
hydroxycoumarin is studied in Chapter 3 of this thesis. 
Limitation of oxygen supply is a serious issue associated with scale-up of oxidative 
bioconversions in fermentation processes (Schmidt 2005). At one time this was 
considered the greatest barrier to cell culture at an industrial scale (Glacken et al. 
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1983), however it should be noted that the issue of oxygen supply in a stirred tank 
bioreactor (STR) is largely considered to be resolved (Chu & Robinson 2001). 
Understanding oxygen demand, however, still aids with improving knowledge of the 
metabolism of the organism, especially critical when the importance of oxygen 
availability for whole cell P450 bioconversions is considered (van Beilen et al. 2003). 
The oxygen transfer rate, commonly represented in the form of the combined 
oxygen mass transfer coefficient (kLa) is an important metric used during bioprocess 
scale up (Pessoa et al. 1996). For many years, it has been the key constant used for 
the scaling of fermentation processes (Marques et al. 2010, Fuchs et al. 1971), and 
maintaining a sufficiently high kLa poses a significant challenge in larger volume 
reactors (hundreds of m3) (Bliem & Katinger 1988). 
Table 1.5. Observed oxygen demands for a range of P450 bioconversions.  
P450 Mutation Host Measurement Condition 
O2 demand during 
bioconversion (µmolL-1min-1) Source 
P450 1A2 
wild type 
Produced in 
Yeast Purified Protein 
deethylation hydroxylation 
Mayuzumi et al. 
1993 
7.5 10.2 
Lys99Glu 2.01 2.16 
Arg137Leu 6.6 8.4 
Lys401Glu 5.1 15.6 
Lys453Glu 2.37 2.37 
Arg455Glu 3.3 3.3 
P450 2C9 - No info (bought purified) Purified Protein 3.55 to 21.6 
dependent on 
substrate and 
activator 
Hutzler et al. 2003 
P450 2B4 - No info (bought purified) 
Immobilised 
Purified Protein 
0.96 ± 0.08 no substrate 
Rudakov et al. 2008 
3.88 ± 0.12 substrate 
P450 2B1 
wild type 
Produced in 
E.coli Purified Protein 
3.4 ± 0.09  
Fang et al. 1997 
Ile114Val 1.91 ± 0.1  
Phe206Leu 1.04 ± 0.12  
Val363Ala 1.18 ± 0.05  
Val363Leu 3.54 ± 0.7  
Gly478Ser 1.09 ± 0.15  
P450 2E1  HepG2 (Human liver carcinoma) Whole Cell 11.7 to 48 
 Sakurai & 
Cederbaum 1998 
CYP21  
Schizosaccharo
myces pombe 
(fission yeast) 
Whole Cell 6 to 8  Dragan et al. 2006 
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1.2.4. Criticality of Oxygen Supply to Microbial Fermentations 
The majority of the key requirements for a microbial fermentation (primary energy 
source, temperature and sufficient mixing for example) can be easily provided, 
monitored and regulated in a standard bioreactor (Schuler & Kargi 2002). However, 
this is significantly more difficult when using small scales (mLs and below) and high 
throughput bioreactor technologies. Until recently, sub optimal performance was 
tolerated (Duetz et al. 2000) rather than overcome.  
In addition, as previously noted, oxygen demand for an organism undertaking an 
oxidative biotransformation is greater than for one which is not (van Beilen et al. 
2003a). The extent of this difference is dependent upon the organism, the enzyme and 
likely also the substrate used (Mayuzumi et al. 1993). A model is suggested by Baldwin 
and Woodley (2006) for the oxidative bioconversion of a ketone by cyclohexanone 
monooxygenase (CHMO), which indicates the preferential utilisation of oxygen for 
oxidative phosphorylation in cellular metabolism, before use in an oxidative 
bioconversion. The model hypothesises the increased demand of an oxygenase 
containing expression system and that, with increasing concentration of enzyme, 
greater oxygen supply is needed to increase reaction rate. 
Table 1.6. shows examples of measured Oxygen Uptake Rates (OURs) for a range 
of microorganisms undertaking different production processes including an E.coli 
strain which relatively speaking would appear to have a high OUR (Çalik et al. 2004). 
In addition, it is interesting to note the difference in OUR as a result of the production 
process being carried out. For example, the difference between Pseudomonas putida 
generating toluene cis-glycol (Carragher et al. 2001) and that carrying out a 
desulphurisation process (Gomez et al. 2006b), with the latter almost four times 
greater.  
Table 1.7 shows the specific oxygen uptake rates, as well as the oxygen required 
for maintenance for a number of different expression systems. Oxygen required for 
maintenance is seen to vary by up to an order of magnitude for a number of these 
organisms including E.coli and Bacillus sp. Interestingly, a similar relationship is seen 
with respect to the specific OUR, and it can be speculated that this may be as a result 
of the environment i.e. available oxygen and nutrients as well as the resultant 
metabolic activity and productivity of the biomass (as indicated by the widely variation 
in values for yield coefficient of biomass on oxygen). 
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Table 1.6. Measured OUR values of different microorganisms from a range of 
investigations.  
Organism Product 
Max. OUR 
observed 
(mmolO2L-1h-1) 
Reference 
Escherichia 
coli 
Benzaldehyde 
lyase 13.0 Çalik et al. 2004 
Xanthomonas 
campestris Xanthan 4.3 
Garcia-Ochoa et 
al. 2000 
Pseudomonas 
putida Toluene cis-glycol 3.4 
Carragher et al. 
2001 
Rhodococcus 
erythropolis 
Biodesulphurisation 
process 1.8-2.5 Gomez et al. 2006 
Pseudomonas 
putida 
Biodesulphurisation 
process 13.0 
Gomez et al. 
2006b 
Rhodococcus 
erythropolis 
Biodesulphurisation 
process 2.7 Santos et al. 2006 
 
1.2.5. Oxygen Mass Transfer 
Aerobic respiration is undertaken in most fermentation processes and so provision 
of sufficient oxygen is critical. In aerobic respiration, oxygen is used to convert glucose 
into water, carbon dioxide and energy in the form of adenosine triphosphate (ATP). 
As previously noted, oxygen is regarded as the limiting substrate in many 
fermentations (Baldwin & Woodley 2006). Provision of enough oxygen is also 
necessary for efficient oxygen mass transfer from gas, to liquid to cell. 
 
1.2.5.1. Mechanism of Oxygen Mass Transfer  
Resistances to oxygen mass transfer before the molecules can be used by a cell 
are summarised in Figure 1.4. The two-film theory of gas absorption explains that the 
rate of gas absorption is controlled by the rate of diffusion through surface films on the 
gas-liquid boundary, a gas film surrounding the liquid, and a liquid film at the surface 
of the liquid (Whitman 1924). Practically speaking, in the case of a bubble with a liquid, 
the liquid film is controlling (Danckwerts 1951).  
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Table 1.7. Specific oxygen uptake rate values and associated parameters from a 
number of investigation in different microorganisms (microbes and yeast). 
 
Organism 
qO2 
(molO2kg
X-1h-1) 
mO2 
(molO2kg
X-1h-1) 
YXO   
(kgX  
molO2-1) 
Primary energy 
source (carbon) Reference 
Bacillus 
thuringiensis 
(kurstaki) 
2-15.5 0.9 17.2 Glucose Rowe et al. 2003 
Escherichia 
coli K12 0.9-23 2.4-6.4 12.5-520 Glucose Çalik et al. 2006 
Escherichia 
coli K12 0.9-17.2 0.4-7.2 0.01-13.6 Glucose Çalik et al. 2004 
Xanthomomas 
campestris  2-15 1.0 0.6 Sucrose 
García-Ochoa et 
al. 2000 
Bacillus 
acidocaldarius 3.1-31.2 2.2-16.6 0.3-43.8 Fructose 
Kocabaş et al. 
2006 
Rhodococcus 
erythropolis  0.2-4.3 0.8 16.4-20 
Glucose, glutamic 
acid & citrate 
Gomez et al. 
2006 
Pseudomonas 
putida 2-18 1.9 52.6 
Glucose, glutamic 
acid & citrate 
Gomez et al. 
2006b 
Trigonopsis 
variabilis 2-3 0.03 13-16 Glucose 
Montes et al. 
1997 
Phaffia 
rhodozyma 1.9 - - Glucose Liu et al. 2006 
Candida 
bombicola 0.3-1 0.01 4.4 Glucose Casas 1996 
Hansenula 
anomala 0.8 - - Glucose Djelal et al. 2012 
Biomass 
molecular 
formula 
(CH1.79O0.5N0.2) 
- 1.0 20.3 Glucose Heijnen & Roels 1981 
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1.2.5.2. Volumetric Mass Transfer Coefficient (kLa) 
The volumetric mass transfer coefficient, kLa is the product of ‘kL’, the liquid-phase 
mass transfer coefficient, and ‘a’ the specific gas-liquid interfacial area, which 
individually are very difficult to measure. Gas bubbles are generated in different sizes 
and with different properties as a result of several factors including thickness of the 
liquid, which in turn varies depending on hydrodynamic conditions. This results in 
widely differing ‘kL’ and ‘a’ values for each bubble. As such, the combined term kLa is 
determined empirically (Andrew 1982).  
Figure 1.4. Steps for transfer of oxygen from gas bubbles to cell (reproduced from 
Doran, 1995). The stages are represented as (i) transfer of oxygen molecules from 
inside the bubble to the gas-liquid interface, (ii) transfer across the gas-liquid interface, 
(iii) diffusion through the liquid film around the gas bubble (iv) oxygen transfer through 
the bulk liquid, (v) diffusion through the liquid film surrounding cells, (vi) transfer across 
the liquid-cell interface, (vii) diffusion through the solid mass to the cell (if cells are in 
a clump or solid particles), (viii) finally, transport across the cytoplasm for utilisation at 
the site of reaction. 
The rate of oxygen transfer can be calculated using Equation 1.1. (Doran 1995): 345 367 = $9! =	:5; ∙ (4∗ − 45)   Equation 1.1. 
Where, OTR is the rate of oxygen transfer (mmolL-1h-1), kLa is the volumetric mass 
transfer coefficient (h-1), C* is the saturated dissolved oxygen concentration (mmolL-1), 
CL is the dissolved oxygen concentration in the liquid (mmolL-1). 
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1.2.6. Factors Influencing Oxygen Mass Transfer 
There are a large number of factors that influence kLa in a stirred bioreactor 
bioreactor. These factors are physical, operational and equipment specific, including 
volumetric gas flow rate, agitation, composition of medium, bubble size, temperature, 
foaming and antifoams. These are regarded as the factors of greatest influence and 
so are discussed more extensively in this section and summarised in Table 1.8. 
Furthermore, each of the factors are considered individually and little comment is made 
as to how they impact on one and other. 
1.2.6.1. Supply of Gas 
1.2.6.1.1. Volumetric Gas Flowrate 
Figure 1.5 shows the typical relationship between air flow rate and kLa. kLa increases 
rapidly to begin with but the magnitude of the rise decreases until around 1.0 vvm. 
After this point, and up to 1.5 vvm good kLa values are seen as a result of high levels 
of available oxygen (Stanbury et al. 1995). Beyond this (>1.5 vvm), kLa tends to 
decrease as excessive air flow rate results in flooding of the impeller region, meaning 
that the impellers are unable to disperse the bubbles efficiently.  
Several works have endeavoured to generate empirical descriptions for avoiding 
flooding of the impeller region, and these are summarised in Table 1.9. 
 
Figure 1.5 Effect on kLa in a mechanically agitated bioreactor as a result of changing 
airflow rate (Stanbury, Whitaker and Hall, 1995). 
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Table 1.8. A brief overview of factors that affect kLa.  
Factors 
affecting kLa 
Increase kLa Decrease kLa 
Volumetric 
airflow rate 
Up to 1.5 vvm, kLa increases, due 
to increased levels of oxygen. 
Optimum kLas are achieved with 
agitation speed at maximum level 
before flooding impeller region 
>1.5 vvm leads to flooding of the 
impeller region, which hinders 
bubble dispersion and break-up 
Agitation 
Improved bubble breakdown and 
dispersion as well as reduced 
bubble thickness, all improve kLa. 
In extreme cases can lead to 
foaming, requiring antifoam, which 
reduces kLa. 
Composition 
of medium 
Decreasing viscosity increases kLa, 
due to thinner film around bubbles 
and improved mixing, Salts in 
media reduces bubble coalescing, 
increasing interfacial surface area 
and gas hold up 
Increase viscosity traps small 
bubbles, increases bubble film 
thickness and reduces oxygen 
availability. High salt concentrations 
may cause bubbles to become 
detrimentally small 
Bubble size 
Small bubbles have large interfacial 
surface areas and long gas hold-up 
time, increasing kLa. 
Bubbles smaller than 3 mm are 
very rigid reducing kL. When 
smaller than 1 mm, oxygen 
concentration equilibrates rapidly 
and bubbles become lodged in 
viscous systems. 
Temperature 
Between 10-40°C, diffusivity of 
oxygen increases with rising 
temperature. 
Above 40°C, solubility decreases 
dramatically, decreasing kLa. 
Foaming and 
antifoam  
Adding antifoam reduces kLa due to 
its mechanism as a surfactant, 
foaming traps bubbles and has an 
overall worse effect on the 
bioprocess  
Pressure 
Increased pressure increases the 
saturation concentration of oxygen 
in water and hence increases the 
mass transfer driving force and 
therefore kLa. 
Increasing pressure increases the 
solubility of all gases, including 
CO2, that at high levels may be 
toxic to cells. 
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1.2.6.1.2. Bubble Size 
Bubble size is also affected by agitation, and this will be commented on in section 
1.2.6.2. Bubble size directly affects interfacial surface area and therefore the area 
available for oxygen transfer. Hence it is one of the key factors influencing kLa. Smaller 
gas bubbles have a larger interfacial surface area, which usually results in a higher 
kLa. Bubbles with diameters below 1mm become problematic as they rapidly become 
depleted of oxygen, removing any relationship between gas hold up and oxygen 
transfer (McGinnis & Little 2002, Heijnen & Roels 1981). Gas hold up refers to the time 
a bubble will spend in the bulk fluid, hence slow rising velocity increases time available 
for oxygen transfer (Doran 1995). In bubbles less than 3mm in diameter, it is noted 
that surface tension is the dominant influencer on the behaviour of the bubble, meaning 
that bubbles have little to no internal gas circulation. This directly results in a 
detrimental effect on kL, reducing overall kLa (Doran 1995). 
A change in gas composition to anything above 21% (atmospheric) will change the 
partial pressure and therefore increase the driving force which causes O2 mass 
transfer (Garcia-Ochoa & Gomez 2009). 
1.2.6.2. Hydrodynamics 
Typically, greater agitation rates result in larger kLa values. This was demonstrated 
by Yagi and Yoshida (1975) and further commented on by Doran (1995). 
Stanbury et al (1995) highlighted a number of reasons for this relationship. Most 
significantly, agitation disrupts bubbles, increasing the number of bubbles in the 
medium and decreasing their mean size, resulting in larger interfacial surface area for 
oxygen transfer. In addition, greater agitation hinders gas bubbles in their passage 
from sparger to the surface of the liquid, hence a greater residence time and therefore 
more time available for oxygen transfer to occur. Furthermore, gas bubbles are 
prevented from coalescing as a result of agitation of the liquid. This acts to prevent the 
kLa from decreasing due to decreasing interfacial surface area, rather than actively 
increasing it. Finally, agitation creates a turbulent hydrodynamic environment in the 
culture liquid. As a result, the liquid film at the gas-liquid interface becomes thinner, 
which leads to a reduced diffusion distance for oxygen transfer, hence greater kLa 
values. 
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Table 1.9. Summary of research into empirical descriptors for avoiding flooding of 
the impeller region in a stirred bioreactor. 
Reference Criteria 
Westerterp et al. 1963 Apply minimum impeller tip speed between 1.5-2.5ms-1 
Biesecker 1972 Maintain energy dissipated by the gas flow rate below that dissipated by the impeller 
Van’t Riet & Tramper 
1991 
As above but only applied to lower section of bioreactor 
where gas dispersion is affected 
Feijen et al. 1987 
Flooding avoided if: 
Fs/ND3 < (0.3)N2D/g     where Fs is the volumetric flow 
rate (m3.s-1), N is the impeller rotational speed (s-1) and D 
is the impeller diameter      
 
1.2.6.3. Medium Composition 
A number of medium-related factors also affect kLa and hence OTR. The starting 
composition of the media affects rheology e.g. with the inclusion of viscous 
components, but also the changing properties of the fermentation culture as it 
progresses. During culture, increasing biomass concentration as well as the formation 
and secretion of extracellular molecules result in a change in the broth properties, 
including the rheology. Values of kLa therefore vary significantly between 
fermentations (Stanbury et al. 1995). Although the exact effect of rheology on 
individual fermentation would require specific experimentation, the general effect of 
rheology on kLa is known. 
Newtonian fluids have negligible effects on oxygen transfer, however non-
Newtonian fluids (which is more often the case in fermentation processes at high cell 
densities) can influence oxygen transfer significantly. The result of a viscous culture 
on kLa values will be detrimental, due to the reduced availability of oxygen and the 
increased resistance to oxygen transfer because of the thick layer surrounding the gas 
bubbles (Doran 1995). The relationship between kLa and viscosity in a fermentation, 
was reported by Buckland et al (1988) to be inversely proportional to the square root 
of the viscosity, as shown in Equation 1.3. This is supported by Steel and Maxon(1966) 
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as well as Wang and Fewkes (1977), who concluded that oxygen was not efficiently 
transferred in viscous fluids. 
:5;		 ∝ 		 1 CDEFGHFE6IJ      Equation 1.3. 
The electrolyte concentration of the medium also has an impact on the solubility of 
oxygen, and therefore a significant influence on oxygen mass transfer (Maier & Büchs 
2001). Higher concentrations of ionic compounds result in reduced oxygen solubility 
(Weisenberger et al. 1996) and lower mass transfer coefficients (Zieminski & 
Whittemore 1970). In providing the necessary media components and supplements for 
cell growth and bioconversion, a negative effect can be impacted upon the oxygen 
transfer capabilities. 
Foam formation is common in mechanically agitated fermentation systems. 
Excessive foaming can result in longer bubble residence times, depleting the oxygen 
in bubbles, detrimentally affecting their ability to transfer oxygen (Hall 1973). Chemical 
surfactants are most commonly used for reducing foam build up, however due to the 
mechanism of action of most surfactants (reducing the mobility of the gas liquid 
interface), these commonly have a negative effect on kLa. (Hall 1973). Interestingly, 
van’t Riet and van Sonsberg (1992) showed that although antifoams cause the break 
up of bubbles, they favour coalescence, meaning that the interfacial surface area of 
the bubbles decrease, reducing kLa. However, both result in a detrimental effect on 
oxygen transfer.  
1.2.6.4. Temperature 
Temperature affects both the oxygen solubility and diffusivity, each of which affect 
mass transfer in opposite ways. As temperature increases, the solubility of oxygen in 
solution tends to decrease. The enthalpy of solutions  can be used to demonstrate why 
increasing temperature is detrimental to the solubility of oxygen (Kotz et al. 2014). With 
energy added, there is a tendency towards gaseous O2 i.e. reduced level of oxygen in 
solution as shown. This in turn reduces the kLa value.  
 
Gaseous O2 + Liquid Solvent   « O2 Saturated Solution + Energy (heat)
Energy added, equilibrium tends
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The diffusivity of oxygen though increases as temperature rises in the range of 10-
40°C. Up to this point, the effect is usually greater than that of oxygen solubility, 
increasing the overall kLa. However, above 40°C, the solubility of oxygen drops 
dramatically, overcoming the positive diffusive effect and adversely effecting mass 
transfer in the system (Doran, 1995).  
The influences of each of these factors on oxygen mass transfer has been 
discussed and due to the fact that they would all appear to be capable of significantly 
impacting on kLa it would be pertinent to investigate more extensively the 
interrelationships between these factors, and how they may effect fermentation 
systems. These relationships are studied in Chapters 4 and 5. 
1.2.7. Oxygen Mass Transfer in Small Scale and Single Use Systems 
The use of microliter scale technologies has increased in recent years particularly 
in early stage bioprocess development and strain screening (Marques et al. 2009), 
mainly due to the advantages offered in terms of low reagent volumes, reduced cost 
and increasing speed of process design and development (Lye et al. 2003). Availability 
of oxygen to the microorganism is a major limitation for microbial fermentations at all 
scales (Baldwin & Woodley 2006). This issue is greater if the expression system is 
also performing an oxidative bioconversion. This is due to oxygen being needed as a 
substrate for the enzymatic conversion process (e.g. that studied in Section 3 of this 
thesis) in addition to its growth and maintenance (Li et al. 2002). Thus, understanding 
oxygen mass transfer capabilities of scale down systems is of critical importance. 
1.2.7.1. Microtiter Plates Types and Geometries 
Achieving suitable hydrodynamics within shaken microwells is vital for ensuring a 
homogeneous environment suitable for growth and biotransformation. However this 
can be difficult in miniaturised culture vessels (Weiss et al. 2002). This section will 
draw reference to the demands of an organism carrying out an oxidative bioconversion 
(Section 1.2.3.), the conditions in various types of microwell and the factors influencing 
these. Furthermore, whether the available oxygen transfer rates are suitable for the 
purpose of microbial growth and biotransformation using an oxygenase enzyme is 
assessed.  
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Microwell plates come in a range of sizes, geometries and materials. Numbers of 
wells per plate range from 6 to 1536 (Kumar et al. 2004); commonly used 
configurations include the 96 and 24 deep square well (DSW) formats, the 24 round 
well format and the 96 round well format. The geometries of wells in some of these 
layouts is shown in Figure 1.6. Also included are the maximum well volumes and the 
cross sectional area, corresponding to the area in contact with the environment and 
available for oxygen transfer while the microtitre well is stationary i.e. the minimum 
area available for gas-liquid mass transfer. 
The maximum Oxygen Transfer Rate (OTRmax) in round microwells is dependent 
primarily on the specific mass transfer area available (a), a product of the shaking 
intensity and dimensions of the well (Hermann et al. 2003), but mass transfer 
coefficient (kL) remains at a constant value regardless of the shaking intensity. Round 
wells also result in oxygen transfer rates of between 25 and 50% of those in square 
vessels with similar diameters, depending on shaking amplitude (Duetz & Witholt 
2004). The corners of square wells act with similar effect to baffles, causing a 
significant increase in oxygen transfer rate and kLa values (Hermann et al. 2003). 
The effect of changing well size and shaking diameter is shown in Table 1.10. 
Square deep wells, of either 18mm or 50mm squared, have been shown to generate 
oxygen transfer rates of approximately 40-60 mmolO2L-1h-1. From Tables 1.6. and 1.7. 
it can be suggested that this would be sufficient for undertaking oxidative 
bioconversions, but could not maintain a culture of high biomass concentration.  
Figure 1.6. Geometries of 
some common microwell 
formats including maximum 
well volumes and surface 
areas when stationary. 96 
DSW (a), 24 round well flat 
bottom (b) and 96 shallow 
round well flat bottom (c) 
geometries are included. 
Interestingly, surface area to 
volume ratios are not 
consistent, although this is 
implicated as an important 
indicator of available gas-liquid 
oxygen mass transfer (adapted 
from Doig et al, 2002). 
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It can also be seen that miniaturisation of the wells beyond the 96 DSW format 
results in a 25-56% reduction in the achievable OTR. It is suggested that this is a result 
of the increased adhesive and capillary forces acting on the liquid, when compared 
with larger vessels. Doig et al (2005) also suggested that this is due to the air-liquid 
surface area (and therefore the area available for oxygen mass transfer) being greatly 
diminished. Work is ongoing into novel well designs (e.g. flower shaped cross sectional 
area) (Funke et al, 2010), with some suggestion that the flower shaped wells provided 
greatest oxygen mass transfer rates. 
1.2.7.1.1. Factors Influencing Mass Transfer in Microwells 
The predominant factors available for influencing mass transfer at microscales are 
the shaking frequency, the shaking diameter and the fill volume (Maier & Büchs 2001). 
Shaking frequency in particular has a threshold (critical shaking frequency) which must 
be overcome in order to achieve effective O2 mass transfer. It has been shown that, 
particularly in round microtiter wells, surface tension of the liquid is the parameter 
which affects the gas-liquid oxygen transfer and hydrodynamics most (Hermann et al. 
2003). 
Equipment to equipment variation is inherent to bioprocesses at all scales (as yet 
there is little standardisation), and this influences a number of important parameters 
(Shivhare & Mccreath 2010). The apparatus used in shaking for example will influence 
the diameter of the shaker orbit, and therefore the hydrodynamics and the efficiency 
of mass and heat transfer (Schäpper et al. 2009). Schäpper et al, also noted that 
temperature control within the microtiter environment can be challenging, due to large 
surface area to volume ratios. Additionally, materials of construction used in the 
production of microtiter plates can affect the oxygen saturation and transfer 
characteristics (Vogelaar et al. 2000). This results from the impact on the superficial 
tension of the culture medium (Hermann et al. 2003).  
Gas liquid mass transfer has been demonstrated to increase with greater shaking 
diameter and frequency (Henzler & Schedel 1991). This is because the culture can 
overcome the critical shaking frequency and increase the maximum oxygen transfer 
rate. Table 1.10. highlights this, showing that a 50mm orbit compared with 25mm, 
results in potentially quadrupling OTR.  
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Well fill volume was shown to influence oxygen transfer rate for growth and 
oxidative bioconversion (Baboo et al. 2012), with higher fill volumes being shown to 
have a potentially detrimental effect on achievable biomass concentration. The use of 
a seal is often employed in order to protect against evaporation and prevent cross well 
contamination (Ferreira-Torres 2008), with potential for reducing O2 availability a 
concern. 
1.2.7.1.2. Observed Oxygen Mass Transfers in Microwells 
A number of studies have been undertaken to characterise the kLa for these 
systems under some of the conditions discussed in section 1.2.7.1.1. Examples of are 
summarised in Tables 1.10. and 1.11. In addition, Figure 1.7. shows the results of a 
study into the effect of shaking diameter and agitation rates in 96 deep square well 
plates (Hermann et al. 2003). 
The data highlight a reasonably good agreement between studies as to the oxygen 
mass transfer capabilities of microwell plates. These are maximum observed values 
and they do not match the values that traditional stirred bioreactors and even a number 
of single use bioreactors are capable of (Table 1.13). 
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Figure 1.7. Maximum oxygen transfer rate and oxygen mass transfer coefficient in 96 
deep square well microtiter plates at different shaking diameters and frequencies. 
Taken from Hermann et al (2003). 
 
Table 1.10. The effect of changing well size and shaking diameter on oxygen transfer 
rate during orbital shaking at 25°C and 300rpm. (a shaking diameter) (adapted from 
Duetz & Witholt, 2004). 
Well Size 
(mm x mm) Volume (mL) 
Oxygen Transfer Rates (mmolO2L-1h-1) 
25mma 50mma 
Square Wells    
4 x 4 0.125 6.7 25.4 ± 5.9 
8 x 8 0.5 15.2 ± 2.4 33.6 ± 4.4 
18 x 18 2.5 39.3 50.5 ± 3.5 
50 x 50 19.5 47.7 58.1 
Round Wells    
6.6 (diameter) 0.26 5.0 16.4 
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Table 1.11. Examples of maximum measured kLa values in different microwell formats 
using a number of methods of oxygen mass transfer determination. 
Plate 
Format kLa determination method 
Max. kLa 
observed (s-1) Reference 
24DSW fluorescent sensors and gassing out method 0.096 
Marques et al, 
2009 
96DSW oxygen limited growth 0.052 Doig et al, 2005 
24DSW fluorescent sensor and dynamic gassing out 0.068 Islam et al, 2008 
24DSW fluorescent sensor and oxygen balancing 0.069 Kensy et al, 2005 
96DSW optical sensor and static gassing out 0.1 Zhang et al, 2008 
24DSW optical sensor and static gassing out 0.028 Zhang et al, 2008 
 
1.2.7.2. Erlenmeyer Flasks 
Shake flasks are, and for many years have been, widely used in bioprocess 
development (Erlenmeyer 1860), particularly for generation of seed material and 
screening evaluation of large numbers of genetic constructs and media compositions 
(Klöckner & Büchs 2012; Gaden 1962). Oxygen mass transfer in shake flasks is widely 
regarded to be poor, with the inclusion of baffles (sometimes referred to as denting) 
an example of one step taken to overcome this (Peter et al 2006; Mcdaniel et al. 1965; 
Smith & Johnson 1954). However until recently it has been difficult to monitor oxygen 
levels and therefore gain a robust understanding of oxygen mass transfer (Section 
1.2.8). 
The development of non-invasive optical sensors by companies such as PreSens 
GmBH and Fluorometrix (Stow, MA) have meant that similarly to traditional 
polarographic probes in stirred bioreactors, oxygen can now be monitored online 
during culture in shaken Erlenmeyer flasks and microwells, with this data used for 
determination of oxygen mass transfer coefficients. Gupta and Rao (2003) showed kLa 
values of 0.0086 s-1 and 0.0164 s-1 in non-baffled and baffled 250mL flasks 
respectively. They also demonstrated that this could be matched by limiting the 
capabilities of a bench top STR and similar growth kinetics observed. Some 
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additionally determined kLa values in shake flasks are highlighted in Table 1.12. These 
values are approximately equivalent to the higher values seen in microtiter plates. 
1.2.7.3. Additional and Supplementary Technologies 
Until recently, stirring and sparging in miniaturised bioreactors was considered 
impractical, with the improvement of oxidative conditions focused on the optimisation 
of orbital shaking parameters and well geometries for microtiter plates (Duetz 2007). 
In the last decade though, a number of alternative technologies have been developed 
and are either nearing, or have recently reached commercial availability.  
Examples include the Micro24 system from Pall Corporation (based on a 24 round 
well geometry) which offers sparged gas supply controlled to individual wells, as well 
as online monitoring and control of dissolved oxygen (DO), pH and temperature. This 
platform has been demonstrated as an accurate scale down mimic of a 2L stirred tank 
bioreactor (Chen et al. 2009). Additionally, the M2P Biolector system, which also offers 
pH, DO and temperature monitoring has been characterised (Funke et al. 2010). 
In addition, the RAMOS (respiratory activity monitoring system) is available for the 
online measurement and analysis of respiratory gases, enabling real time 
measurement of oxygen transfer and carbon-dioxide evolution rates. The system has 
been demonstrated to work with microbial and mammalian expression systems 
(Anderlei et al, 2004) 
Table 1.12. Examples of oxygen mass transfer values determined for shaken 
Erlenmeyer flasks in the literature. 
Erlenmeyer flask 
geometry Method  
Max. kLa observed 
Reference 
(s-1) (h-1) 
500mL Sulphite oxidation 0.040 144 Henzler & Schedel 1991 
500mL Sulphite oxidation 0.027 97.2 
Veljkovic et al. 
1995 
500mL 
Dynamic gassing out 
(polarographic probe) 0.020 72.0 
Suijdam et al. 
1978 
250mL Baffled  Non-invasive sensors 0.016 59.2 
Gupta & Rao 
2003 
250mL Unbaffled Non-invasive sensors 0.009 30.8 
Gupta & Rao 
2003 
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The Ambr®250 system from Sartorius Stedim Biotech, operating automated single 
use fermentation cultures up to 250ml. A Rushton turbine impeller, feed addition ports, 
gassing and monitoring capabilities provide a mimic of a production scale bioreactor 
(Hart 2013). This system is noted to be capable of a kLa up to 500h-1 (Bareither et al. 
2013).  Interestingly, many of the developments of note in recent times have 
concentrated on the monitoring and provision of oxygen and adequate hydrodynamics 
in the culture media, an indicator of how important these parameters are as drivers for 
improvements in fermentation development. Major advances in culturing technologies 
(e.g. Micro24 and Ambr®250 systems) have removed the issue of surface moderated 
oxygen transfer. 
1.2.7.4. Single Use Bioreactors (SUBs) 
The use of SUBs is becoming more prevalent in industry for use in pre-clinical, 
clinical and production scale manufacturing in biotechnology (Eibl et al. 2010). SUBs 
are being used as alternatives to traditional stainless steel bioreactors as the benefits 
of doing so are significant, including operation without the need for clean in place (CIP) 
and sterilise in place (SIP) steps, reducing turnaround times, resources, waste 
generation, validation, space and cost of goods as well as capital expenditure (Galliher 
2007).  
However, there are also limitations with single use bioreactor systems including 
scalability (beyond 2000L), materials compatibility (most notably the concern over 
extractables and leachables), availability of specialised components and regulatory 
and validation concerns (Whitford 2010). Although less significant an issue in some 
reactor designs, oxygen transfer is commonly poor and prediction of kLa is unreliable. 
Enhancing oxygen transfer and prediction of kLa is highly desirable in industry, hence 
SUB designs mimicking traditional STRs as closely as possible are being developed 
and becoming increasingly prevalent.  
Increasing interest and adoption has meant a rise in the number of SUBs in 
development. These differ with regards to the scale of the container, the design 
geometry, the instrumentation and the power input (Eibl et al. 2010). There are three 
main categories of SUBs; non-mechanically agitated bag (such as the Wave™ 
bioreactor), mechanically agitated bag (such as the Xcellerex Disposable Reactor 
(XDR) and rigidly moulded bioreactors that closely mimic STRs, such as the Ambr®250 
system. Each will be looked at briefly here for their advantages and disadvantages, as 
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well as exploring what is currently commercially available. Additionally, the 
mechanically agitated and moulded SUBs will be used in this thesis (Section 5), as 
non-mechanically agitated bioreactors are beyond the scope of this research. 
1.2.7.4.1. Single Use Bags 
There are two categories of single use bag. The ‘pillow’ type, such as the Wave™ 
bioreactor, which is held in place on a rocking platform (Figure 1.8A), responsible for 
generating the mixing and therefore the oxygen mass transfer (Shukla & Gottschalk 
2013). Achievable oxygen mass transfer was initially seen to be poor, with neither the 
2 or the 20L bags exceeding a kLa of 4 hr-1 (Singh 1999). Though this is satisfactory 
for early stage mammalian culture, it would not be sufficient for microbial expression 
systems. Recently, Oosterhuis et al (2013) have noted that they were able to achieve 
kLa values of up to 300h-1 using the CELLtainer system with a two-dimensional rocking 
motion. This would be more appropriate for microbial fermentation. 
The alternative form of single use bag is based on a bag, fitted into a frame or 
cage, inflated before filling and then mixed with mechanical agitation, typically an 
impeller driven either by a motor or magnetically (Figure 1.8B). There are numerous 
examples of these bioreactors commercially available including the BioStat Cultibag 
(Sartorius Stedim), the Appliflex (Applicon), the XDR system (Xcellerex) and the 
Hyclone SUB STR (ThermoFisher). Studies have highlighted the ability of these SUBs 
to match the performance of traditional cell culture bioreactors (Werner et al. 2010; 
Brecht 2009), Again there is little investigation for microbial fermentation, but to say 
that Dreher et al (Dreher et al. 2013) demonstrated the potential for using the BioStat 
Cultibag STR system for E.coli fermentation, however this did require highly adapted 
feeding and gassing strategies. 
1.2.7.4.2. Single Use Bioreactors of Rigid Construction  
Single use bioreactor geometries are becoming increasingly similar to traditional 
stirred tank bioreactors. Initially this was with the transition from one and two-
dimensional rocking bags to mechanical agitation of cylindrical bags within a rigid 
frame. The next stage was the introduction of single use bioreactors of rigid 
construction which would hold a number of advantages for microbial fermentation. The 
potential for increased airflow rates due to higher pressures in the vessel, and 
35 
improvement in sensoring technologies (Isett et al. 2007; Diehl et al. 2015) would both 
be beneficial. 
An early commercially available SUB STR of rigid construction was the Mobius 
CellReady, which operates a marine impeller within a 3L vessel and is capable of 
oxygen mass transfer coefficients in the region of 70h-1 (Nienow et al. 2013). Additional 
data including maximum achievable impeller tip speeds of <0.5ms-1 (Millipore, 2009 
technical data sheet) indicates suitability for mammalian processing, but not microbial 
expression systems. 
 
 
 
 
 
Figure 1.8. WAVE Bioreactor (A) and BioStat Cultibag STR (B). Images courtesy of 
Singh, 1999. and Sartorius.com respectively. 
 
The original Ambr®15 system is a small (15mL) 24 or 48-way parallel bioreactor 
system designed specifically for mammalian processing, achievable kLa values of less 
than 20h-1 (Nienow et al. 2013). More recently, Sartorius have developed a 
fermentation version of the Ambr®15 which uses a Rushton style impeller and 
implements feeding and pH control pumping (Stedim 2016). The Ambr®250 is the 
larger scale (up to 250mL working volume) offering, and is geometrically similar to 
larger scale STRs (Grebe et al. 2014) with a high oxygen mass transfer coefficient (up 
to 500h-1) (Bareither et al. 2013). Two configurations are available, one of which is 
specifically designed for microbial fermentation (two, six-blade Rushton turbine 
impeller), with the system itself designed for 12 or 24 parallel fermentations with 
automated sampling.    
(A) (B) 
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1.2.7.4.3. Observed Oxygen Mass Transfers in SUBs 
Table 1.13. summarises the range of commercially available SUB technologies 
and their capabilities. Most importantly it highlights that some of the recently available 
SUBs are able to provide sufficient OTRs to support microbial fermentation including 
an oxidative bioconversion. 
 
Table 1.13. Configuration and oxygen mass transfer capabilities of commercially 
available single use bioreactors in literature. 
Reactor Working Vol. (L) Bag type 
Mixing 
type kLa (h
-1) 
Wave Bioreactor™ 1-200 Pillow Rocking <10 
CELL-tainer®-20 0.2-2.5 Pillow or Square 2D Rocking >400 
CELL-tainer®-200 5-200 Pillow or Square 2D Rocking >400 
BIOSTAT Cultibag 50-200 Tankliner Stirred >150 
HyPerforma SUB 30-300 Tankliner Stirred >600 
XDR SUB (mamm.) 10-2000 Tankliner Stirred <20 
Mobius® Cell Ready 50-200 Tankliner Stirred <70 
Ambr®15 0.01-0.015 
Moulded PC 
STR Stirred <20 
Ambr®250 0.1-0.25 Moulded PC STR Stirred £500 
Table adapted from Oosterhuis et al, 2013. Bareither et al, 2013. Nienow et al, 2013 
and Jones 2015. PC STR – Polycarbonate Stirred Tank Bioreactor. This table is 
expanded upon in Chapter 5 based on the findings of the work in this section. 
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1.2.8. Common Correlations for Oxygen Mass Transfer  
A number of correlations have been empirically developed for the relationship 
between kLa, power consumption and superficial gas velocity. The equation can be 
generally expressed as: 
:5; = 4 ∙ KLM D⁄ OP ∙ DQR     Equation 1.4. 
Where, Pg is the gassed power consumption (W), Vs is the superficial gas velocity 
(m.s-1) and C, α and β are empirical factors specific to the system under investigation 
Over the last 40 years, a number of studies have determined the coefficients of the 
correlation, however there is significant disagreement between reports (as shown in 
Table 1.14.). Bartholomew (1950) demonstrated that the correlation is dependent on 
the scale of the reactor, which accounts for some of the differences between values, 
but as already discussed (Section 1.2.6.) there are a number of factors which affect 
kLa which these correlations do not take into account. 
After evaluation of similar experiments and their correlations, Van’t Riet (1983) 
concluded that for coalescing air-water dispersion systems, the values fall within 20-
40% when C = 0.026, α = 0.4 and β = 0.5. Therefore, the empirical correlation 
proposed was: 
:5; = 0.026 ∙ KLM D⁄ O/.- ∙ DQ/..    Equation 1.5. 
Table 1.14. Some commonly reported correlations for kLa in stirred tank reactors (2-
2600 L). 
Investigated fluid Correlation with coefficients Reference 
Air-water with ions kLa = 0.224(Pg / V)0.35Vs0.52 Gill et al. 2008 
Air-water with ions kLa = 0.002(Pg / V)0.7Vs0.2 Van’t Riet 1979 
Air-water-sulphite solution kLa = 0.007(Pg / V)0.94Vs0.65 Vilaça et al. 2000 
Air-water kLa = 0.01(Pg / V)0.699Vs0.581 Linek et al. 2004 
Air-water kLa = 0.01(Pg / V)0.475Vs0.4 Smith 1977 
Air-water kLa = 0.031(Pg / V)0.4Vs0.5 Zhu et al. 2001 
Yeast suspension kLa = 1.645(Pg/V)0.5VS0.64 Ni et al. 1995 
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Van’t Riet (1983) went on to describe the correlation of a non-coalescing (salt/ions 
containing) air-water system (Equation 1.6.), though this solution is more comparable 
to fermentation media, the properties are such that the correlation could not be directly 
applied: 
:5; = 0.002 ∙ KLM D⁄ O/.W ∙ DQ/.%    Equation 1.6. 
From these correlations, it can be seen that kLa is larger for water without salt/ion. 
However, kLa tends to be larger in actual fermentation broth. This can be attributed to 
the concentration of salt, the non-Newtonian behaviour of cultures and the presence 
of antifoams, cells and nutrients, none of which are taken into account here. As a result, 
empirical correlations give a misleading representation of kLa in a vessel. 
Nevertheless, the correlations are sufficient for use as a guide prior to experimental 
determination (Stanbury et al. 1995). There is a need for modelling of oxygen mass 
transfer landscapes which can be applied to a broad range of experimental conditions, 
and ideally bioreactor types and scales. This is investigated experimentally in Chapter 
5. 
1.2.9. Techniques for O2 Mass Transfer Quantification 
Experimental methods have been developed over time to try and accurately 
quantify oxygen mass transfer in bioreactors of all scales and geometries. Some of the 
most commonly used are gassing out techniques, gas analysis, sulphite oxidation and 
oxygen limited growth. Each is discussed here, and summarised in Table 1.15. 
1.2.9.1. Static Gassing Out 
Gassing-out techniques involve the measurement of change in dissolved oxygen 
tension (DOT) in a solution during aeration and agitation at known rates (Estrada et al 
2014, Stanbury et al. 1995). During static gassing out, the solution is stripped of oxygen 
by applying nitrogen gas. The liquid is then aerated and agitated and the increase in 
DOT measured using a probe (Wise 1951). 
The following equation describes the increase in DO concentration (CL): 345 367 = 	:5; ∙ (4∗ −	45)    Equation 1.7. 
which, when integrated gives: 
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XY(4∗ −	45) = 	−:5; ∙ 6     Equation 1.8. 
where C* is the saturation concentration of dissolved oxygen. As such, ln(C* – CL) 
can be plotted against time such that the gradient is equal to - kLa, as shown in Figure 
1.9A. 
1.2.9.2. Dynamic Gassing Out 
In the dynamic gassing out method the fermentation broth is deoxygenated using 
the respiratory activity of respiring organisms. A linear decrease in DO concentration 
is achieved. Once the fermentation broth reaches a sufficiently low oxygen threshold 
(typically <5%) the bioreactor is aerated and rise in DO concentration is measured as 
in the static gassing out method (Bandyopadhyay et al. 1967). 
The increase in DO concentration over the period BC, shown in Figure 1.9B, is the 
difference between oxygen transfer into the solution and the uptake of oxygen by the 
respiring culture (Stanbury et al. 1995). This change is expressed by the following 
equation: 345 367 = 	:5; ∙ (4∗ −	45) − Z[\%    Equation 1.9. 
where, x is the concentration of biomass and QO2 is the specific respiration rate 
(moles of oxygen kg-1 biomass s-1). The value of xQO2 is obtained from the gradient of 
line AB in Figure 1.9B. kLa can be found as the negative reciprocal of the gradient, on 
the plot shown in Figure 1.9C. 
1.2.9.3. Gas Analysis 
The amount of oxygen transferred into the solution (difference between oxygen in 
and oxygen out) is directly measured during fermentation. OTR is then determined 
directly using the following equation (Wang et al. 1979): 
$9! =	 (7.32 × 10. D5⁄ ) ∙ ([` ∙ L` ∙ a` 9`⁄ − 	[\ ∙ L\ ∙ a\ 9\⁄ )  Equation 1.10. 
where VL represents the broth volume in the vessel (in dm3), Qi and Qo volumetric 
airflow rates at air inlet and outlet respectively (dm3.min-1), Pi and Po the total pressure 
at the air inlet and outlet (in atm), Ti and To the temperature of the gases at air inlet 
and outlet (in K) and Yi and Yo the mole fraction of oxygen at the inlet and outlet. 
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kLa is then calculated using the equation: 
:5; = $9! (4∗ − 45)⁄      Equation 1.11. 
Although monitoring the living culture directly, there are a number of limitations to 
this method. Firstly, invasive probes are needed as well as large volumes and gas 
flows. Additionally, measurements can only be made when cells are actively 
consuming oxygen and the measurements themselves are limited by the oxygen 
analyser equipment used (Garcia-Ochoa & Gomez 2009). 
1.2.9.4. Sulphite Oxidation 
The sulphite oxidation method, originally described by Cooper et al (1944) is based 
on the reaction of sodium sulphite with dissolved oxygen in the presence of a catalyst 
(typically a copper or cobalt cation). The basic reaction is shown in Equation 1.12. The 
reaction is limited by the rate of oxygen mass transfer, and therefore by sampling the 
reaction and monitoring the rate, the rate of oxygen mass transfer can be calculated 
using a plot of sulphite concentration over time and the Equation 1.13. 
2	b$-%( −	$% − 2	b$c%( = $    Equation 1.12. −34de%Q\c 367 = 2	:5; ∙ 4∗    Equation 1.13. 
Although used in a large number of experimental determinations of oxygen mass 
transfer (Dussap et al. 1985; Ogut & Hatch 1988; Thibault et al. 1990; Yang & Wang 
1992; Benadda et al. 1997; Garcia-Ochoa & Gomez 1998; Liu et al. 2006),there is a 
significant limitation in that the physicochemical properties of the liquids used are fixed 
and differ greatly from fermentation broths, resulting in differences (particularly bubble 
size) which lead to unrealistically high kLa values (Van’t Riet, 1979). It was noted by 
Maier et al (2001) that an update on this method was needed and that the assumption 
that the concentration of oxygen in the sulphite solution is zero is in fact incorrect and 
leads to a significant underestimation in the kLa. A simple adjustment of data to account 
for one or the other would therefore not be sufficient to correct for these errors. 
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Figure 1.9. Plot of ln(C* – CL) vs. time (A), where the gradient is 
equal to - kLa.  %DOT vs. time (B), as generated during the 
dynamic gassing-out method, aeration was ceased at point A and 
then pumped back in from point B. Finally, a plot of CL against 
dCL/dt + xQO2  (C) produced by taking the tangent from figure 1.9B 
BC at given values of CL. This gives a straight line with a gradient 
of  -1/ kLa. 
 
(A) (B) 
(C) 
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1.2.9.5. Oxygen Limited Growth 
Using a strict aerobic microorganism (i.e. one that cannot respire anaerobically), the 
oxygen mass transfer coefficient can be determined using the growth profile of the culture. 
Duetz et al (2000) demonstrated this in 96 deep square well microtiter plates using P. putida 
and observed kLa values of up to 188h-1. The growth rate during oxygen limited growth is 
determined and a conversion factor applied in order to calculate OTR (equal to kLa in this 
oxygen limited environment). 
Although this method has the advantage of measuring the oxygen mass transfer directly 
during culture, making it more likely to provide representative values, there are a number of 
limitations. It is experimentally laborious in comparison with other techniques, but the greater 
issue is that significant assumptions about growth kinetics are required e.g. that the growth 
rate under oxygen limited conditions remains constant during the measurement period. 
1.2.10. Design of Experiments (DoE) 
A Design of Experiments (DoE) approach to experimentation will be used throughout this 
work and so it is important to introduce the basic concepts here. These will be expanded on 
at appropriate points later in the thesis. 
Traditional experimentation is based around a ‘one-factor-at-a-time’ (OFAT) approach, 
where all but a single factor are fixed while an optimal level for the factor under investigation 
is determined (Czitrom 1999). There are a number of drawbacks to this approach including a 
high number of experimental runs and resource demand for a limited gain in terms of 
understanding the system, potential experimental bias based on legacy information 
influencing experimental factors and levels, and no guarantee that the best value for each 
individual factor will result in the optimum set of conditions for the system as a whole due to a 
failure to consider interactions (Montgomery 2017; Lendrem et al. 2015).  
The multifactorial approach however, interrogates the entirety of the experimental space 
without bias, investigating factors and levels in parallel in order to determine, through iteration, 
a true optimum. DoE is a structured approach for determining cause and effect relationships 
which can be applied to any process with measurable inputs and outputs (Anderson & 
Whitcomb 2007). Additional advantages include a reduction in cost and resource demand for 
an experimental campaign (Barker & Milivojevich 2016). Figure 1.10. highlights the difference 
in approach between the OFAT and DoE methodologies for a simple three-factor investigation, 
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including a summary of the experimental demands. 
Although employed in many industries, in particular the process industries for many years 
(Anderson & Whitcomb 2007), use of DoE in biology is less established. This is surprising 
considering the complexity of biological systems, and the advantages that DoE offers in terms 
of identifying the influence of interacting factors. 
Depending on the objective of the experiment, different types of experimental design are 
available which offer distinct advantages and disadvantages of their own. Specific design and 
model approaches will be discussed and justified in the chapters where they are applied. 
 
Table 1.15. Brief overview of the different methods for measurement of the oxygen mass 
transfer coefficient and their advantages and disadvantages for determination of kLa. 
Method Advantages Disadvantages References 
Static 
gassing-out 
Quick, can be used with 
actual fermentation 
media 
Delay in probe response 
time causes error which 
needs to be adjusted for, 
method is limited to 
reactors with height <1 
m, point sampling 
Van’t Riet 
(1979) and 
Rodrigeuz, et 
al., (2014) 
Dynamic 
gassing-out 
Quick, low cost, kLa 
measured with live cells, 
OUR of cells can be 
determined 
All of those seen for 
static method, limited 
range for DO 
measurement (due to 
respiring cells), not 
simple to operate 
Van’t Riet and 
Tramper (1991) 
and Doran 
(1995) 
Oxygen 
balancing 
Steady-state oxygen 
conc. measured, so 
probe response time is 
not an issue, simple 
operation and data 
available online 
Oxygen solubility must 
be known (accurately, 
and conversion to 
engineering units), point 
sampling, only suitable 
for small-scale 
Wang, et al., 
(1979) and 
Doran (2013) 
Sulphite 
Oxidation 
Simple to operate, long 
established and well 
understood 
Physiochemical 
properties of the 
solutions results in 
misleading values, 
assumptions may also 
result in misleading kLa 
values 
Van’t Riet 
(1979), Maier et 
al (2001) 
Oxygen 
limited growth 
Applied to live culture Laborious and significant 
kinetic assumptions 
required 
Duetz et al 
(2000) 
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Figure 1.10. Comparing one-factor-at-a-time (OFAT) (A) and Design of Experiments (DoE) 
(B) experimental approaches in a simple experiment in which three-factors are investigated. 
 
 
1.3. Aims and Objectives 
Biocatalysis is a field that holds considerable potential within biotechnology. It is currently 
implemented in a broad range of industrial manufacturing processes, but with a market size 
and applications which are growing rapidly (Section 1.2.1). 
With the advancement of genetic engineering techniques and the emergence of areas 
such as synthetic biology (Section 1.1), the range of enzymes that can be expressed using 
microbial organisms is constantly expanding. Combined with the fact that microbes are 
relatively cheap and simple to grow (Section 1.2.4.), fermentation is a potential route to the 
manufacture of high value products which until recently had not been available. Expression 
and bioconversion using oxidative biocatalysts in particular appear to be an area of great 
potential, with a broad range of industrial processes either employing or trialling these already 
(Sections 1.2.1.2 and 1.2.2.4).  
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Oxygen is the terminal electron acceptor in aerobic metabolism, meaning it plays a crucial role 
in growth and generation of secondary metabolites and recombinant molecules. The oxygen 
demand of microbial expression systems (Section 1.2.4), not only due to their fast doubling 
times, is significantly higher than most other cell types, meaning that the demand placed on a 
fermentation system during culturing is somewhat greater than for alternative expression 
systems (e.g. mammalian cells). 
Oxygen mass transfer is a complex and multi-faceted issue. There are a broad range of 
factors that have been demonstrated to have an influence on mass transfer, including 
bioreactor hydrodynamics, fluid rheology, the composition of supplied gas and environmental 
factors such as temperature (Section 1.2.6). The effect that these have changes greatly 
relative to one and other, however research to date has focused on using an OFAT approach, 
testing parameters independently. Understanding these factors and how they impact upon 
oxygen mass transfer, both individually and in combination with one and other, is critical in 
determining which bioreactor technologies are appropriate for culturing microbial expression 
systems, and to what extent they can be expected to scale (up or down) to other technologies. 
As such, this thesis will use a multi-factorial approach (Section 1.2.10.), investigating factors 
simultaneously in order to quantify potential interactions. 
There have been a number of techniques developed for the determination of oxygen mass 
transfer coefficients (Section 1.2.9). These include gassing out methods (both static and 
dynamic), sulphite oxidation and oxygen limited growth, all of which have significant 
limitations, and so improved quantification methods are needed. In addition, a number of 
empirical correlations have been developed over the past 40 years using these methods. 
These correlate oxygen mass transfer capabilities with specific bioreactor types and 
geometries, under highly specific conditions. This specificity makes it extremely difficult to 
ascertain the capacity of a system for oxygen mass transfer without experimental 
determination for a particular explicit configuration. Development of multifactorial models, 
which have been rigorously examined for their statistical validity, provide a means by which 
this can be overcome.  
High throughput scale down systems (in particular microtitre plates) are of critical 
importance for early stage bioprocess development and strain screening (Section 1.2.7). 
However, little work has been undertaken on accurate quantification of the oxygen mass 
transfer capabilities of these systems, meaning they are potentially underutilised and their use 
as an accurate scale up mimic is currently limited.   
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Single use bioreactors are gaining momentum in industrial bioprocessing due to their 
versatility, reduced turnaround times and minimisation of validation requirements for steps 
such as cleaning (Section 1.2.7.4). There are a range of different geometries and 
configurations commercially available depending on the demands of the process. However, 
few of these technologies are available at micro- to millilitre scales, with recent advancements 
such as the Ambr®250 one of a limited number of systems capable of providing an 
environment akin to that of a traditional STR. As such it is vital that cheaper, more widely 
adopted technologies are evaluated for their applicability to microbial fermentation. In addition 
to a lack of characterisation with respect to oxygen transfer capabilities, an additional limitation 
on single use bioreactor technologies is cost, and evaluating the resource demand of a 
disposable system. This is significantly more complex than with a traditional bioreactor system 
as, not only are there a large number of consumables to be replaced after each run, but each 
fermentation could conceivably be completely different to its predecessor.  
Multifactorial methods such as design of experiments (DoE) have been applied in a 
number of industries including chemical manufacture for decades, however to date they are 
underutilised in biocatalysis. This is a surprising scenario, as the investigation of multiple 
factors simultaneously would seem ideally suited to a field as complex as biology, where there 
is a large amount of interdependence and in many ways a lack of understanding with regards 
to the biology itself.  
The overall aim of this thesis therefore will be to determine the applicability of commercially 
available SUB technologies for microbial fermentation, particularly those undertaking oxidative 
bioconversions. This will involve evaluation of some widely used scale down technologies as 
well as of some larger, pilot scale single use bioreactors in order to determine their applicability 
with regard to microbial fermentation. All work will be undertaken using multifactorial DoE 
methodologies with a number of different modelling strategies (e.g. optimisation, predictive 
landscapes) in order to comprehensively characterise the experimental space and determine 
the validity of the models developed and conclusions drawn.  
• The initial objective was to establish a multifactorial methodology and strategy to 
optimise microbial fermentation in terms of growth and (oxidative) biocatalytic 
productivity in microwells. This optimised process would then be scaled into bench top 
stirred tank bioreactors so as to experimentally determine the maximum oxygen 
demand under different operating strategies. A whole cell P450 monooxygenase 
(P450SU2) in E.coli was used as a model system due to the potential commercial 
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applicability, challenges regarding provision of sufficient oxygen and the previous work 
done with this enzyme (Section 1.2.2). These findings could then be used to evaluate 
the relative rates of oxygen utilisation for cell maintenance, growth and bioconversion. 
The results of this work are described in Chapter 3. 
• The second objective is to improve the current level of understanding and to improve 
the accuracy of oxygen mass transfer rate quantification in microwell plates. An 
improvement on the traditional dynamic gassing out method will be developed based 
on the limitations observed in the literature (Section 1.2.9.). This will improve 
understanding of the mechanism of oxygen mass transfer in plates by evaluating the 
truly dynamic nature of the fermentation culture, and endeavour to capture the change 
in environment across a multifactorial experimental design, rather than under a 
selection of individual, idealised scenarios. Additionally, an attempt will be made to 
achieve equivalent culture performance across different plate formats (from 96 to 24 
DSWs) using the methodology developed here. The results of this work are presented 
and discussed in Chapter 4. 
• Subsequently, it will be necessary to evaluate the oxygen transfer capabilities of 
several commercially available SUB systems to undertake microbial fermentation by 
interrogating their oxygen mass transfer capabilities. The SUBs will be characterised 
in comparison with a traditional bench top STR, across multifactorial experimental 
landscapes which will comprise a range of widely used fermentation conditions, both 
in terms of the mechanical process parameters, but also the commonly overlooked 
media aspects. The results of this work are elaborated in Chapter 5. 
• Once the validity of using a single use bioreactor system for microbial fermentation 
was established, the final objective was to develop a tool for evaluation of the economic 
feasibility and sensitivity. This tool will approximate the consumables and resource 
commitment for a single fermentation run and estimate the associated cost, allowing it 
to be used for project costing and a rapid cost benefit analysis of a given fermentation 
investigation against the anticipated outputs. The results of this work are deliberated 
in Chapter 6. 
In addition to the above, Chapter 2 describes the materials, equipment and experimental 
methods used during this work; in particular operation and control of a number of fermentation 
systems, including the Ambr®250 high throughput and the New Brunswick BioFlo 310. 
Methodologies developed throughout the work are included in Chapters 3 to 7. Conclusions 
and suggestions for future work building on these studies are discussed in Chapter 7. 
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2. Materials and Methods 
 
2.1. Introduction 
The chapter describes the materials and methodologies used in this research. Section 2.2. 
outlines the materials used, while Section 2.3. describes the equipment used, with a focus on 
the bioreactors investigated. Section 2.4. outlines the general experimental methods including 
preparation of fermentation media both for culturing and oxygen mass transfer investigation 
and establishing master and working cell banks. Section 2.5. covers the experimental methods 
used for optimisation and scale up of a whole cell oxidative bioconversion using multifactorial 
methods, while Section 2.6. outlines the methods used for developing an accurate oxygen 
mass transfer characterisation methodology. Section 2.7. describes the methods used for 
oxygen mass transfer characterisation in single use bioreactors. Finally, Section 2.8. details 
the analytical equipment and methods used throughout this thesis. 
2.2. Materials 
2.2.1. Chemicals 
7-ethoxycoumarin (99.45%), 7-hydroxycoumarin (≥98%), yeast extract (premium grade), 
tryptone, glycerol (≥99%), glycerol solution (84-89%), ampicillin sodium salts (>91%), 5-
aminolevulonic acid (ALA) (~98%), iron III chloride (FeCl3) (97%), isopropyl-β-D-1-
thiogalactoside (IPTG) (≥99%), polypropylene glycol (PPG), potassium phosphate monobasic 
(KH2PO4) (≥98%), potassium phosphate dibasic (K2HPO4) (≥98%), poly-propylene glycol, 
acetonitrile and trifluoroacetic acid (TFA) (99%) were obtained from Sigma-Aldrich Company 
Ltd (Poole, UK). Chloramphenicol (≥99%) was obtained from Fluka (Poole, UK). Sodium 
chloride (general purpose grade) was obtained from Fischer Scientific (Loughborough, UK). 
2.2.2. Microorganisms 
E. coli BL21 Star (DE3) pLysS [pQR368] expressing the cytochrome P450 
monooxygenase P450SU2 were generously provided by J.Baboo (Department of Biochemical 
Engineering, University College London, UK), having been described previously by Hussain 
and Ward (2003).  
E. coli Top10 expressing CometGFP from DNA2.0 was kindly provided by Synthace Ltd. 
(London, UK). 
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2.3. Equipment 
2.3.1. Bioreactors 
Three stirred tank bioreactors are used during this work: a BioFlo 310 from New Brunswick 
(Eppendorf, Germany), an XDR-10 single use bioreactor from Xcellerex (GE Healthcare, USA) 
and an Ambr®250 bioreactor system from TAP biosystems (now Sartorius-Stedim Biotech, 
GmbH, Goettingen, Germany). Table 2.1 highlights the key properties of the three bioreactors. 
The major engineering characteristics of the reactor types, with regard to oxygen mass 
transfer, are compared in the following sections. 
2.3.1.1. Gas Supply  
One of the most important factors for oxygen mass transfer in terms of reactor design is 
the supply of gas, and the main source of this is through sparging (Kaster et al. 1990). Each 
of the bioreactors interrogated have different sparger types which influence the gassing 
capabilities, including flowrates, bubble size and residence times (Bareither et al. 2013, Minow 
et al. 2014, New Brunswick Scientific, 2008). 
The BioFlo 310 has a perforated ring sparger which enables a wide range of gas flowrates 
(up to 10Lmin-1) and supplies gas directly to the impeller region resulting in good bubble 
breakup and distribution. For maximising oxygen mass transfer this would be the preferred 
arrangement. The Ambr®250 has an open tube sparger, meaning that bubble size at the 
sparger tip is more strongly controlled by gas flow rate, and breakup of bubbles and their 
distribution is reliant on having a well-mixed environment. The XDR differs again, with four frit 
spargers positioned directly below the impeller, this allows the control of flowrate and bubble 
size from the gas inlets (as any combination of the four spargers can be used). 
2.3.1.2. Geometries  
The XDR and the BioFlo have similar reactor geometries (aspect ratios of 1.47 and 1.46 
respectively), while the Ambr®250 has a higher ratio at 2.0. The impeller ratios (Di/Dv) of the 
two reactors containing Rushton impellers are similar, 0.29 for the BioFlo and 0.33 for the 
Ambr®250, which is close to the figure classically seen for STRs employing Rushton turbines 
(Chisti & Moo-Young 2001). The pitch blade impeller however has a higher ratio (0.41), most 
likely to try and gain optimal mixing and gas distribution with the less shear intensive impeller 
design. 
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2.3.1.3. Impeller Configurations 
Both the BioFlo and the Ambr®250 are fitted with dual, six blade Rushton turbine impellers, 
highly effective at energy input and dissipation (and therefore bubble distribution) and more 
common in microbial bioreactors where shear stress is not such a concern and oxygen 
demands are higher. The pitch blade impeller used in the XDR is much less effective at bubble 
breakup however the positioning directly over the impellers and the use of different pore sizes 
on the frit spargers should aid in overcoming this. 
2.3.1.4. Probe Type and Data Recording  
The determination of oxygen mass transfer rates rely heavily on the sensors used to 
measure dissolved oxygen (Najafpour 2015). As such it is important to comment on the type 
of probes used in each reactor type and how this information in recorded. Both the XDR and 
the BioFlo use traditional polarographic probes, while the Ambr®250 employs a DO sensor 
spot (PreSens Precision Sensing GmbH, Germany) and optical sensor, and although probe 
response time is taken into consideration for calculations, to directly compare, ideally this 
would not change between reactors. 
Additionally, each of the reactor types uses proprietary software whereby the interrogation 
of the data requires exporting in different file formats and use of an additional software 
package to compile structured data tables which can then be analysed. The recording of 
dissolved oxygen tension is carried out at different frequencies (every 12 seconds for the 
Ambr, up to 8 seconds for the BioFlo). This arrangement also requires significant reworking 
of the raw data. 
2.3.1.5. Bioreactor Configurations 
Each of the reactor types have different configurations with respect to their physical and 
engineering characteristics. Although some properties are shared, each of the bioreactors 
differs in terms of either their geometry or the gassing and mixing set up. Based on these 
arrangements, the limitations of the system set up (including agitation speed and gas flow 
restrictions), and using literature information and prior knowledge, the oxygen mass transfer 
capabilities of each of the reactors relative to one and other can be hypothesised. 
The BioFlo 310 is likely to provide the greatest kLa. It is configured with the preferred 
combination of features for oxygen mass transfer with Rushton impellers, perforated ring 
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sparger and the polarogrpahic probe. It is also reasonable to expect that the Ambr®250 will 
provide good oxygen mass transfer with the impeller type and ratio similar to that of the BioFlo 
and the potential for high agitation and airflow rates. The main properties which may restrict 
the kLa are the open tube sparger and the optical probe, although good mixing and repeat 
readings to give confidence in the data should limit the effect of these. 
The XDR10 however, has an inferior impeller type, limitations on the airflow rates (due to 
the plastic bag construction and maximum pressure), and agitation rates, and although the frit 
sparger has the potential for ensuring small bubbles at entry to the culture this is unlikely to 
overcome the other restrictions and so the rate of oxygen mass transfer is likely to be low 
(relative to the BioFlo and the Ambr). 
2.3.2. Additional Culture Vessels and Equipment 
100 and 500mL glass Erlenmeyer flasks (unbaffled) and 100 and 500mL polycarbonate 
Erlenmeyer flasks (baffled and unbaffled) were supplied by Corning (NY, USA). A Kuhner 
Shaker X Orbital shaker (Kuhner, Basel, Switzerland) and Thermomixer Comfort (Eppendorf, 
Hamburg, Germany) were used for orbital shaking of culture vessels. 1.5 and 2.0mL sterile 
Eppendorf tubes, 96 Deep Square Well (DSW) plates and 24 Deep Square Well (DSW) plates 
were obtained from Starlab (UK) Ltd (Milton Keynes, UK). 24 Deep Square Well Oxodish 
Plates were supplied by PreSens. 
Analytical equipment is described in Section 2.8. 
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Table 2.1. Properties and geometries of the three bioreactors in which oxygen mass transfer 
rates are investigated. Images courtesy of New Brunswick BioFlo310 Guide to operations, 
Bareither et al, 2013 and GE life science XDR-10 data sheet. 
Bioreactor 
Image 
Properties 
 
Total volume (L) 7.5 
Diameter (vessel): Dv (m) 0.23 
Height (vessel): Hv (m) 0.41 
Diameter (impeller): Di (m) 0.08 
Aspect ratio: (Hv/Dv) 1.46 
Impeller ratio: (Di/Dv) 0.29 
Impeller type 2 x 6-blade Rushton turbine 
Sparger type Perforated ring 
 
Total volume (L) 10 
Diameter (vessel): Dv (m) 0.32 
Height (vessel): Hv (m) 0.47 
Diameter (impeller): Di (m) 0.13 
Aspect ratio: (Hv/Dv) 1.47 
Impeller ratio: (Di/Dv) 0.41 
Impeller type Single, base mounted 4x pitch blade 
Sparger type 4x frit sparger of 2x pore size 
 
 
Total volume (L) 0.25 
Diameter (vessel): Dv (m) 0.06 (at base) 
Height (vessel): Hv (m) 0.12 
Diameter (impeller): Di (m) 0.02 
Aspect ratio: (Hv/Dv) 2.0 
Impeller ratio: (Di/Dv) 0.33 
Impeller type 2 x 6-blade Rushton turbine 
Sparger type Open tube 
 
BioFlo 310 
XDR-10 
Ambr®250 
 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Mechanical drawing of New Brunswick BioFlo310 stirred tank bioreactor. 
Additional information on dimensions and configuration of the bioreactor can be found in Table 
2.1. (image courtesy of the New Brunswick BioFlo310 guide to operations). 
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Figure 2.2. Mechanical drawing of tank liner for the Xcellerex XDR-10 single use bioreactor. 
Dimensions shown are in inches. Additional information on dimensions and configuration of 
the bioreactor can be found in Table 2.1. (image courtesy of the GE life science XDR-10 data 
sheet). 
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Figure 2.3. Mechanical drawing of Ambr®250 single use bioreactor. Dimensions shown are in 
millimetres. Additional information on dimensions and configuration of the bioreactor can be 
found in Table 2.1. (image modified from Bareither et al, 2013). 
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2.4. General Methods 
2.4.1. Preparation of Fermentation Media 
Growth media both for fermentation and oxygen mass transfer investigations was prepared 
as follows, with additional media requirements commented on when relevant. Typical 
fermentation media prepared were as follows: 
• Luria-Bertani (LB) Growth Media – 10gL-1 tryptone, 10gL-1 sodium chloride, 5gL-1 yeast 
extract, 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-1 ampicillin 
(antibiotics added after media sterilisation) 
• Terrific Broth (TB) – 12gL-1 tryptone, 24gL-1 yeast extract, 4mL.L-1 glycerol, 10mgL-1 
chloramphenicol (pre-dissolved in ethanol) and 100mg.L-1 ampicillin (antibiotics added 
after media sterilisation) 
• 40% v/v glycerol solution – 40mL glycerol, 60mL ddH2O, mixed and 0.2 micron sterile 
filtered 
• Additional media were prepared in accordance with DoE designs generated 
throughout the thesis (e.g. in Chapter 3). Further details will be provided where 
relevant, while the method for preparation remains the same as for standard media.  
Once prepared, all growth media were autoclaved on a liquid cycle to 121ºC and held for 20 
minutes in order to ensure sterility. 
2.4.2. Preparation of Cell Banks (Master and Working Stock Generation)  
Generation of master and working cell banks in order to secure the strains used is 
essential to ensure consistency in the biology and so that work can continue on the organisms 
beyond this thesis. 
2.4.2.1.  E. coli [pQR368] 
A 1mL frozen stock of E. coli [pQR368] was inoculated into a 100mL baffled shake flask 
containing 19mL LB growth media with chloramphenicol and ampicillin under sterile 
conditions. The shake flask was incubated for 16 hours overnight at 200rpm and 37°C in an 
orbital shaker. 40 % v/v glycerol solution was added to the overnight culture in a 1:1 ratio (20 
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% v/v final glycerol concentration) and 1mL aliquots were aseptically transferred to sterile 
Eppendorf tubes before storage in a -80°C freezer. 
2.4.2.2. E. coli Top10 expressing CometGFP 
A 1mL frozen stock of E. coli Top10 CometGFP was inoculated into a 500mL baffled shake 
flask containing 99mL LB growth media with kanamycin under sterile conditions. The shake 
flask was incubated for 16 hours overnight at 200rpm and 37°C in an orbital shaker. Stocks 
were then prepared as outlined in Section 2.4.2.1. 
2.4.3. Multifactorial Experimental Design Methods (DoE) 
Of critical importance to all investigations undertaken in this thesis is the use of 
multifactorial, design of experiment methodologies (Tabora & Domagalski 2017). 
Characterisation of many systems, be they biological or physical has traditionally been 
undertaken using a ‘one factor at a time’ approach which does not take into consideration 
interactions between factors affecting the system and as such may lead to inaccurate 
optimisation for a desired response (Lendrem et al. 2015). 
2.4.3.1. Selection of Factors 
Throughout this thesis, factors and experimental ranges for multifactorial designs are 
selected on the basis of the objective of the experiments, the factors themselves and the 
limitations of the apparatus used. Additional detail on the selection of particular factors and 
ranges is included where relevant throughout the thesis. 
2.4.3.2. Analysis and Influence on Subsequent Design 
Analysis of DoE designs and models throughout this thesis is carried out using JMP 
versions 10 to 13 (SAS Institute, North Carolina, USA) or Design Expert version 8 or 9 
(Statease, Minneapolis, USA). The basic mathematics and statistical analysis underpinning 
each is the same, and both provide the opportunity to examine the statistics and analysis of 
variance (ANOVA) in order to explore the validity of parameters and models as a whole. 
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2.4.3.3. Design Ethos and Progression 
2.4.3.3.1. Screening 
In an initial screening design, many factors are included and the ranges set as wide as 
possible in order to determine which of the factors and combinations of factors have a 
statistically relevant effect. The large number of factors are used to construct a relatively 
sparse design as the objective is to find any response away from the normal distribution. In 
this work initial screening designs employed up to 10 factors. 
2.4.3.3.2. Refinement 
A reduced number of factors and refined ranges are used in order to explore a different 
area of design space based on the outputs of the screening experiment (in this case between 
5 and 7 factors). This should help in the progression towards an optimum. 
2.4.3.3.3. Optimisation 
In order to determine the local optimum, the number of factors are reduced again and the 
ranges set around where the optimum is perceived to be from the first two stages (screening 
and refinement). The design will often include axial, face residing and centre points in order 
to look for curvature in the response surface (Box et al. 2005). Potential design types include 
Response Surface Method (RSM), Definitive Screening Design (DSD) or composite designs 
(Tabora & Domagalski 2017; Candioti et al. 2014). The number of factors included in 
optimisation designs ranged from 3 to 4. 
2.5. Methods for Optimisation and Scale Up of a Whole Cell Oxidative Bioconversion 
Multifactorial experimental designs for the studies outlined in Sections 2.5.1. to 2.5.3. are 
summarised in Table 2.2.  
2.5.1. Screening Investigation (DoE 1) 
2.5.1.1. Additional Materials 
Additional materials required for DoE 1 are described here. Four media of differing 
compositions (A-D) were investigation, based on the initial composition of TB medium (Section 
2.4.1). Media A comprised 12gL-1 tryptone, 10gL-1 yeast extract, 4mLL-1 glycerol, 10% v/v 
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Phosphate Buffer Solution (pre-sterilised using a 0.2µm filter) 10mgL-1 chloramphenicol (pre-
dissolved in ethanol) and 100mgL-1 ampicillin (antibiotics added after media sterilisation). 
Media B was made up of 12gL-1 tryptone, 10gL-1 yeast extract, 4mLL-1 glycerol, 10mgL-1 
chloramphenicol (pre-dissolved in ethanol) and 100mgL-1 ampicillin (antibiotics added after 
media sterilisation). Media C was composed of 12gL-1 tryptone, 30gL-1 yeast extract, 4mLL-1 
glycerol, 10% v/v Phosphate Buffer Solution (pre-sterilised using 0.2µm filter) 10mgL-1 
chloramphenicol (pre-dissolved in ethanol) and 100mgL-1 ampicillin (antibiotics added after 
media sterilisation). Media D comprised of 12gL-1 tryptone, 30gL-1 yeast extract, 4mLL-1 
glycerol, 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-1 ampicillin 
(antibiotics added after media sterilisation). 
2.5.1.2. Inoculum Preparation 
Preparation of fermentation inoculum for all microwell fermentations was as described in 
Section 2.4.2. However, TB media was used instead of LB media. 
2.5.1.3. Microwell Fermentation 
A nine-factor design of experiments investigation with 64 runs was designed using Design 
Expert 8® software. The layout of the design can be seen in Appendix 1.1. additional figures 
will be used to aid in the explanation of the experimental method. 
To begin, 500µL of the appropriate media (A-D) was added to each of 96 wells across four 
96 DSW plates; into the remaining wells, 500µL of sterile water was added to reduce heat loss 
during the process. The layout of media in each well can be seen in Appendix 1.2. The plate 
was covered during the process with a breathable, hydrophobic rayon seal (Starlab (UK) Ltd) 
in order to minimise evaporation. 5 µL of the overnight inoculum was added to each of the 
wells containing media and shaken at 37°C and 300 or 1100rpm in an Eppendorf Thermomixer 
Comfort. The arrangement is displayed in Appendix 1.2. After 2 hours, the temperature in two 
of the thermomixers was reduced to 25°C, after which 1mM ALA and 0.5mM FeCl3 was added 
to half of the cultures. The same wells were then induced using 1mM IPTG and after 10 
minutes 0.1 or 1mM 7-ethoxycoumarin (pre-dissolved in ethanol) was added to half of the 
induced cultures (as shown in Appendix 1.1. for wells). One half of the wells were then 
increased to a volume of 1mL using inoculated culture in additional wells. After a further hour, 
0.1 or 1mM 7-ethoxycoumarin (pre-dissolved in ethanol) was added to the other induced wells. 
The remaining wells were induced after an additional two hours, and the timing pattern of 
volume increase and substrate addition is repeated for these wells. Eight hours after their 
 60 
induction, half of the cultures were harvested, the OD recorded as a measure of culture growth 
(as described in Section 2.8.2.1) using a Cecil Aquarius Spectrophotometer (Cecil Instrument, 
Cambridge, UK), and the product of the bioconversion (7-hydroxycoumarin) measured using 
a Dionex HPLC system as described in Section 2.8.3. The remaining wells are harvested 65 
hours after induction and the same measurements of OD and product concentration 
measured. 
2.5.2. Refinement Investigation (DoE 2) 
2.5.2.1. Additional Materials 
Four media of differing composition for investigation, based on the outputs of the first round 
of investigation (Section 3.2.1.) were required. Media A was made up of 12gL-1 tryptone, 25 
gL-1 yeast extract, 4mLL-1 glycerol, 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 
100mgL-1 ampicillin (antibiotics added after media sterilisation). Media B was composed of 
12gL-1 tryptone, 25gL-1 yeast extract, 4mLL-1 glycerol, 10% v/v Phosphate Buffer Solution (pre-
sterilised using 0.2µm filter) 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-
1 ampicillin (antibiotics added after media sterilisation). Media C comprised 12gL-1 tryptone, 
40 gL-1 yeast extract, 4mLL-1 glycerol, 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 
100mgL-1 ampicillin (antibiotics added after media sterilisation). Media D was made up of 
12gL-1 tryptone, 40gL-1 yeast extract, 4mLL-1 glycerol, 10% v/v Phosphate Buffer Solution (pre-
sterilised using 0.2µm filter) 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-
1 ampicillin (antibiotics added after media sterilisation). 
2.5.2.2. Microwell Fermentation 
A seven-factor design of experiments investigation with 64 runs was designed using 
Design Expert 8® software. The layout of the design is shown in Appendix 1.3. 
The method for the experiment is similar to that in Section 2.5.1. but was carried out in two 
96 DSW plates. After 50 hours half of the wells are harvested, the OD recorded as a measure 
of growth (as described in Section 2.8.2.1.) using a spectrophotometer and the product of the 
bioconversion (7-hydroxycoumarin) measured using HPLC as described in Section 2.8.3. 
After a further 25 hours the remaining wells are harvested and the same OD600 and product 
concentration measurements taken.   
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Table 2.2. Experimental designs used for multifactorial optimisation of a P450 whole cell oxidative bioconversion in microwells. This table 
summarises experiments performed in three stages (1: Screening, 2: Refinement, 3: Optimisation). 
 
DoE 
Round Factor     Factor Name Unit 
Range 
Low High Change 
1 
A Post Induction Time hr 8 65 - 
B Substrate Concentration mM 0.1 1.0 - 
C Post Induction Volume mL 0.5 1.0 - 
D Pre-Induction Time hr 2 5 - 
E Bioconversion Temperature °C 25 37 - 
F Substrate Addition Time (Post Induction) hr 0.17 1.0 - 
G Yeast Extract Concentration gL-1 25 40 - 
H Buffered Media - No Yes - 
J Orbital Shaking Speed rpm 300 1100 - 
2 
A Post Induction Time hr 50 75 Higher 
B Substrate Concentration mM 0.75 1.25 Higher 
C Post Induction Volume mL 0.5 1.0 No change 
D Pre-Induction Time hr 2 5 No change 
E Yeast Extract Concentration gL-1 25 40 Higher 
F Bioconversion Temperature °C 22 30 Lower 
G Buffered Media - No Yes No change 
3 
A Substrate Concentration mM 0.75 1.0 Lower 
B Yeast Extract Concentration gL-1 40 50 Higher 
C (Post Induction Time) hr 0 75 Continuous time course 
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2.5.3. Optimisation Time course (DoE 3) 
2.5.3.1. Additional Materials 
Three media of differing composition were required, Media A was made up of 12gL-1 
tryptone, 50gL-1 yeast extract, 4mLL-1 glycerol, 10% v/v Phosphate Buffer Solution (pre 
sterilised using 0.2µm filter) 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-
1 ampicillin (antibiotics added after media sterilisation).Media B was composed of 12gL-1 
tryptone, 40gL-1 yeast extract, 4mLL-1 glycerol, 10% v/v Phosphate Buffer Solution (pre 
sterilised using 0.2µm filter) 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-
1 ampicillin (antibiotics added after media sterilisation). Media C comprised of 12gL-1 tryptone, 
45gL-1 yeast extract, 4mLL-1 glycerol, 10% v/v Phosphate Buffer Solution (pre-sterilised using 
0.2µm filter) 10mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100mgL-1 ampicillin 
(antibiotics added after media sterilisation). 
2.5.3.2. Microwell Fermentation 
A two-factor central composite face-centred (CCF) DoE investigation with four centre 
points (eight runs total) was designed using Design Expert 8® software. The experiment was 
also designed to run over a 75 hour time course, with harvesting at selected time points using 
the sacrificial well approach. The layout and arrangement of the design can be seen Appendix 
1.4. 
To begin, 1 mL of the appropriate media (A-C) was added to each of 96 wells across a 96 
DSW plate. Microwell experiments were then performed as described in Section 2.5.1. with 
the following modifications. After 2 hours, the temperature was reduced to 30°C, after which 
1mM ALA and 0.5mM FeCl3 were added. The cultures were then induced using 1mM IPTG 
and after 10 minutes 0.75, 0.88 or 1mM 7-ethoxycoumarin (pre-dissolved in ethanol) was 
added to the induced cultures. After 5 hours, the first column of wells was harvested (see 
Appendix 1.5.), the OD recorded as a measure of culture growth (as described in Section 
2.8.2.1.) using a spectrophotometer, and the product of the bioconversion (7-
hydroxycoumarin) measured using HPLC as described in Section 2.8.3. Additionally, samples 
were taken and prepared for a free glycerol assay as described in Section 2.8.4. 
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2.5.4. Scale Up Fermentation 
2.5.4.1. Overnight Inoculum 
In order to ensure continuity of the fermentation inoculum, the inoculum preparation 
process described in 2.5.1.2. was also used for 7.5L scale up fermentation inoculum 
preparation. However, in order to secure sufficient material for the inoculation of the stirred 
tank reactors, a 500mL flask was used containing 99mL of TB. 
2.5.4.2. 7.5L Fermenter Operation 
For the scale up fermentation, a 7.5L (New Brunswick Scientific Co, New Jersey, USA) 
0.18m internal diameter bioreactor with aspect ratio (Hv/Dv) and impeller ratios (Di/Dv) of 1.6 
and 0.3 respectively was used. This bioreactor is geometrically and operationally similar to the 
BioFlo310 described in Section 2.3.1. Agitation was provided by two six-blade Rushton turbine 
impellers connected to a top-driven impeller shaft. The bioreactor was filled with an optimised 
TB medium (with 40gL-1 yeast extract instead of the standard 24 gL-1) containing 10% v/v 
phosphate buffer solution (starting volume 3 L) and 0.5mLL-1 PPG.  
The dissolved oxygen tension (DOT) probe was calibrated between 0% in pure nitrogen, 
and 100% in gaseous air.  The pH probes were calibrated using standard pH 4 and 7 buffers. 
The probes were installed into their respective ports and the whole vessel was sterilised by 
autoclaving at 121°C for 20 minutes. After removal from the autoclave and cooling, 100mgL-1 
ampicillin (0.2 micron filtered) and 10mgL-1 chloramphenicol (pre-dissolved in ethanol) were 
added to the vessel. 12.5% ammonia solution and 10% phosphoric acid were transferred to 
the base and acid addition bottles respectively, for control of pH as necessary. The pH probe 
underwent an offline check of the media pH, and the DOT probe a final review, and both were 
recalibrated as appropriate if necessary. The conditions of the bioreactor were set to 37°C, 
750rpm, pH7.0 and 1vvm (in this case 3 Lmin-1) air addition.  
The vessel was inoculated with 1% v/v of the working volume of the reactor from the 
overnight inoculum culture. The operating conditions were selected based on a Reynolds 
number (Re) number in the turbulent region, and are consistent with those selected for work 
previously carried out with this cell line (Baboo, 2012). The pH was both monitored and 
controlled, as previously direct comparison with the microwell has been carried out and the 
purpose of this experiment was both to attempt to demonstrate scalability from microwells, 
whilst also determining if this bioconversion would be enhanced by utilising some of the 
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features that are offered by the scale up fermenter. 2 hours after inoculation, the temperature 
was reduced to 30°C and the agitation rate to 600rpm as the conditions for enzyme expression 
and bioconversion. Once the temperature had reduced, 1mM ALA and 0.5mM FeCl3 were 
added to the reactor as components which have been shown to enhance the P450 expression 
and the bioconversion. After this, the culture was induced using 1mM IPTG and after 10 
minutes 1mM 7-ethoxycoumarin (pre-dissolved in ethanol) was added as the bioconversion 
substrate. The culture was then run for a total of 28 hours with samples taken periodically for 
OD readings as a measure of culture growth as described in Section 2.8.2.1. and 500µL 
aliquots taken for offline bioconversion product quantification by HPLC as described in Section 
2.8.3. 
2.5.4.3. Quantification of Bioreactor Inlet and Outlet Gas Compositions 
Quantification of bioreactor inlet and outlet gases during fermentation in the 7.5L New 
Brunswick bioreactors required reconfiguration of the gassing set up in the Advanced Centre 
for Biochemical Engineering (ACBE, University College London) fermentation facility. The new 
set up is as shown in Figure 2.4. The accurate quantification of inlet and outlet gas 
compositions was crucial for determining oxygen uptake rates under different fermentation 
conditions (Garcia-Ochoa et al, 2009), and as such understanding the demands of the 
expression system on the culture environment. 
 
 
 
 
 
Figure 2.4. Diagrammatic representation of the rearranged gas measurement set up in the 
UCL ACBE fermentation suite to allow accurate quantification of inlet and outlet gas 
compositions from the bench top STR. 
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Table 2.3: Experimental design for oxygen mass transfer rate determination in 24 deep square 
well microtitre plates (Section 2.6.2.). 
 Factor 
Fill volume (mL) Agitation rate (rpm) Culture Temp. (°C) OD600 
Lo 1.6 200 30 
0,1,5,10,20,50 
Hi 3.2 250 37 
 
2.6. Methods for Developing Accurate Oxygen Mass Transfer Characterisation in 
High Throughput, 24 Microwell Plates 
For measuring online dissolved oxygen tension in microwell plates, the PreSens Oxodish 
system was used, with the set up as shown in Figure 2.5. The Duetz clamp system (Duetz et 
al. 2000) was also used in order to hold the Sensordish® Reader with the Oxodish placed on 
top and the microwell plate held in position above that. Where possible during microwell 
determination of kLa, experiments were carried out in duplicate in order to ensure that data 
was representative. 
 
 
Figure 2.5. Diagrammatic representation of the set 
up for online dissolved oxygen measurement in 24 
DSW Oxodish plates (image courtesy of PreSens 
GmbH) 
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2.6.1. Inoculum Preparation 
As with previous experiments, the inoculum is generated as described in Section 2.5.1.2.  
2.6.2. Fermentation in 24DSW PreSens Plates for Establishing the Baseline Model 
When building the initial linear model for kLa, a four factor, two level, full factorial design 
was used, with the design blocked for each biomass concentration, with the intention of 
generating a linear model. The design can be seen in Table 2.3. Each design point was 
replicated in the plate. 
The evening prior to inoculation, wells of a 24 Deep Square Well Oxodish were filled with 
the appropriate volume of media, covered with a breathable seal, a rubber seal with holes 
above the location of each well to allow gas exchange and a metal lid also with holes above 
the well locations, before being incubated overnight in a floor standing shaking incubator in 
order to ensure sterility prior to inoculation. During this time the online DOT recording is also 
started in order to allow readings to stabilise prior to calibration. Each well was inoculated with 
overnight culture grown for 16 hours (as described in Section 2.5.1.2.), and the microtitre 
plates incubated at the temperatures and agitation rates according to the experimental design 
(Table 2.3.). Starting biomass concentrations were achieved by measuring the OD600 of the 
overnight culture and calculating the required proportional volume to give a desired OD600. In 
the case of higher ODs, concentration of the culture using bench top centrifugation was 
required before resuspension in media at a higher concentration, followed by immediate 
inoculation into the wells. Three hours post inoculation, the culture is induced with 2mM L-
Rhamnose for the expression of CometGFP (from DNA 2.0). The culture was then continued 
for a further 27 hours with online readings recorded.  
2.6.3. Fermentation in 96 and 24DSW PreSens Plates for Developing an Improved 
Quantification Method for Oxygen Mass Transfer  
E. coli cultures in 24DSW plates for establishing an oxygen mass transfer model were 
carried out as described in Section 2.6.2. with the exception of the factors and ranges as part 
of the experimental design. These are highlighted in Table 2.4. 
Fermentations in 96 DSW plates for comparison with the larger scale 24 DSWs were also 
undertaken as described in Section 2.6.2. with the exception of the orbital shaker (a 
Thermomixer comfort) and the corresponding agitation rates. Proportional differences are also 
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made in the set up and experimental design, in line with the difference in well volume. The 
experimental design is outlined in Table 2.4. Further information regarding how the 
experimental data generated was processed and analysed for building the model of oxygen 
mass transfer in 24 DSW plates is covered in Chapter 4. 
2.6.4.  Determination of OUR and kLa from online DOT Profiles 
In order to quantify OUR and kLa using the online dissolved oxygen measurements, the 
following analysis was undertaken. 
Once the DoE experiments were performed (Section 4.3.) and the DOT profiles extracted 
from the PreSens monitoring software, the raw DOT profiles were normalized to 100% 
saturation, before being converted to engineering units (mgO2L-1) using the appropriate 
saturation concentration of oxygen for the corresponding temperature at that point in design 
space (Rice et al. 2012). 
OUR is calculated during the time at which the mixing of the system has been stopped 
and therefore it is assumed that there is zero mass transfer of oxygen into the liquid (i.e. kLa 
= 0) and therefore Equation 2.1. can be simplified such that OUR = dCL/dt (see (A) in Figure 
2.6.). kLa is then determined during the phase where mixing has been restarted in the system 
(see (B) in Figure 2.6.) and therefore oxygenation of the system is also returned. By plotting 
CL against dCL/dt + OUR, kLa is determined from the gradient of the slope. 
These values can then be used in order to determine factors that influence the oxygen 
mass transfer rate and generate baseline models for both OUR and kLa. 
 
!"# = %&'()∗ − )&) + ./0.1      Equation 2.1. 
%&' =	 3456789:;0<9= >?(/∗7	/0)       Equation 2.2. 
 
Where C* is the saturation concentration of O2, CL is the oxygen concentration in the first order 
system at a given time, d(CL)/dt represents the first derivative of oxygen concentration with 
respect to time. 
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Figure 2.6. Example DOT profile demonstrating the effect of ceasing aeration (A) and 
restarting it (B) during the dynamic gassing out method. Figure 2.6. also illustrates how OUR 
and kLa are calculated respectively. 
Figure 2.7. Representative example experimental DOT profiles used for analysis. (A) shows 
the period after cessation of aeration and (B) after restarting aeration.  
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Table 2.4. Experimental design for building a model for oxygen mass transfer during E. coli 
fermentation in 24DSW PreSens Oxodish plates, and 96DSW microwell plates. 
Plate type Factor Unit 
Range 
Lo Hi 
24 Deep 
Square 
Well 
PreSens 
A Fill Volume µL 1600 3200 
B Agitation Speed rpm 200 400 
C Post Induction Temp. °C 30 37 
D % Inoculum % 1 5 
E Log hour time points hr 
PreInd (t0), Post Ind (t8), 
t24, t32, t48, t56 
96 Deep 
Square 
Well 
A Fill Volume µL 400 800 
B Agitation Speed rpm 600 1100 
C Post Induction Temp. °C 30 37 
D % Inoculum % 1 5 
E Log hour time points hr 
PreInd (t0), Post Ind (t8), 
t24, t32, t48, t56 
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2.7. Methods for Characterisation of Oxygen Mass Transfer Coefficients (kLa) in 
Commercially Relevant Single Use Bioreactors (SUBs) 
Quantification of oxygen mass transfer coefficients is central to the main aim of this thesis 
(Section 1.3.), and as such it is crucial to understand the methodologies used, and notably the 
differences which were required due to the constraints of the different vessels and 
measurement systems. Experimentally, the static gassing out method was used for kLa 
determination as described by Garcia-Ochoa et al, 2009. Where appropriate measurements 
were made in triplicate. 
2.7.1.  New Brunswick BioFlo310 
2.7.1.1. Run Order 
Run ordering was a key experimental consideration and although randomisation of run 
order would have been ideal, this was not practical. The reasoning and remedial actions are 
discussed fin the relevant sections of Chapter 5. 
2.7.1.2. Quantification of kLa Values 
Before building a model for the oxygen mass transfer, the kLa under each set of conditions 
must be quantified. Firstly, the dissolved oxygen tension is plotted against time (see Figure 
2.8A) in order to identify the period of the experiment over which there is an exponential 
change in DOT, as this is the region from which kLa can be calculated. For this data, Equation 
2.3. can be rearranged and applied to each data point used to calculate a value for Ln(C*/C*-
CL) (Equation 2.4.), with the output then plotted against time (Figure 2.8B). The gradient of 
this plot is then equal to the kLa. It must be noted that this method does not take into account 
probe response time (PRT), which, in such a rapidly changing system is needed, and so this 
data is used for the preliminary indication of trends across the experimental landscape, and 
for validation of the kLa values calculated with PRT taken into account. Subsequent 
multifactorial analysis was carried out as described in Section 2.4.4.2. 
 
@)& @AB = %&' ∙ ()∗ − )&)     Equation 2.3.  
DE()∗ )∗⁄ − )&) = %&' ∙ A     Equation 2.4. 
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2.7.1.2.1. Adjusting for Probe Response Time 
Due to there being a delay between the change in environment and the recording of this 
change by the probe, it is crucial to account for this in the calculation of kLa (Tribe et al. 1995). 
First the readings should be normalised using Equation 2.5 where YL is the normalised oxygen 
concentration. 
G& = ()∗ − )&) )∗⁄      Equation 2.5. 
It is then necessary to calculate the normalised probe response using Equation 2.6. Here 
R1 is the reciprocal of kLa and R2 is the mean measured probe response time (in the case of 
the BioFlo 310 this is 34.8 seconds from n=5 measurements). YP is the normalised oxygen 
concentration allowing for probe response. 
GH = 	 I#J ∙ KL7 =MNO − #P ∙ KL7 =MQOR (#J − #P)B    Equation 2.6. 
Following this, the squared error is calculated using Equation 2.7., and from this the sum 
of the errors for the desired data set can be determined. The data set used is the same as 
when calculating kLa without PRT, highlighting the exponential range, which should cover at 
least 66% of the complete DOT range measured. 
STTUT = (G& − GH)P     Equation 2.7. 
In order to determine kLa from this, the value of R1 is adjusted in Equation 2.6. so as to 
minimise the sum of the square errors over the experimental range. This can be achieved 
either manually or, more practically, using a computer program e.g. Microsoft Excel’s solver 
function. kLa is then found by calculating the reciprocal of the R1 value which gives the 
minimised sum of square errors. Table 5.5., highlights the difference in kLa values when 
calculated with and without taking probe response time into consideration.  
 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 Plots of dissolved oxygen tension (A) and Ln(C*/C*-CL) (B) against time for 
calculating kLa in the New Brunswick BioFlo 310 reactor.  represents 0.43vvm and 419rpm, 
 0.43vvm and 881rpm, Ο 1.07vvm and 419rpm and Δ 1.07vvm and 881rpm. Both plots use 
the same representative sample from the data set generated in the BioFlo 310 STR. 
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2.7.2. Ambr®250  
The method for quantification of the oxygen mass transfer coefficient is as outlined in 
Section 2.7.1.  
The protocol for quantification of kLa in the Ambr®250 was based on that in Section 2.7.1. 
The protocol was automated using the Ambr’s Pegasus software. The progress in design and 
development of this protocol are detailed in Section 5.4. Appendix 4.8. shows the software 
protocol. 
2.7.3. XDR10 
Execution and  analysis of the output data streams, the method is as described in Section 
2.7.1. 
2.8. Analytical Equipment and Techniques 
2.8.1. Analytical Equipment 
The HPLC System used was a Dionex Thermostatted Column Compartment TCC-100 
with Dionex P680 Pump, Dionex UVD 170U UV-Vis Detector and LC Packings Famos 
Autosampler (Dionex, California, USA). A Cecil Aquarius spectrophotometer (Cecil 
Instruments, Cambridge, UK) was used for OD600 measurements, a CLARIOstar plate reader 
(BMG Labtech GmbH, Germany) and a Tecan Geneios Plate reader (Tecan, Switzerland) 
were used for absorbance and fluorescence measurements. Clear and black 96 well flat 
bottom microtitre plates were supplied by Starlab (Milton Keynes, UK). A Prima VB mass 
spectroscopy gas analyser (from Thermo Scientific, Waltham, MA, USA) was used for offline 
gas analysis and quantification during scale up fermentation. Measurement of glycerol was 
done using a Free Glycerol Assay Kit (Colorimetric) (Cell Biolabs, California, USA) and DNA 
purification and quantification used a QIAminiprep® kit (Qiagen®, Hilden, Germany). Manual 
handling of samples and reagents was using P1000, P100, P20 Gilson pipettes (Middleton, 
WI, USA) and 1mL, 200µL and 20µL sterile pipette tips (supplied by Starlab, Milton Keynes, 
UK). An Eppendorf microfuge (Eppendorf, Germany) was used for centrifugation of samples. 
A Nanodrop 2000c was used for quantification of purified DNA concentration. 
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2.8.2. Quantification of Biomass Concentration 
2.8.2.1. At Line Quantification of Biomass Concentration 
The Optical Density (OD600) of fermentation samples was measured using a Cecil Aquarius 
spectrophotometer or Clariostar plate reader at 600 nm for shake flask, microwell and 
bioreactor fermentations. During shake flask and bioreactor fermentations, triplicate readings 
were taken. During the Design of Experiments rounds in microwells, duplicates were 
measured where possible, but replication of samples was not necessary as the way in which 
the experiments are designed ensures that replicates are inherent within the design (Tabora 
& Domagalski, 2017). For all measurements, samples were prepared in a Class II biosafety 
cabinet. 
Composition of media was included in experiments throughout the thesis, and each 
affected the optical density at 600 nm. Thus, in order to ensure accuracy of readings, each 
sample was measured after blanking with the fermentation medium. Dilutions were also done 
using the fermentation media. 
2.8.2.2. Off Line Quantification of Biomass Concentration 
A calibration curve for biomass concentration against OD600 was generated from a number 
of fermentations in the benchtop stirred tank bioreactor (New Brunswick 7.5L). Fermentation 
samples were collected in triplicate and their OD600 recorded. 1mL of sample were then placed 
into pre-weighed 2mL Eppendorf tubes before being centrifuged at 13,000rpm (~18,000 x g) 
and having the supernatant carefully removed. Samples were then washed with phosphate 
buffered saline, before being centrifuged again and having the supernatant removed. Samples 
were then weighed again and the difference between this and the initial weight of the tube 
taken as the wet cell weight per mL of culture (converted to gL-1 by multiplying by 1000). The 
tubes were then left in an oven to dry for a minimum of 16 hours, and after being allowed to 
cool were weighed and again, the difference from the initial weight taken as the dry cell weight 
per ml of culture (converted to gL-1 by multiplying by 1000). The calibration curve obtained 
was then used to convert OD600 measurements into wet cell weight per litre of culture (gWCWL-
1) or dry cell weight per litre of culture (gDCWL-1). A change in OD600 of one corresponded to a 
WCW of 1.55 gL-1 and a DCW of 0.34 gL-1. 
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2.8.3. Quantification of Bioconversion Substrate and Product Concentrations 
2.8.3.1. High Performance Liquid Chromatography (HPLC) 
2.8.3.1.1. Sample Preparation 
Aqueous samples from bioconversions were prepared by mixing a 500µL sample with 
500µL methanol. Where a 500µL sample was not available, as large a sample as possible 
was taken and mixed in a 1:1 ratio with methanol. The sample with methanol was vortex mixed 
for 15 seconds and then centrifuged at 13,000 rpm for 5 minutes. 150µL of the solvent layer 
was then transferred to an HPLC vile, sealed, and analysed using HPLC as described in 
Section 2.8.3.1.2. The UV-Vis detector response to the samples was measured as an 
integrated peak area. 7-ethoxycoumarin was used for substrate standards and 7-
hydroxycoumarin (umbelliferone) was used for the product standards. Sample calibration 
curves for 7-ethoxycoumarin and 7-hydroxycoumarin can be seen in Appendix 1.6.  
2.8.3.1.2.  HPLC Operation and Quantification 
A Dionex HPLC system (Dionex, California, USA), fitted with an ACE 5 C18 column (ACE, 
Aberdeen, UK) with guard column, was used to analyse the conversion of 7-ethoxycoumarin 
to 7-hydroxycoumarin. The mobile phases used were B: Acetonitrile and C: 0.1% 
Trifluoroacetic acid (TFA) in water. The column was equilibrated for 30 minutes prior to the 
sample analysis with 10% mobile phase B and 90% mobile phase C flowing at 1mLmin-1. The 
column was maintained at a temperature of 30°C and 20µL samples were injected into the 
column, also at a flow rate of 1mL/min. A ten minute programme was used at this flow rate. 
Product and substrate were detected at a wavelength of 325 nm (see Appendix 1.7.) using 
the UV-Vis detector.  
2.8.3.2. Quantification of Green Fluorescent Protein expression 
Fermentation samples were vortex mixed for 30 seconds before being diluted 1 in 20 with 
phosphate buffered saline (PBS) solution as the diluent, and 200µL transferred into 96 round 
well, flat bottom black microtitre plates. Triplicate samples were prepared and blanks 
containing 200µL of PBS distributed in the plate. Determinations of fluorescence were made 
using a CLARIOstar plate reader, from the top, at excitation and emission wavelengths of 395 
and 509 nm respectively. The mean of the three sample readings was taken and the 
background (mean of the three blank samples) subtracted.  
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2.8.4. Quantification of Free Glycerol Concentration 
2.8.4.1. Sample Preparation 
A Free Glycerol Assay Kit from Cell Biolabs (California, USA) was used to measure the 
consumption of glycerol from the media throughout the bioconversion.  250µL sample of the 
fermentation broth was collected and transferred to an Eppendorf tube. This was centrifuged 
at 5000 rpm and 4°C for 10 minutes. The supernatant was collected without disturbing the cell 
pellet and vortex mixed for 10 seconds. Each sample was then stored at -80°C until all were 
ready to be assayed. 
2.8.4.2. Assay Protocol 
All samples and materials were maintained on ice for the duration of the assay preparation. 
Samples were thawed on ice and then vortex mixed for 10 seconds each. At the beginning of 
each assay set, a freshly prepared standard curve was prepared (see Appendix 1.8.). 
10µL of diluted glycerol standards (at 0, 6.25, 12.5, 25, 50, 100, 200 and 400µM) and 
samples added to a 96 well plate. The reaction mixture was prepared using the volumes 
shown in Table 2.5, mixing well after the addition of each of the components. 90µL of this 
reaction mixture was added to each of the 10µL samples. The plate was covered with foil and 
incubated for 15 minutes at 25°C in an orbital shaker. The absorbance was then read on a 
Tecan Geneios plate reader at 570nm. The standard curve generated was then used to 
calculate the glycerol concentration in each of the samples. A sample calibration curve can be 
found in Appendix 1.8. 
Table 2.5. Component volumes for makeup of Glycerol Assay reaction mixture. 
Deionised 
Water (mL) 
10X Assay 
Buffer (mL) 
5X Enzyme 
Mixture 
(mL) 
200X 
Colorimetric 
Probe (µL) 
Total Reaction 
mixture volume 
(mL) 
No. tests 
available 
5.95 1 2 50 9 100 
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3. Quantification of Oxygen Utilisation for a Microbial P450 Oxidative 
Bioconversion 
 
3.1 Context and Aim 
Oxidative bioconversions are currently applied in a number of industrial processes 
(Section 1.2.1.). These include the manufacture of Pravastatin by Daiichi-Sankyo 
(Watanabe et al. 1995), Rocaltrol from Vitamin D3 by Roche (Sakakis et al. 1992) and 
Leukotoxin B for pathophysiologic responses in humans (Falck et al. 2001). There is 
considerable future potential to apply oxidative conversions in the manufacture of 
antibiotics (Shafiee & Hutchinson 1988; Anzai et al. 2012; Tian et al. 2013) and 
pharmaceuticals including the chemotherapeutic Taxol® (Kirby & Keasling 2009). 
Additional applications can be found in the fragrances and cosmetics (Sakaki 2012) 
and food and pigments (Gillam et al. 2000) industries. Despite industrial application for 
almost two centuries, when production of acetic acid from ethanol began in the early 
1800s (Wandrey et al. 2000), oxidative bioconversions have seldom been fully 
characterised.  
P450s, as described in Section 1.2.2, are a family of haem-proteins, responsible 
for catalysing mainly oxidative bioconversions. When expressed in microbial hosts 
they have the potential for application in a wide range of industrial processes 
generating high value products. There are however, a number of significant issues 
associated with their use. These include instability, complexity (Sakaki 2012), limited 
oxygen transfer rates (van Beilen et al. 2003) and insufficient yields when compared 
with those traditionally required for a successful chemical process (Straathof et al. 
2002). 
In order to be able to properly quantify factors contributing to the oxygen demand 
of P450 bioconversions, expression levels of the enzyme need to be increased to 
easily quantifiable levels. Multifactorial optimisation using a DoE methodology 
provides a potential solution to this with significant advantages over a traditional OFAT 
approach (Section 1.2.10) (Zhang et al. 2006; Adinarayana & Ellaiah 2002). In 
particular it is possible to determine a ‘true optimum’ set of parameters based on a 
desired output, such as enzyme activity (Islam et al. 2007; Shivhare & Mccreath 2010). 
DoE is a tool widely used in chemistry, but greatly underutilised with biological systems 
(Jansen 2003). Employing a set of DoE principles and experimental procedures, may 
aid in overcoming some of the issues associated with whole cell P450 bioconversions, 
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particularly the problem of industrially inadequate expression levels and hence product 
titres. 
Microorganisms have a particularly high metabolic requirement for oxygen, 
especially when compared with alternative expression systems such as mammalian 
cells (Micheletti & Lye 2006; Fleisehaker & Sinskey 1981). This is an established 
challenge for culturing microbial expression systems, particularly in vessel designs 
which are known to have oxygen transfer limitations, including microwells (Eibl et al. 
2010). It is important therefore that when assessing the needs of an organism carrying 
out an oxidative bioconversion, where O2 is a substrate both for metabolism and a 
biocatalytic process, that the maximum O2 demands are determined. 
At present, there is little understanding in the literature of the balance between 
metabolism and bioconversion with regard to total oxygen demand during whole cell 
bioconversions. By distinguishing between the O2 required for metabolism and the O2 
required for bioconversion, understanding of O2 utilisation will be significantly 
improved. The limited previously published work has concluded that the extent of the 
requirement differs depending on organism, enzyme and substrate used (Mayuzumi 
et al. 1993). In addition there has been a suggestion that a P450 bioconversion in 
E.coli is responsible for just 1.5% of the total oxygen utilised (Shet et al. 1997), 
however this was concerned with only millilitre scale experiments. This lack of 
knowledge is a major shortcoming from a bioprocessing standpoint, as a thorough 
understanding of the demands of the system on the culture environment is imperative 
when developing commercially relevant strains and processes. 
3.1.1. Aims 
The aim of this chapter is to establish the methodologies which can be used for 
effectively optimising, and accurately quantifying OUR for a microbial expression 
system under optimised conditions. In order to achieve this, a number of objectives 
can be identified:  
• Multifactorial DoE methods will be used to optimise the oxidative 
bioconversion of a P450 monooxygenase expressed in E.coli, such that the 
productivity, growth and therefore oxygen demand of the expression 
system is maximised.  
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• A 3000-fold scale up to a 7.5L stirred tank bioreactor will be carried out, 
including reconfiguring of a mass spectrometer set up for accurate oxygen 
mass transfer quantification.  
• Comparison of three cultivation strategies (non-induced batch, induced 
batch and induced fed-batch, denoted as NI-B, I-B and I-FB respectively) 
will then be used to examine the preferred conditions for carrying out a 
whole cell P450 bioconversion and the demands on the culture 
environment.  This will also support the better elucidation of oxygen 
demands for metabolism and bioconversion.  
 
  
3.2. Optimisation of P450 Bioconversion 
A multifactorial Design of Experiments (DoE) methodology was employed in order 
to optimise the expression of the P450 expressed in E. coli and the subsequent 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin (Section 2.4.5). This would 
establish a set of conditions which maximise the activity of the bioconversion, making 
the OURs more easy to measure once transferred into pilot scale bioreactors, as well 
as providing an insight into the kinetics of the culture and bioconversion at the 
microwell scale. 
This process was carried out in three stages. First, an initial ‘Screening’ round was 
conducted (Section 3.2.1) to identify factors and interactions which have a significant 
impact on bioconversion product titre and therefore require further investigation. 
Second, a ‘Refinement’ round was undertaken (Section 3.2.2) which took those factors 
identified as being of interest and refined the ranges based on the outputs of the 
screening round in order to move closer to an optimal set of conditions.  Finally, an 
‘Optimisation time course’ was performed (Section 3.2.3) in order to refine a set of 
parameters and ranges to investigate the kinetics of the culture and bioconversion at 
the microwell scale. The changes in the factors and set points of the experimental 
stages is shown in Table 3.1. 
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Table 3.1. Factors and ranges for each of the rounds of multifactorial optimisation for 
the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin by E. coli PQR368. 
Experiments performed as described in Section 2.4.5. Factors and ranges selected as 
discussed in Section 3.2. Change indicates variation in factor range compared to 
previous round of DoE experiments. 
 
DoE Round Factor Unit 
Range 
  Low    High      Change 
1 
(Screening) 
A Post Induction Time hr 8 65 - 
B Substrate Concentration mM 0.1 1.0 - 
C Post Induction Volume mL 0.5 1.0 - 
D Pre Induction Time hr 2 5 - 
E Bioconversion Temperature °C 25 37 - 
F 
Substrate Addition Time 
(Post Induction) hr 0.17 1.0 - 
G Yeast Extract Concentration gL-1 25 40 - 
H Buffered Media - No Yes - 
J Orbital Shaking Speed rpm 300 1100 - 
2 
(Refinement) 
A Post Induction Time hr 50 75 Higher 
B Substrate Concentration mM 0.75 1.25 Higher 
C Post Induction Volume mL 0.5 1.0 No change 
D Pre Induction Time hr 2 5 No change 
E Yeast Extract Concentration gL-1 25 40 Higher 
F Bioconversion Temperature °C 22 30 Lower 
G Buffered Media - No Yes No change 
3 
(Optimisation 
Time course) 
A Substrate Concentration mM 0.75 1.0 Lower 
B Yeast Extract Concentration gL-1 40 50 Higher 
C (Post Induction Time) hr 0 75 Continuous time course 
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3.2.1. Screening 
A 10 factor, 128 run experiment (split into two blocks of 64 run experiments) was 
constructed in a resolution IV fractional factorial design (Whitcomb & Anderson 2004). 
This means that two factor interactions may be aliased with other two factor 
interactions, and three factor interactions with main effects (Goos & Jones 2011). The 
design was split into two blocks since two different shaking speeds could not be 
achieved simultaneously. It therefore allowed the determination of whether this was a 
significant factor in the context of the current design.  
Figure 3.1. shows the half normal plot generated through analysis of the experimental 
data using Design Expert 8™ software. The half normal plot indicates factors or 
combinations of factors which lead to outputs which do not fit within the normal 
distribution (represented by the orange line on Figure 3.1.) and therefore have a 
statistically significant impact on the system. 
Factors were selected on the basis of prior knowledge and literature data (Section 
1.2.2.), in order to choose those which would appear to have the greatest chance of 
influencing productivity and growth. Ranges were selected on the same basis and 
spread wide enough that if there was an effect to be seen, it would become apparent. 
The design set points for this screening stage can be seen in Table 3.1 as DoE Round 
1 (Screening). The experimental design complete with experimental data can be seen 
in Appendix 2.1. 
A number of effects are evident (Figure 3.1.) including three main effects (post 
induction time - A, substrate concentration - B and buffering of the media - H), three 
two-factor interactions and a single three-factor interaction. Shaker speed is also a 
highly influential main effect (Figure 3.2.) not seen on the half normal plot as the design 
was broken down into two blocks around this factor. Figure 3.2. demonstrates the clear 
influence of shaking speed on productivity of the expression system, with the parity 
plot showing all experiments at a greater shaking speed result in higher 7-
hydroxycoumarin concentration. As discussed previously (Sections 1.2.2. to 1.2.4.) 
oxygen availability is a crucial factor in the metabolism of microbial organisms, and for 
use as a substrate in P450 bioconversions. It would therefore be expected that there 
would be a significant positive influence of increasing shaking speed, which in turn 
increases oxygen mass transfer into the culture (Hermann et al. 2003).  
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Figure 3.1. Half Normal Plot highlighting those factors with a statistically significant 
effect. Three main effects can be seen (A, H and B), as well as three two-factor 
interactions (AB, GH and HJ) and a single three factor interaction (ABD). Factors D 
and AD are included in order to ensure that the model is hierarchical. Experiments 
performed as described in Section 2.5.1. Factors and ranges defined in Table 3.1.   
 
 
 
 
 
 
 
 
 
Figure 3.2. Parity plot for the P450 optimisation screening experiments. A clear 
influence of shaker speed on product concentration is seen. At greater shaker speed 
(red symbols) greater product concentration is seen when compared with lower shaker 
speed (blue symbols), irrespective of all other factors investigated. Experimental data 
generated as described in Section 2.5.1. Model generated using Design Expert 8 
software. 
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As may be expected, increased substrate concentration and a longer post 
induction time result in increased final product concentrations. This indicates that over 
the ranges investigated there is no inhibition to the bioconversion seen as a result of 
substrate toxicity, nor that degradation of the product occurs such that it is no longer 
detected above noise. 
The sole three factor interaction (post induction time, substrate concentration and 
pre-induction time) also incorporates one of the two factor interactions seen (between 
post induction time and substrate concentration). The influence of this interaction can 
be seen in Figure 3.3. It should be noted that the identification of multi-factor 
interactions such as this is one of the major advantages of using a DoE methodology. 
Three factor interactions are particularly difficult to decipher, but it can be seen that at 
the higher substrate concentration, increasing post induction time and lowering pre-
induction time results in a greater product concentration, with an approximately four-
fold increase in product titre. At low substrate concentration however, having both the 
post- and pre-induction times greater, results in increased product concentration. It is 
clear though that lower substrate concentrations result in lower product concentrations 
compared with those seen at higher substrate concentrations. The experimental 
against predicted data is an excellent fit (close to y=x), as shown in Figure 3.2., 
indicating that the model is highly representative of the system. 
Additional two factor interactions are seen between yeast extract concentration 
and buffered media, and shaker speed and buffered media. The former indicates that 
when the media is buffered, increasing yeast extract concentration results in greater 
product concentration. Conversely, when the media is not buffered, increasing yeast 
extract concentration results in a reduced product concentration. This effect can be 
seen in Figure 3.4A, and is most likely as a result of the inability of the culture to 
maintain a favourable pH when the components of the complex media are broken 
down and used as an energy source upon depletion of the primary available carbon. 
The latter interaction highlights that at a higher shaker speed, buffering of the media 
results in reduced final product concentration, while at a lower shaker speed, the 
difference in product concentration between buffered and unbuffered media is 
negligible (Figure 3.4B). 
The outputs of this stage of the investigation were used as the basis of the next 
round to inform factor and range selection as indicated in Table 3.1.
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Figure 3.3. Three factor interaction between post induction time, substrate concentration and pre-induction time showing the effect on 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. Black lines represent trends at low substrate concentration (0.1mM), while red lines 
represent high substrate concentrations (1.0mM). Experiments performed as described in Section 2.5.1. Model generated using Design Expert 
8 software. Error bars represent one standard deviation about the mean. 
Low Pre Induction Time High Pre Induction Time 
Medium Pre Induction Time Low Pre Induction Time High Pre Induction Time 
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Figure 3.4. Two factor interactions observed during screening and refinement of the 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin by E. coli PQR368. A) Two 
factor interaction between yeast extract concentration and buffering of the media. Red 
line represents buffered media, while the black line represents unbuffered. B) Two 
factor interaction between shaker speed and buffering of the growth media. Red line 
represents buffered media, while the black line is unbuffered. C) Two factor interaction 
between post induction time and post induction temperature. Red line represents high 
post induction temperature (30°C), while black line represents low post induction 
temperature (22°C).  D) Two factor interaction between yeast extract concentration 
and post induction temperature. Red line represents high post induction temperature 
(30°C), while black line represents low post induction temperature (22°C). Experiments 
performed as described in Section 2.5.2. Factors and ranges defined in Table 3.1.   
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3.2.2. Refinement 
For the refinement stage, a seven factor, 64 run experiment was constructed in a 
resolution VII fractional factorial design (Whitcomb & Anderson, 2004). In this case, 
three factor interactions are aliased with four factor interactions, and notionally, five 
factor interactions with two factor interactions (Goos & Jones, 2011). 7-
hydroxycoumarin concentration, resulting from the bioconversion of 7-ethoxycoumarin 
was again measured as the response. Figure 3.5. shows the half normal plot to 
highlight the factors and interactions of significant effect.  
Four main effects (post induction time, substrate concentration, yeast extract 
concentration and post induction temperature) were identified using the half normal 
plot. At the higher substrate concentration used, a negative effect was observed, 
meaning that final product concentration is reduced with increasing substrate 
concentration. Combined with observations from the first round, it can be concluded 
that concentrations of substrate exceeding 1.0mM are likely to be inhibitory, and that 
the optimum is in the range of 0.75 to 1.0mM. The greatest impact seen is as a result 
of post induction temperature, with the increase from 22 to 30°C resulting in a 14-fold 
increase in final product concentration (Figure 3.6.). 
The presence of two, two-factor interactions is also indicated (Figure 3.4 C&D). 
These both include post induction temperature, interacting with post induction time and 
yeast extract concentration independently. The first of these relationships shows that 
when post induction temperature is higher, increasing post induction time results in 
increased final product concentration, with all product titres significantly greater than 
those seen with lower post induction temperature. The interaction with yeast extract 
concentration is similar, with greater post induction temperature resulting in a positive 
relationship with increasing yeast extract concentration with respect to final product 
concentration. However, at the lower temperature the effect of yeast extract 
concentration can be considered negligible. 
Finally, a single three factor interaction is identified between post induction time, 
post induction temperature and substrate concentration. For both high and low 
substrate concentrations, increasing post induction time and temperature results in 
greater product accumulation. Also, at high substrate concentration, increasing post 
induction time and temperature results in a more significant increase in final product 
concentration. 
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It can be seen that certain factors appear to show an effect repeatedly. Post 
induction time for example, suggesting that even under non-optimal conditions, the 
bioconversion will continue, however slowly, without inhibiting itself or creating a 
scarcity in key resources e.g. notably with cofactors. Additionally, post induction 
temperature is seen repeatedly as a positive effect, highlighting the requirement for 
energy input to the system to aid the progression of the oxidative bioconversion. 
3.2.3. Bioconversion Kinetics Under Optimised Conditions 
The optimisation time course incorporated two factors (substrate and yeast extract 
concentrations) investigated over a post induction time course. A sacrificial sampling 
method as described in Doig et al. (2002) was used to generate the time course of the 
bioconversion in microwells and a central composite facing (CCF) design, allowing for 
the determination of curvature within the ranges of the remaining variables. The design 
was constructed with four centre points. 
This optimisation stage, highlighted the detrimental influence of substrate 
concentration (within the optimised band) on growth i.e. greater substrate 
concentration resulted in reduced biomass concentration. 
The time course element showed that at around 20 hours post inoculation, there 
was a significant deterioration in the rate of biomass accumulation as the primary 
carbon source was depleted and there was a switch in metabolism to the deamination 
of yeast extract components (this was confirmed by free glycerol concentration assays 
and pH change measured over the culture). A similar effect is seen with bioconversion 
product concentration that plateaus alongside the depletion of the primary carbon 
source, indicating readily available carbon is crucial for bioconversion productivity, or 
that in the microwell environment there is a limited specific productivity that the culture 
can achieve. 
From these observations, feeding of additional primary carbon source, as well as 
online pH monitoring and control is going to be critical during scale up to pilot scale 
STRs. It should also be noted that little effect was seen on bioconversion product 
formation as a result of the factor ranges employed, indicating that this is a relatively 
stable region of design space (Tholudur et al. 2005). 
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Figure 3.5. Half Normal Plot highlighting those factors of significant statistical effect 
during refinement of the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin by 
E. coli PQR368. Four main effects can be seen (factors F, A, B, E), as well as two, 
two-factor interactions (EF, AF) and a three factor interaction (ABF) (see main body of 
text for comments). Factors and ranges defined in Table 3.1.   
 
 
 
 
 
 
 
 
 
Figure 3.6. One factor effect plot highlighting a potential 14 times increase in final 
product concentration across the post induction temperature range (22-30°C) during 
refinement of the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin by E. coli 
PQR368. 
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Table 3.2 provides a summary of the effects and interactions during the first two 
rounds of optimisation. This highlights several things, firstly an iterative progression 
towards a multifactorial optimum, a significant dependence on Post Induction Time for 
the progression of the bioconversion, and in the second stage, as the models become 
more refined, a significant positive relationship between the productivity of the culture 
and the post induction temperature (both as a main effect and within interactions). 
Table 3.3. uses analysis of variance (ANOVA) to highlight the statistical 
significance of the models generated in each of the DoE rounds. The p-value indicates 
a measure of the confidence that can be held in the model, with a value less than 0.05 
typically considered significant (Rice 1989). The Cook statistic indicates which of the 
runs would have the greatest impact on the model if it were removed. If all values are 
small (<1) then the model can be considered a good representation of the data. The 
number of outliers in the residuals is the number of experimental runs which do not fit 
within the normal distribution once the model is applied. A measure of signal to noise 
has also been included, with ratios of 31.1 and 54.1 to one found in the models for the 
first two rounds of DoE. This shows that the data is valid and not an artefact of the 
noise of the system. Additionally, all models are seen to conform to a high degree of 
statistical certainty as demonstrated by the ANOVA data (Table 3.3.).  
Table 3.4. summarises the overall gains in biomass and product accumulation, 
using the multifactorial optimisation approach, when compared with preliminary work 
done as part of this research, but also with previous work carried out at UCL on this 
expression system (Baboo et al. 2012). After three rounds of DoE, 3.3 and 2.0 times 
increases in bioconversion product and biomass accumulation were seen over 
preliminary experiments in microwells with respect to product titre and biomass 
concentration respectively, with a specific product concentration increase of 1.5 times. 
In addition, as a comparison with previous optimisation work on this expression system 
(Baboo 2012), there is a 1.1 to 1.4 times increase in the identified responses. 
It can be seen that, although successful in increasing the product concentration, 
the optimisation was not able to considerably increase specific productivity i.e. product 
generated per unit of biomass (Table 3.4.). 
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Table 3.2. Summary table of the statistically significant effects and interactions on the 
yield of 7-hydroxycoumarin during two rounds of multifactorial optimisation on the 
bioconversion from 7-ethoxycoumarin using E. coli PQR368.  
 
DoE Round Interaction Factor/s Units 
Range Effect 
Low High +/- 
1 
(Screening) 
Main Effect 
Post Induction Time hr 8 65 + 
Substrate Concentration mM 0.1 1.0 + 
Shaker Speed rpm 300 1100 + 
Buffered Media - No Yes - 
Two Factor 
Interaction 
Post Induction Time, 
Substrate Concentration 
hr, 
mM 
8, 
0.1 
65, 
1.0 
+ 
Yeast Extract 
Concentration, Buffered 
Media 
gL-1, 
- 
10, 
No 
30, 
Yes 
+ 
Buffered Media,            
Shaker Speed 
-, 
rpm 
No, 
300 
Yes, 
1100 
- 
Three 
Factor 
Interaction 
Post Induction Time, 
Substrate Concentration,  
Pre Induction Time 
hr, 
mM, 
hr 
8, 
0.1, 
2 
65, 
1.0, 
5 
- 
2 
(Refinement) 
Main Effect 
Post Induction Time hr 50 75 + 
Substrate Concentration mM 0.75 1.25 - 
Yeast Extract 
Concentration gL
-1 25 40 + 
Post Induction 
Temperature °C 22 30 
+ 
Two Factor 
Interaction 
Post Induction Time,        
Post Induction 
Temperature 
hr, 
°C 
50, 
22 
75, 
30 
+ 
Post Induction Time,       
Yeast Extract 
Concentration 
hr, 
gL-1 
50, 
25 
75, 
40 
+ 
Three 
Factor 
Interaction 
Post Induction Time,        
Post Induction 
Temperature, Substrate 
Concentration 
hr, 
°C, 
mM 
50, 
22, 
0.75 
75, 
30, 
1.25 
+ 
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Table 3.3. Analysis of Variance (ANOVA) for the models generated during 
multifactorial screening and refinement of the bioconversion of 7-ethoxycoumarin to 7-
hydroxycoumarin by E. coli PQR368. 
DoE 
Round 
p-value Cook statistic. 
(largest value to 
model) 
No. outliers 
in residuals 
Signal:Noise 
(x:1) 
1 <0.0001 0.209 2/64 31.1 
2 <0.0001 0.161 1/64 54.1 
 
Table 3.4. Calculated gains in biomass accumulation, 7-hydroxycoumarin 
concentration and specific product concentration upon scale up of the whole cell 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin using E. coli PQR368.  
Table shows significant increases in biomass and bioconversion product compared 
with preliminary microwell cultures and previous work (Baboo, 2012). 
 
 
In addition to increased product and biomass concentration, the output of the three 
rounds of experiments was a set of optimised conditions to be translated to pilot scale. 
These conditions are shown in Table 3.5. Media compounds and levels were fixed 
based on the DoE timecourse experiment, while other factors specific to STRs e.g. 
RPM and DOT set points, were established based on prior knowledge of E. coli 
fermentation and literature precedent. 
 
 
Biomass 
 
gL-1 
[7-
Hydroxycoumarin] 
 
mgL-1 
Specific                             
[7-Hydroxycoumarin] 
(x10-3) 
Preliminary Work 
(µ-well) 2.3 0.8 
0.4 
Prior Work 4.1 2.0 0.5 
After DoE 4.5 2.8 0.6 
Increase: 
- vs. prelim. µ-well 
- vs. Baboo (2012) 
 
2.0x 
1.1x 
 
3.3x 
1.4x 
 
1.5x 
1.3x 
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3.2.4. Scale Up to Pilot Fermentation Scale 
3.2.4.1. Initial Scale Up Comparison with Microwells 
After optimising the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin in E. 
coli PQR368 in microwells, scale up to bench top bioreactors was undertaken in order 
to: (i) quantify the oxygen demand (using the adapted mass spectrometer configuration 
as described in Section 2.5.4.), (ii) determine the mechanism of oxygen utilisation and 
so, (iii) demonstrate the optimised conditions in industrially relevant bioreactors. 
Without characterisation of the oxygen mass transfer in the microwells, scale up was 
performed on the basis of providing a turbulent flow environment and literature values 
appropriate for E. coli fermentation. Direct comparison between microwells and stirred 
tank bioreactors is poorly characterised (as discussed in Section 1.2.7.), and so with 
the objective to quantify the maximum oxygen demand of the optimised system, the 
decision was made to ensure that a turbulent flow environment was achieved to ensure 
effective oxygen mass transfer. 
 
Table 3.5. Set points and starting conditions for all pilot scale STR cultures of whole 
cell bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin using E. coli PQR368.  
Factor Set 
point 
Unit 
Media: 
• Yeast Extract 
• Tryptone 
• Glycerol 
• Phosphate Buffer 
• PPG 
 
40 
12 
4 
10 
0.5 
 
gL-1 
gL-1 
mLL-1 
%v/v 
mLL-1 
DOT 40 % 
pH 7 - 
Agitation 750 rpm 
Temperature 
• Pre Induction 
• Post Induction 
 
37 
30 
 
°C 
°C 
Pre Induction Time 2 hr 
Post Induction Time 28 hr 
Substrate 1 mM 
Starting Volume 3 L 
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The basic trends from the scale up comparison can be seen in Figure 3.7. In 
microwells, biomass concentration increases to 2.0 gDCWL-1 after 20 hours, and shows 
a characteristic growth curve. In parallel, product concentration increases to a 
maximum of 0.05mgL-1 between 20 and 25 hours after inoculation, with the 
accumulation rate closely aligned to the increase in biomass concentration. In STRs 
under induced, batch conditions the rate of biomass accumulation is greater, reaching 
approximately 5.0 gDCWL-1 after 20 hours. As with the microwells, product accumulation 
is closely aligned with the increase in biomass concentration, reaching a maximum of 
1.36 mgL-1 after 30 hours.  
Figure 3.7. shows a positive correlation between biomass concentration and 
bioconversion product concentration at both microtiter (1mL) and batch pilot bioreactor 
(3L) scales. However, it can be seen that the product formed per unit biomass is 
significantly greater in the case of the pilot scale bioreactor. Table 3.6. reinforces this, 
demonstrating a 10 times greater specific product concentration than could be 
achieved in microwells. There are a number of reasons for this. Firstly, the pilot scale 
bioreactor sparges air directly into the culture (Figure 2.1, Section 2.3.1), rather than 
relying on gas-liquid mass transfer across the surface of the culture. This means 
greater oxygen mass transfer and therefore more available oxygen for use as a 
metabolic and bioconversion substrate. Additionally, in the case of the pilot bioreactor 
more O2 is made available than can be utilised for growth due to the limited supply of 
carbon in batch mode. As such, the excess oxygen as represented by the maintenance 
of DOT values at 40%, is more freely available for use in the P450 bioconversion. 
It should also be noted that previous work suggests that a microwell may not be 
able to sustain the biomass and bioconversion titres achieved in the batch pilot scale 
fermentation, with maximum achievable OTRs reported to be 150 mmolL-1hr-1 (2.5 
mmolL-1min-1) (Hermann et al. 2003).  A question is therefore raised over the suitability 
of microwells to provide an accurate scalable mimic for stirred tank bioreactors when 
studying oxidative bioconversions. This suggests a requirement for either novel plate 
designs (Funke et al. 2010) or sparged microwell systems (Betts et al. 2014).  
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Figure 3.7. Comparison of growth and bioconversion kinetics between optimised 
microtiter plate and pilot scale bioreactor cultures of E. coli PQR368 for the 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. Closed symbols and solid 
lines show the biomass concentration (DCW) in microwells () and batch pilot scale 
bioreactor (¢). Open symbols (,£) and dashed lines show bioconversion product 
concentration for microwell and bioreactor respectively. Cultures were induced at two 
hours post inoculation. Growth data has been fitted with a sigmoidal function curve to 
illustrate growth kinetics. Experiments performed as described in Section 2.5.4. Error 
bars represent one standard deviation about the mean (n=3). 
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3.2.5. Pilot Scale Culture Strategy Comparison 
In order to further elucidate the oxygen requirements for growth and bioconversion 
three fermentation strategies were explored; non-induced batch (NI-B), induced batch 
(I-B) and induced fed batch (I-FB). Comparisons were made in terms of their growth, 
P450 bioconversion productivity and the resultant demands of the system for oxygen. 
All fermentations were performed based on the optimised conditions in Table 3.5.  
Biomass accumulation across the three fermentation strategies was found to differ 
greatly. Figure 3.8A and Table 3.6 shows the relationship between biomass 
concentrations and accumulation rates under each of the three fermentation 
conditions. As expected, biomass accumulation is greatest in the induced fed batch 
culture, reaching a peak cell density of over 25gL-1 after 28 hours. Interestingly, non-
induced batch culture grows significantly better than induced batch, reaching densities 
of around 15gL-1 and 5gL-1 respectively after approximately 12 and 25 hours. This is 
the result of a number of influences. A significant volume of ethanol is introduced to 
the culture after two hours (used to dissolve bioconversion substrate). The impact of 
this can be seen between two and eight hours in Figure 3.8A, during which time the 
non-induced culture enters log phase, rapidly accumulating biomass, while this is 
delayed in the cultures to which ethanol is added. This is seen in Figure 3.9. also, 
where the volumetric productivity of induced cultures is impeded. 
Additionally, the induced batch culture has an increased demand for energy and 
oxygen due to the bioconversion (Figure 3.9.). As there is no provision of carbon 
source during batch mode, the ability of the culture to enter a phase of sustained 
growth is impeded.  
The bioconversion though, proceeds alongside reduced growth. This is most likely 
due to metabolism having a greater energy requirement than the bioconversion. A 
large portion of a cells activities involve acquiring and utilising energy for metabolism 
(Cooper 2000), while the bioconversion is a single enzymatic reaction, and therefore 
does not have the same amount of energetic demands. This observation relates to the 
productivity of the induced batch and fed batch cultures also.  
Figure 3.8B and Table 3.6 highlight that the priority of the induced fed batch culture, 
in the carbon rich environment is on growth. Product titres achieved are approximately 
half that of the batch culture (0.66mgL-1 compared with 1.36 mgL-1 maximum). Figure 
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3.7. and Figure 3.9. do highlight that there is a correlation between culture growth and 
bioconversion activity, however it has been demonstrated that the relationship is more 
complex than this with respect to the titre achieved, as discussed in Section 3.2.3. This 
is reinforced by the difference in specific product concentration, which is over 10 times 
greater during batch culturing (Table 3.6.). 
3.2.6. Oxygen Demand Quantification at Pilot Scale 
Oxygen demands during whole cell oxidative bioconversions must be understood 
in the context of the individual culture performance, but also in terms of the impact of 
each of the three fermentation modes. To do this, Figure 3.9 compares the biomass 
accumulation and bioconversion productivity with the OUR for each of the three 
fermentation strategies independently, while Figure 3.10 compares the oxygen 
demands of each of the three fermentation strategies directly. This allows 
understanding of the mechanism for oxygen utilisation and a clear appreciation of the 
preferred bioprocess conditions. In order to achieve this, gas lines into, and out of the 
bioreactor were configured such that they were measured directly by a mass 
spectrometer. Thus, accurate quantification of the gas stream compositions was 
possible (Section 2.5.4.3.).  
A comparison of the oxygen demand for each of the three fermentation strategies 
over the 30 hour culture is shown in Figure 3.10. It serves to demonstrate the varying 
requirement for oxygen throughout the culture, which depends upon the phase of the 
culture, the mode of operation and the condition of the culture environment. For 
example, the induced fed batch culture maintains a high OUR, most likely as oxygen 
is being prioritised for growth, and the maintenance of the culture, and the availability 
of carbon is making this possible. 
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Figure 3.8. Comparison of three pilot scale fermentation strategies with respect to (A) growth of E. coli PQR368 strain and (B) kinetics of the 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin carried out by E. coli PQR368. Non-induced batch (), induced batch (¢) and induced 
fed batch (p) are shown, with induction and the start of feeding at two and eight hours post inoculation respectively. Errors bars represent one 
standard deviation about the mean (n=3). Growth data has been fitted with a sigmoidal function curve to illustrate growth kinetics. Experiments 
performed as described in Section 2.5.4. 
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Figure 3.9. Relationship between kinetics of bioconversion of 7-ethoxycoumarin to 7-
hydroxycoumarin by E. coli PQR368 (), volumetric productivity with respect to biomass 
accumulation (solid line), and oxygen uptake rate (dashed line) during non-induced batch (A), 
induced batch (B) and induced fed batch (C) pilot scale cultures. Induction and start of feeding 
are at two and eight hours post inoculation respectively. Errors bars represent one standard 
deviation about the mean (n=3). Experiments performed as described in Section 2.5.4. 
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3.2.7. Identifying Oxygen Requirements and Prioritisation 
Figure 3.9. allows interpretation of the mechanism by which each of the culture modes are 
utilising oxygen and how this impacts on culture outputs. Each of the cultures are plotted on 
different scales so as to highlight the relationships between variables within each separate 
culture. Figure 3.9A shows the use of oxygen during the non-induced batch culture, which is 
exclusively for accumulation of biomass. There is a direct interaction between the transition 
into log phase and the sharp rise in the uptake of oxygen as the culture enters a period of 
exponential growth. After this period, when the culture enters stationary phase, the 
requirement decreases as the biomass concentration in the culture is sustained (stationary 
phase), rather than increasing (exponential phase). 
For induced cultures, OUR begins to rise dramatically when volumetric productivity with 
respect to biomass accumulation reaches approximately 0.3gL-1h-1 (Figures 3.9B&C). OUR 
for the NI-B culture however, starts to increase at a much greater volumetric productivity 
(~1.3gL-1h-1) (Figure 3.9A). This is most likely due to the additional burden, both in terms of 
oxygen and energy, of generating the P450 enzyme and carrying out the bioconversion in 
induced cultures. In addition, for NI-B culture growth has not also been negatively impacted 
by the introduction of chemical inhibitors (e.g. ethanol for dissolution of substrate). Peak OUR 
is seen in batch cultures between 1 and 3 hours after peak volumetric productivity as the 
system attempts to respond to the culture demand. The fall in OUR corresponds with the end 
of the transition from exponential into stationary phase in all cases. In fed batch culture, where 
growth is sustained, peak OUR directly coincides with maximum volumetric productivity. This 
further supports the point made pertaining to the mechanism of oxygen utilisation and its 
dependence on the condition of the culture. Additionally, the stage of the fermentation can be 
seen to have a significant impact on the O2 demand in each of the three fermentation 
strategies.  
In order to better illustrate the differences in OUR demand between the three fermentation 
strategies, Figure 3.10. shows the oxygen uptake rate for each plotted on the same scale for 
direct comparison. The maximum oxygen demand seen during fed batch culture is 25.8 
mmolL-1min-1, which, while greater than that of the non-induced culture, does not correlate 
directly with the almost doubling in peak biomass concentration. This demonstrates the 
presence of additional influences on the oxygen demand. 
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Figure 3.10. Oxygen uptake rate during induced fed batch (solid line), induced batch (dashed 
line) and non-induced batch (dotted line) pilot scale cultures of E. coli PQR368 carrying out 
the bioconversion of 7-ethocycoumarin to 7-hydroxycoumarin. Experiments carried out as 
described in Section 2.5.4. 
 
 
 
 
 
 
 
 
 
Figure 3.11. Breakdown of maximum oxygen uptake rates observed during non-induced 
batch, induced batch and induced fed batch pilot scale cultures of E. coli PQR368 carrying out 
the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. Contributions due to 
bioconversion (white), growth (light grey), maintenance of the biomass concentration (dark 
grey) are shown as well as peak total OUR (black). Values determined as described in Section 
2.5.4. 
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Table 3.6. Effect of fermentation mode on the biomass accumulation and bioconversion 
productivity for the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumrin using E. coli 
PQR368 in optimised microwell culture and each of three pilot scale fermentation modes (non-
induced batch - NI-B, induced batch - I-B, induced fed batch – I-FB). Experiments performed 
as described in Section 2.5.4. 
 Unit DSW NI-B I-B I-FB 
Peak OUR mmolL-1min-1 - 19.9 5.68 25.8 
Peak DCW gDCWL-1 2.12 14.4 4.10 26.2 
Peak [7-Hydroxycoumarin] mgL-1 0.05 - 1.36 0.66 
Peak Volumetric Productivity gDCWL-1h-1 - 2.31 0.31 1.56 
Specific [7-
Hydroxycoumarin] x10
-4 0.24 - 3.30 0.25 
 
Figure 3.11. shows the breakdown of the maximum observed oxygen uptake rate during 
culturing for each of the three fermentation strategies. In addition to maintaining the biomass 
concentration, the OUR can be attributed to both the oxygen utilised as substrate in the 
bioconversion and the oxygen required for growth. Batch mode culture demands the lowest 
peak oxygen uptake rate. The OUR is more than four times lower than that of the fed batch 
culture, highlighting the dominance that growth has on the required oxygen. In addition, Table 
3.6. helps to highlight the influence of fermentation strategy, and the relationship between 
maximum oxygen demand and productivity.  
Table 3.7 shows the contribution of each of the three major influences on culture oxygen 
demand; sustaining the level of biomass present in the culture at that time, increasing biomass 
concentration through growth and the P450 bioconversion of 7-ethoxycoumarin to 7-
hydroxycoumarin. Thus, the effect on the total OUR of each of these is highlighted. The 
contributions were derived using simultaneous equations and the data generated during the 
pilot scale cultures under each of the three different fermentation strategies. By comparing the 
oxygen demands derived for each of the cultures and their performance in terms of the major 
influences on oxygen uptake (growth, maintenance and bioconversion), the oxygen 
requirement which can be attributed to each is calculated as shown in Appendix 2.2. 
Therefore, based on this investigation, the peak total OUR can be estimated using Equation 
3.1. 
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!"#$	&'(#)	*+, = 0.71	2 + 4.23	7 + 1.09	9   Equation 3.1. 
Where α represents the maximum biomass concentration during culture (gDCWL-1), β the 
peak volumetric productivity (gL-1h-1) and γ the maximum 7-hydroxycoumarin concentration 
(mgL-1). 
 
Table 3.7. Contribution to the peak total OUR for each of the three major components; 
sustaining the level of biomass present in the culture at that time, increasing biomass 
concentration through growth and the P450 bioconversion of 7-ethoxycoumarin to 7-
hydroxycoumarin. Calculated using simultaneous equations formed from the fermentation 
data generated for each of the three culture strategies. 
Component of total OUR Contribution (%) 
Sustaining current biomass 11.8 
Growth 70.1 
Bioconversion 18.1 
 
Although the specific oxygen requirement for the bioconversion is much greater than for 
growth (approximately 250 times), the percentage conversion is very low. As such, in the case 
of induced batch culture, although bioconversion titre is greater than other cultures, low 
volumetric productivities and biomass concentrations result in a much lower total OUR. 
Growth is shown to be a more significant influencer on total OUR proportionally (when 
compared to maintenance), however, as Figure 3.11. shows, the OUR required for maintaining 
biomass concentration can outweigh that for growth due to the quantity of biomass. 
In order to meet the demands of these high oxygen demand expression systems, there is 
a need for DOT controlled microwell cultivation systems, particularly for microbial, whole cell 
oxidative bioconversions. Previous data suggests that oxygen supply to microwells would be 
insufficient for the demands under the optimal conditions seen in this investigation. This is 
something which will be investigated in Chapter 4 of this thesis. It has been shown that optimal 
shaking of the DSWs can provide a maximum OUR of 150 mmolL-1hr-1 (equating to 2.5 mmolL-
1min-1) (Hermann et al. 2003), with all oxygen delivered through surface gas-liquid mass 
transfer. It is possible to extrapolate from the OUR relationship in Table 3.7. to suggest that 
the OUR for the optimised scale down culture (using biomass concentration, bioconversion 
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product concentration and assuming volumetric productivity equal to the I-B pilot culture) 
would be approximately 2.9 mmolL-1min-1, which is close to the oxygen transfer limit identified 
by Hermann et al (2003), and explains the limitations in achievable cell density and product 
titre.    
3.2.8. Summary 
The aim of this chapter was to establish the methodologies for effective optimisation of a 
whole cell oxidative bioconversion using a microbial expression system at microwell scale, 
and accurate quantification of OUR for a microbial expression system under the conditions 
which result in peak oxygen demand. 
Two of the greatest obstacles limiting the application of whole cell P450 monooxygenases 
in industry are insufficient bioconversion yields, and a lack of understanding regarding the 
demands on the culture environment, particularly in terms of the oxygen requirement of these 
expression systems. 
The bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin using P450SU2 has been 
optimised using a multifactorial DoE methodology. Three rounds of DoE (screening, 
refinement and optimisation) were carried out resulting in a 3.3-fold increase in product titre 
and a 1.5-fold rise in specific productivity. Despite this, bioconversion yields achieved remain 
insufficient for commercial application, particularly when compared with what has been stated 
as necessary to replace a chemical process (Straathof et al. 2002). As such, in this case it 
appears that the limitations are with the biological system, rather than with the engineering.  
Scale up characterisation over a 3000-fold volume increase, under optimised conditions 
showed that microwells, because of the OTR limitations, do not provide an accurate scale 
down model in terms of growth rates and yields.  In this chapter, investigating microbial 
oxidative bioconversions, product concentrations achieved were more than 25 times lower at 
the smaller scale. Scale up characterisation suggests that more advanced, DOT controlled 
microwell systems would be better suited to providing a direct mimic to a pilot scale bioreactor 
when culturing a whole cell, oxidative bioconversion. A tenfold greater specific productivity 
was achieved in the bioreactor and the most likely cause is the limited achievable oxygen 
supply in microwells. 
Batch mode fermentation proved to be the favoured route for increased product 
generation, with yields achieved (1.36 mgL-1) approximately double that of the fed batch 
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counterpart. Although a correlation is observed between biomass accumulation and 
bioconversion product concentration, they are not directly linked. The relationship is more 
complicated, requiring sufficient oxygen and energy for the bioconversion to take place, but 
ensuring that which is provided is limiting to growth. Additionally, it has by far the lowest 
oxygen demand of the three fermentation modes.  
Peak oxygen demands derived were in the range of 5.68 to 25.8 mmolL-1min-1, and 
showed not only that cellular metabolism is the priority for oxygen utilisation, but also 
confirmed that microwells are incapable of providing sufficient oxygen to match the peak 
demands of the larger scale cultures they are attempting to replicate. 
A relationship was identified between the three main contributors to OUR (maintenance, 
growth and bioconversion) as indicated in Figure 3.11. Oxygen requirement due to 
maintenance of the biomass was highlighted as the greatest proportional contributor. The 
greatest specific demand on oxygen was the bioconversion, however due to low 7-
hydroxycoumarin yields it contributes little to the total OUR, with maintenance of accumulated 
biomass and growth demanding the majority. 
The mechanism for oxygen utilisation has been determined, with biomass accumulation 
the priority, rather than supplementary cellular activities. This corroborates the work of Baldwin 
& Woodley (2006) and Luedeking & Piret (1959) which hypothesises that metabolism is 
prioritised over additional cellular activities in the utilisation of oxygen. The relationship 
between the major influencers on OUR has been determined, further indicating growth as the 
key driver behind peak OUR. 
 In the following chapter oxygen mass transfer rates will be quantified in high throughput 
scale down systems. This will involve the development of an improved method for 
quantification in microwell plates in order to enhance understanding of oxygen mass transfer 
during microbial cultivation.  
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4. Accurate Quantification of Oxygen Mass Transfer Rates in High 
Throughput Scale Down Systems. 
 
4.1. Context and Aim 
In the previous chapter the importance of understanding the relationship between 
bioreactor oxygen transfer capability and the utilisation of oxygen in an oxidative, 
whole-cell bioconversion process was demonstrated (Section 3.2.6). That work was 
performed in a conventional laboratory scale bioreactor equipped with a polarographic 
dissolved oxygen probe and off-gas mass spectrometry for analysis of inlet and outlet 
gas compositions (Section 2.5.4.3). Modern approaches to microbial fermentation 
process development make use of high throughput scale down systems (Bareither et 
al. 2013; Ellert & Vikstrom 2014) where the challenge of characterising and 
understanding oxygen mass transfer capabilities is a substantial one. The challenge is 
confounded by an abundance of commercially available technologies (Section 1.2.7); 
not only do scales range by up to six orders of magnitude, from microliters to hundreds 
of millilitres, but geometries, configurations, methods of mixing and gas delivery also 
differ from system to system. This chapter will focus on oxygen transfer quantification 
in two of the most commonly used microwell systems (24- and 96-deep square well 
plates) and the relationship between them. 
Single use scale down microwell systems are seeing a year on year increase in 
uptake, particularly as simple and inexpensive culture vessels for high throughput 
screening applications and process development before scale up (Büchs 2001;  Kensy 
et al. 2005). Unfortunately, though, due to the dependence of mass transfer on 
transport across the gas-liquid interface, oxygen, a key substrate for microbial 
expression systems is often limiting (Marques et al. 2010; Büchs 2001). This growing 
uptake of microwell culture systems leads to a question of compatibility and 
comparability with larger laboratory and pilot scale bioreactors such as stainless steel 
(and increasingly, single use) stirred tank bioreactors. However, this too is difficult to 
reconcile. There are a range of influences to consider including heat transfer, 
hydrodynamics, nutritional and process parameters.  
Oxygen is the terminal electron acceptor in aerobic metabolism, required for 
growth, cellular maintenance and the generation of primary and secondary 
metabolites. Provision of adequate oxygen is arguably the greatest influence on 
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productivity of a microbial system (van Beilen et al. 2003). This makes it a key factor 
in what makes transferring between scales extremely challenging (Junker 2004). As 
such, it is imperative that the oxygen mass transfer capabilities of microwell systems 
are accurately quantified.  
Until recently it has been difficult to measure and characterise oxygen mass 
transfer in smaller scale bioreactor formats during cultivation. Previously, it has been 
necessary to rely on methods such as sulphite oxidation (e.g. Linek & Vacek 1981; 
Hermann et al. 2001; Maier et al. 2001), or calculation of interfacial surface areas (Doig 
et al. 2005). More recently work has been carried out with a miniature DOT probe 
inserted into a single well of a microwell plate (Baboo, 2012), but this has its limitations 
also (Section 1.2.9).  
Now however, it is possible to measure DOT online in 24 DSW plates using the 
SDR SensorDish® system with OxoDish® plates (as described in Section 2.6), which 
use fluorescent spots and readers to non-invasively quantify the extent of oxygen 
saturation. This means that DOT profiles can be generated enabling the calculation of 
oxygen mass transfer in a manner much more akin to larger, process relevant 
bioreactors using polarographic probes. Indeed, it has been noted by Gupta & Rao 
(2003) that non-invasive optical sensors are a superior method of determining oxygen 
mass transfer coefficients than the sulphite oxidation method. A similar technology 
employing fluorescent chemical compounds was used in microwells for animal cell 
culture (Deshpande & Heinzle 2004), however, this is simpler as it operates over much 
longer time periods and with much slower changes in DOT. For a more extensive 
review of oxygen mass transfer characterisation methodologies see Section 1.2.9. 
Use of the SDR system to generate oxygen saturation profiles offers some 
improvements over the previously mentioned methods. Oxygen mass transfer 
characterisation using either static (Wise 1951; de Ory et al. 1999; Puthli et al. 2005; 
Özbek & Gayik 2001 etc.) or dynamic gassing out methods (Bandyopadhyay et al. 
1967; Parente et al. 2004; Islam et al. 2008; Ni et al. 1995) is possible, each of which 
have their limitations, including a need for correction of values due to the response 
time of sensors (Gupta & Rao 2003) and the assumption that cultures remain 
unchanged for the duration of the measurements (Garcia-Ochoa et al. 2010), thus not 
taking into consideration the dynamic properties of a fermentation culture. 
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There is also significant disparity in bacterial culture between the OURs measured 
using the traditional dynamic method, and those observed by calculation using online 
process data (Santos et al. 2006). Additionally, these measurements are commonly 
taken under a single set of conditions, assuming that the environment will not change. 
Determination of how the aeration environment changes under the influence of a range 
of factors is important. 
This work focuses on overcoming the obstacles of characterizing oxygen mass 
transfer rates in small scale culture technologies, translation to commercially relevant 
process scales and the limitations of traditional measurement methodologies.  
4.1.1. Aims 
Many scale down systems are unable to meet the maximum oxygen demands 
determined in the previous chapter (Section 3), the increasing use of microwell 
technologies for screening and initial process development, and the limitations with 
current methods for oxygen mass transfer quantification. To this end, the aim of this 
chapter is to develop a new method for accurate quantification of oxygen mass transfer 
in two microwell scales, and describe the relationship between them.  
Depending on the experimental objective and workflow, both 96 DSW and 24 DSW 
are highly relevant. 96 DSW geometries are commonly used for high throughput 
screening applications, while 24 DSWs are capable of providing sufficient material for 
small scale down stream processing studies. As such it is important to be able to 
transition between the two geometries and understand the implications of doing so. 
Specific objectives are to: 
• Improve the precision of oxygen mass transfer quantification in two widely 
used geometries of microtitre plate, developing a new method (Figure 4.1) 
for OUR characterisation under a range of culture conditions; 
• Build statistical models for oxygen mass transfer in 96 and 24 DSW plates 
and characterise the overlap between the two in terms of oxygen mass 
transfer capability; 
• Provide a mathematical translation between 96 and 24 DSW plates in terms 
of parameter set points (e.g. shaking speed) to achieve equivalent oxygen 
mass transfer rates; 
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• Demonstrate that equivalent culture performance can be achieved in 96 
and 24 DSW microwell geometries. 
Using the new method, accurate quantification of oxygen mass transfer values 
(kLa, OUR, QO2) during small scale cultures will be enabled. As the new method will 
aim to accurately determine kLa using representative experimental conditions with live 
biomass, it is likely that values will be slightly lower than those previously reported in 
literature for the same geometries, although they would be expected to follow similar 
trends. The experimental strategy is summarised in Figure 4.1. 
The physiological responses of a microorganism expressing a recombinant protein 
to changes in the aeration environment are needed for direct comparison of the two 
plate geometries. The previous chapter highlighted that growth and maintenance of 
biomass were the major contributors to oxygen demand (Section 3.2.5.), and with the 
productivity of the P450-containing strain being low, the decision was made to use a 
similar E. coli strain expressing a different, more easily measured protein (green 
fluorescent protein – GFP).  
It is expected that, based on previous observations in lab scale fermentations 
(Section 3.2.5.), during culture the maximum specific growth rate will coincide with 
maximum specific oxygen consumption rate (QO2). Additionally, it is anticipated that 
the achievable biomass concentration will be affected by the availability of oxygen and 
therefore by engineering and physical factors determined to be of influence during the 
development of the initial screening model. In terms of recombinant protein production, 
it is expected that oxygen limitation will restrict expression. This is due to the 
prioritization of essential metabolic activity. 
It is also crucial to enhance the achievable online data stream in scale down 
fermentations to include DOT, biomass concentration, substrate utilization and product 
accretion profiles as well as preliminary derived data analysis. Without this it is not 
possible to gain a sufficiently thorough understanding of scale down systems to 
determine appropriate applications. 
  
 
109 
 
 
Figure 4.1. Overview of the experimental strategy for determining accurate oxygen 
mass transfer rates in microwell plate geometries. An initial screening model is used 
to determine kLa (i) using the traditional dynamic gassing out method, online culture 
profiles are generated in a multifactorial experimental design (ii) to quantify changes 
in the culture, and compared with the initial screening model to determine the oxygen 
demand of the expression system in the microwell environments during culture (iii). 
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4.2. Initial Screening Models for kLa and OUR in 24 Deep Square Well Plates 
4.2.1. Building the Design 
A multifactorial DoE approach was used to design an experimental landscape that 
would enable quantification of kLa and OUR in 24 DSW plates and the subsequent 
modelling of these responses to provide a baseline for calculation of the same 
responses during culture.  
Factors and ranges were selected through review of the literature (Section 1.2.6) 
such that they are likely to have an influence on oxygen mass transfer (and therefore 
oxygen availability) in microwell plates. Also, as this design is to be used in the culture 
stages, effects on growth and productivity were considered. In addition, being able to 
build an equivalent design in 96 DSW was important. 
A four factor, full factorial design blocked for each of the six biomass concentrations 
(by OD600) to be used, was built. Table 4.1. shows the design. Design points were 
replicated in order to ensure that DOT profiles were reproducible and representative. 
The traditional dynamic gassing out method was used (Section 2.6.2. & 2.6.4.) with a 
range of biomass concentrations in order to understand the effect on kLa and to what 
extent there is an impact on OUR. 
 
 
Table 4.1. Experimental design for determination of kLa and OUR values in 24 DSW 
plates when building the initial screening models for oxygen mass transfer. 
Experiments performed as described in Section 2.6.2. 
 
 
Range 
Factor 
Fill Volume 
(mL) 
Shaker Speed 
(rpm) 
Culture Temp. 
(°C) 
Biomass Conc. 
(OD600) 
Low 1.6 200 30 
0,1,5,10,20,50 
High 3.2 250 37 
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4.2.2. kLa Determination in 24 DSW (Dynamic Gassing-Out Method) 
Examples of raw data are shown in Figure 4.2. and derived kLa and OUR values 
under the range of different parameter set points in Figure 4.3. Additional detail on 
quantification of kLa values can be found in Section 2.6.4. There is a distinct trend seen 
as kLa decreases with increased fill volume and reduced shaking speed, in agreement 
with literature (Section 1.2.6.) These physical parameters impact upon the available 
surface area for gas liquid mass transfer and are regarded as being influential to 
oxygen mass transfer at all culture scales. Table 4.2. further emphasises this as the 
key relationship for kLa. Temperature appears to have little effect on the oxygen mass 
transfer coefficient under these conditions. In addition, the biomass concentration had 
no significant effect on kLa. This is likely due to a limitation on O2 in the system. 
 
 
Figure 4.2. Example DOT profiles at low (31.3h-1, represented by ), medium 
(65.5h-1, represented by ×) and high (104.1h-1, represented by ◼) kLa values. 
Experiments performed as described in Section 2.6. 
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Table 4.2. kLa value ranges observed within the experimental landscape by fill volumes 
and shaker speeds. Experiments performed as described in Section 2.6, analysis as 
described in Section 2.6.4. Data shown in Figure 4.3.  
Fill Volume 
(mL) 
Shaker Speed 
(rpm) 
kLa 
(h-1) 
1.6 250 80-120 
1.6 200 60-100 
3.2 All <60 
 
 
Across the experimental landscape, the kLa was seen to range between 30.1 and 
122.3 h-1. The range of values seen are similar to those previously reported for 
microwell plates using sulphite oxidation method in 96 well plates (Hermann et al. 
2003; Kensy et al. 2009; Kensy et al. 2005a; Kensy et al. 2005b), oxygen limited growth 
of aerobic microorganisms in 96 well plates (Doig et al, 2005) and optical sensors 
(Islam et al. 2008; John et al. 2003) (Table 4.3.). Additionally, these values can be 
compared with kLa values observed in other, larger scale, single use bioreactors (Table 
1.13.). 
The O2 mass transfer coefficient was also modelled (Figure 4.3. and Table 4.4), such 
that the statistical model generated can be used to predict kLa across the equivalent 
design space during culture. A linear model was constructed based on data from the 
full factorial design. Good agreement is seen between the experimental and modelled 
values (Figure 4.3), and this is confirmed by the low standard error (a measure of the 
statistical accuracy) for each the model parameters. 
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Table 4.3. Comparison of kLa values reported in this work with literature values of 
maximum kLa values for a range of microwell geometries. Measured kLa values taken 
from Figure 4.2.  
 
*In plate geometry column, number refers to number of wells in microtitre plate. 
RW = round wells, SW = square wells, DW = deep wells, FB = flat bottom, RB = round 
bottom and PB = pyramidal bottom.  
 
Table 4.4. Factors and parameter value estimates for the initial screening model of kLa 
in 24 DSW plates. The resultant model equation can be seen in Equation 4.1. Standard 
errors were 3.41 for each of the parameters.  
Term Unit Coefficient Estimate p-value t Ratio 
Intercept - 68.7 - 20.1 
Fill Volume mL -24.3 0.0006 -7.13 
Shaker Speed rpm 10.4 0.007 3.05 
Reference: Plate Geometry* 
Method of kLa 
determination Max. kLa (h-1) 
Hermann et al, 2003 96 RW, FB Sulphite Oxidation ~160 
Kensy et al, 2005a 24 RW, FB Sulphite Oxidation ~250 
Kensy et al, 2005b 48 RW, FB Sulphite Oxidation ~ 350 
Kensy et al, 2009 96 RW, FB Sulphite Oxidation ~300 
Duetz, 2007 96 DW O2 limited growth & Sulphite Oxidation 188 
Doig et al, 2005 
24 RW, FB 
96 RW, FB 
384 RW, FB 
O2 limited growth & 
Sulphite Oxidation 
~180 
~200 
~115 
Islam et al, 2008 
 
24 SW, PB 
24 SW, RB 
48 RW, FB 
Optical Sensors 
~250 
~190 
~90 
John et al, 2003 96 RW, RB Optical Sensors ~130 
This work 24 SW, PB Optical Sensors ~120 
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Figure 4.3. kLa and OUR values determined in 24 DSW microwell formats as a function of shaker speed, well fill volume and temperature. Dark 
grey bars represent OUR values (in mgO2L-1h-1), while light grey bars show kLa values. Error bars represent the range of experimental values 
(n=2). Experiments performed as described in Section 2.6. kLa values determined using Equation 2.2 and OUR values based on Equation 2.1. 
All data with the exception of the four right hand bars (1.75 gDCWL-1) were determined at a biomass concentration of 0.35 gDCWL-1. 
250rpm	 250rpm	 250rpm	 250rpm	 250rpm	250rpm	200rpm	 200rpm	 200rpm	 200rpm	
1.6mL	 1.6mL	 1.6mL	3.2mL	 3.2mL	
30°C	 30°C	37°C	 37°C	
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4.2.3. OUR Determination in 24 DSW (Dynamic Gassing-Out Method) 
Example raw data profiles for determination of OUR are shown in Figure 4.4. and the 
derived OUR values at the different parameter set points used are shown in Figure 
4.3. Additional detail on the quantification of OUR values can be found in Section 2.6.4. 
The greatest influence on oxygen uptake rate was biomass concentration. As 
expected, a greater number of cells resulted in a greater OUR. The oxygen uptake rate 
appears to follow the opposite trend to kLa, increasing with greater fill volume and 
reduced shaker speed (Figure 4.3. & 4.6.). This would seem counterintuitive as it would 
be expected that the greatest oxygen uptake would occur under conditions that would 
provide the greatest oxygen availability (i.e. highest kLa), however higher shaker speed 
may result in increased levels of stress, while increased fill volumes and lower shaker 
speeds result in poorer mixing and therefore less renewal of oxygen at the base of the 
well, hence OUR appears greater.  
Figure 4.4. Example DOT profiles at low (32.5 mgO2L-1h-1, represented by ), medium 
(58.4 mgO2L-1h-1, represented by ×) and high (87.6 mgO2L-1h-1, represented by ◼) 
OUR values. Experiments performed as described in Section 2.6. 
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The relationship between OUR and biomass concentration is not linear, with OUR 
appearing to be limited by the availability of O2 into the culture (indicated by kLa and 
shown in Figure 4.3.). This explains the difficulty in determining kLa at higher biomass 
concentrations (3.5 gDCWL-1 and higher), where the method requires the depletion of 
oxygen before attempting to return to 100% of saturation. It is likely that the biomass 
present instantly demands all of the O2 made available in the system. 
!"# = 68.73 − 	24.35 ∙ (1233	453.67.8):.; + 10.42 ∙ (?@A.677B)7B    Equation 4.1.  
OUR was also modelled. Figure 4.6, Equation 4.2. and Table 4.5. show these 
effects as part of a linear model, and the magnitude of the coefficients within it. The 
influence that biomass concentration has is large, while the effect of the physical 
parameters (shaking speed and fill volume) are proportionally lower, when compared 
to the model for kLa. Figure 4.7. and Table 4.5. highlight a good agreement between 
the modelled and experimental data (low p-value, high t ratio), providing confidence in 
the statistical model generated. 
The influence of fill volume and shaker speed on kLa and OUR were inverse to one 
and other i.e. greater fill volume had a negative effect on kLa, and a positive influence 
on OUR (Figure 4.5. & 4.6.). This may result from their basic mechanisms, with kLa a 
measure of oxygen into the culture and OUR its removal by the organism, and the 
calculation of kLa being dependent on an OUR already determined when using the 
dynamic gassing out method.  
CDE = 119.45 + 	57.08 ∙ (GHIJ#KK	LIMN.−3.0)2.0 + 	9.41 ∙ (OHPP	QIP. −2.4)0.8 − 8.70 ∙ (ERS.−225)25 			 
Equation 4.2. 
In summary, the models that have been generated provide a good baseline for 
quantifying and understanding the oxygen mass transfer properties of 24 DSW plates. 
Both models are linear, due to the use of a full factorial design, meaning curvature 
cannot be detected. The linear model though is suitable for this purpose. The analysis 
of variance shown in Table 4.6. and the parity plots for kLa (Figure 4.7. A) and OUR 
(Figure 4.7. B) demonstrates a high degree of confidence can be had in each model, 
with good agreement between the model generated and experimental data in both 
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cases. Root Mean Square Error (RMSE) is included, providing a statistical measure of 
how concentrated the data is around the line of the model. 
4.3. Establishing a New Method for Oxygen Mass Transfer Quantification 
During Microbial Fermentation in Microwell Plates 
4.3.1. Building the Design 
The experimental design used to quantify and model the oxygen mass transfer 
properties of a microbial culture in 24 DSW microwell plates was designed to mimic 
the experiments run for the building of the initial screening model (Section 4.2.). The 
experimental design for the 96 DSW used the principle that the ranges should provide 
the greatest potential for overlap with the 24 well format in terms of the aeration 
environment. 
 
Table 4.5. Estimates of parameter coefficients for each of the significant factors in the 
initial screening model of OUR in 24 DSW plates. The resultant model equation can 
be seen in Equation 4.2. 
Term Unit Coefficient Estimate p-value t Ratio 
Intercept - 119.4 - 30.7 
Biomass 
Concentration OD600 57.1 <0.0001 14.7 
Fill Volume mL 9.41 0.006 3.20 
Shaker Speed rpm -8.70 0.009 -2.96 
 
Table 4.6. Comparison of analysis of variance for the linear models of kLa and OUR 
in 24 DSW microwell plates. 
 Model 
kLa OUR 
p-value <0.0001 <0.0001 
R-squared 0.80 0.94 
RMSE 14.7 11.7 
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Figure 4.5. Main effects plots of the initial screening model for kLa 
in a 24 DSW plate for shaker speed (A) and fill volume (B) across 
their respective experimental ranges. Blue lines represent a 95% 
confidence interval, and red dashed lines highlight the value for kLa 
at the centre point of the experimental range. Raw data can be 
found in Appendix 3.1. 
 
 
 
Figure 4.6. Main effects plots of the initial 
screening model for OUR in a 24 DSW 
plate for shaker speed (A), fill volume (B) 
and biomass concentration (C) across 
their respective experimental ranges. 
Blue lines represent a 95% confidence 
interval, and red dashed lines highlight 
the value for OUR at the centre point of 
the experimental range. OUR values are 
in mgO2L-1h-1. Raw data available in 
Appendix 3.1. 
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Figure 4.7. Predicted versus experimental values of the statistical models for (A) 
kLa and (B) OUR in 24 DSW plates. kLa values are in reciprocal hours, OUR values 
in mgO2L-1h-1. Black dots represent data points which have been measured 
experimentally and calculated by the model, the red line indicates a line of parity 
i.e. y=x, and the red shaded area shows the 95% confidence interval. Experiments 
undertaken as described in Section 2.6. Analysis as described in Section 2.6.4. 
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In order that the oxygen mass transfer environment be modelled, a multifactorial 
DoE method was used to construct a five factor, two level, full factorial design for both 
microwell plate formats using a sacrificial sampling method with six time points (0, 8, 
24, 32, 48 and 56 hours post inoculation). The design was blocked for each of the 
sampling time points. Tables 4.7. and 4.8. show the designs for 24 and 96 DSW plates 
respectively. Points in the design space were replicated within the same plate in order 
to ensure that profiles and responses were representative. 
Factor and ranges in the design for the 96 DSW plate have been calculated and 
set either using correlations based on the geometries of the well, such as fill volumes 
which are set at 0.25 times that of the 24 DSW (maximum fill volume is 2.5mL 
compared to 10mL) or based on commonly used ranges for corresponding equipment.  
 
Figure 4.8. Example DOT profiles for six hours after culture inoculation at low (34.0 h-
1, dotted line), medium (54.81h-1, solid grey line) and high (82.7 h-1, solid black line) kLa 
values. Experiments performed as described in Section 2.6. Analysis of profiles for 
quantification of oxygen mass transfer rates as described in Section 2.6.4.  
0
1
2
3
4
5
6
7
8
0 1 2 3 4 5 6
Di
ss
ol
ve
d	
O
xy
ge
n	
Co
nc
en
tr
at
io
n	
(m
gO
2L
-1
)
Time	(h)
121 
Table 4.7. Experimental design for OUR quantification in 24 DSW microwell plates 
during microbial culture by dynamic gassing out methods. The design was intended to 
mimic the initial screening model (Section 4.2.) as closely as possible. 
Factor Unit 
Range 
Low High 
A Fill Volume mL 1.6 3.2 
B Shaker Speed rpm 200 250 
C Post Induction Temp. °C 30 37 
D Inoculum Conc. %v/v 1 5 
E Log Hour time course hr t0, Post Ind(t8), t24, t32, t48, t56 
 
Table 4.8. Experimental design for OUR quantification in 96 DSW microwell plates 
during microbial culture. The design is intended to mimic that of the 24 DSW and 
provide the greatest potential overlap in oxygenation of the culture. 
Factor Unit 
Range 
Low High 
A Fill Volume mL 0.4 0.8 
B Shaker Speed rpm 600 1100 
C Post Induction Temp. °C 30 37 
D Inoculum Conc. %v/v 1 5 
E Log Hour time course hr t0, Post Ind(t8), t24, t32, t48, t56 
 
4.3.2. Determination of OUR and QO2 During Culture Using the New Method 
Due to the issues outlined previously with the use of the traditional dynamic 
gassing out method (Section 1.2.9. and 4.1.), here the intention was to devise an 
improved technique for determining responses of the culture to forced differences in 
oxygen availability using the strategy outlined in Section 4.1. The experimental method 
differs from traditional dynamic gassing out since it is run continuously as a culture 
stage (Section 2.6.3.). The interpretation and analysis of the online data traces 
generated then differs also. This is explored in this section. Example DOT profiles 
122 
during culture are shown in Figure 4.8. It is observed that with increased kLa, the 
reduction in DOT to a minimum begins later and is prolonged. As increased kLa means 
greater input of oxygen into the culture, this would seem reasonable.  
In order to quantify OUR and QO2 using online dissolved oxygen measurements 
during culture, the analysis steps were as follows. 
As with analysis of the traditional dynamic method, once the DOT profiles have 
been obtained, they are normalized to 100% saturation, before being converted to 
engineering units (mgO2L-1) using the appropriate saturation concentration for that 
experiment (Figure 4.8.). 
For example, for a solution of pure water at 20°C, the saturation concentration of 
oxygen is 9.1 mgO2L-1 (Eaton et al. 2005). Therefore at 50% of saturation: 
!"	$%&$. ()*!"+,-ℎ,-) = 	1!2	(%)	×	!"	5678967:%&	$%&$.																		Equation 4.3. 																																																;< 	= 0.5	 × 	9.1 																																																							= 4.55	)*!"+,-ℎ,-	 
At this point, the method for quantification differs. The first derivative of CL with 
respect to time (dCL/dt) is calculated over the first 15 hours of culture, every five 
minutes. This time frame is significantly shorter than the doubling time for E. coli, and 
so it can be assumed that there is no change in the ‘instantaneous’ biomass 
concentration between calculated points. In addition, the interval is short enough to 
observe the responses in the traces, but not so short that it increases error due to 
noise in the profile (e.g. Figure 4.18). Using the derived values and the initial model for 
kLa (Section 4.2), the OUR can then be calculated using Equation 4.4. 
!BC = D<6 ∙ (;∗ − ;<) − HIJHK     Equation 4.4. 
Where C* is the saturation concentration of oxygen and CL is the concentration of 
oxygen at a given time in the first order system. 
Using equation 4.4, OUR is calculated as follows (data from an experiment at 37°C, 
400 rpm, 1600 µL fill volume, where kLa was determined to be 54.8 h-1): 
!BC = D<6 ∙ (;∗ − ;<) − L;< − ;<	K,M 7< − 7K,MN O 
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!BC = 54.8	 ∙ (6.71 − 		3.34) − (3.34 − 3.18 0.083⁄ ) 
!BC = 183.1	)*!"+,-ℎ,- 
The specific oxygen consumption rate can then be calculated using equation 4.5. 
!BC = UVW"     Equation 4.5. 
Where CL t-5 is the concentration of oxygen in the first order system five minutes 
prior to the current measurement, tL is the current time, tt-5 is the time 5 minutes prior 
to the current measurement (tL – tt-5 should therefore remain as 0.083 h using this 
method). U represents the biomass concentration and QO2 the specific oxygen 
consumption rate. 
4.3.3. Modelling OUR in 24 DSW Plates Using the New Dynamic Gassing Out 
Method. 
Initially, a model was built using all design factors (Table 4.7. and Figure 4.9.). This 
highlighted that, as with kLa, fill volume and shaker speed were the most significant 
factors influencing OUR (Figure 4.9A and 4.9B respectively), with only a small effect 
due to biomass concentration (Figure 4.9D) and no significant effect due to 
temperature (Figure 4.9C). The effects of fill volume and shaker speed are opposite, 
increasing fill volume resulting in a large decrease in OUR, and increase in shaker 
speed resulting in a rise in the OUR. Table 4.9. highlights the magnitude of each of the 
parameter coefficients in the model and statistical analysis of the factors of 
significance, showing that the model can be used with a high degree of confidence. 
The high R-squared (0.99) in combination with a low p-value (<0.0001) and RMSE 
(19.9) indicate that the model is a very good fit for the experimental data. In addition, 
Figure 4.10. shows the diagnostic plots. The predicted against actual plot (Figure 
4.10A) shows no outlying data points, and therefore a good agreement between the 
experimental data and that generated by the model. The half normal plot (Figure 
4.10B) demonstrates the effects and how strong they are, while the plot of residuals 
against run number (Figure 4.10C) shows no systematic bias in the design or its 
execution. The model is shown in Figure 4.11. and exhibits the significant impact that 
the two main effects have, with the range of OURs from around 200 mgO2L-1h-1, 
approximately quadrupling to 800 mgO2L-1h-1.  
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Figure 4.9. Effects plots showing the variation of calculated OUR with well fill volume, shaking speed, post induction temperature and inoculum 
concentration in 24 DSW microbial culture. Fill Volume (A), shaker speed (B) and inoculum concentration (D) are seen to have a significant effect, 
while temperature (C) did not. Blue shaded areas represent a 95% confidence interval, while dashed red lines highlight OUR values at the mid-
point of the experimental range. Experiments were performed as described in Section 2.6. Analysis as described in Section 2.6.4. 
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Table 4.9. Estimates of model coefficients and statistical analysis for each of the 
significant factors and interactions in the quadratic model of OUR in 24 DSW plates 
using the new dynamic gassing out method during culture. Standard errors are 3.52 
for all terms in the model. 
Term Parameter coefficient p-value 
Intercept 462.2 <0.0001 
Fill Volume -160.5 <0.0001 
Shaker Speed 84.8 <0.0001 
Inoculum Conc. -11.0 0.005 
Fill Vol. – Shaker Speed -18.0 <0.0001 
Shaker Speed – Temp. 17.2 <0.0001 
 
 
 
The experimental data was reanalysed using kLa as the input factor in place of fill 
volume and shaker speed, as these were the two factors shown to have the most 
significant effect on OUR (as well as kLa in the initial screening model). This was to 
determine if there was a correlation to be made between kLa and OUR directly, as 
shown in Section 4.4. kLa became the only significant factor in a model with an R-
squared value of 0.96 and p-value of <0.0001. The relationship was positive, and 
further demonstrates the importance that availability of oxygen has on the culture and 
the ability to utilise it i.e. with the provision of more oxygen (greater kLa), the culture 
responds by using more oxygen (greater OUR). This is highlighted both in Table 4.11. 
and Figure 4.11. This is in contrast with the relationship seen with non-growing cells 
during development of the initial screening model (Section 4.2.). 
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Figure 4.10. Diagnostic plots for the linear 
model to describe OUR during 24 DSW culture. 
The predicted against experimental plot (A), the 
half normal plot (B) indicating the significance 
and fill volume, and the residuals against run 
number plot (C) all indicate a good agreement 
between the model generated and the 
experimentally determined data. 
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Figure 4.11. Response surface plot for the model of OUR in 24 DSW culture. Light to 
dark indicates the increase in OUR value, and black dots represent experimental data 
points. Experiments performed as described in Section 2.6. OUR values calculated as 
described in Section 2.6.4. 
 
4.4. Comparing the Initial Screening Model and the Culture Model 
Although the primary use of the initial screening model was to provide the 
landscape for kLa which was then the basis for calculations of OUR during culture, the 
OUR using the traditional dynamic gassing out method can also be calculated. Table 
4.10. shows a comparison of the OURs observed using the two measurement 
methods, with OURs during culture up to over 10 times greater in magnitude. This can 
be explained as during the traditional method, aeration (in the case of this study by 
shaking) to provide oxygen is stopped and the calculation is based on the oxygen 
utilisation of non-growing biomass in a static environment. Whereas during culture, the 
128 
cells are being provided with O2, and so consuming and metabolising it at a much 
greater rate. This provides insight into oxygen utilisation in microwells which cannot be 
achieved with the traditional method, and suggests that OURs determined using the 
traditional dynamic gassing out method, though indicative, are of little quantitative 
value as they do not accurately represent the demands of the organism to be cultured. 
The process of generating modelled biomass concentration data and the 
calculation of the corresponding volumetric productivity with respect to biomass 
accumulation is shown in Figure 4.12. The biomass concentration of sacrificial 
microwell samples is measured (as described in Section 2.8.2.) before a sigmoidal 
curve fit is applied to the data. The model equation is then used to calculate the 
estimated biomass concentration at 10 minute intervals. Volumetric productivity can 
then be calculated as the change in biomass concentration over each of these periods 
(dX/dt) and plotted. 
 
 
Table 4.10. Comparison of oxygen uptake rates using the traditional dynamic gassing 
out method and using the new dynamic gassing out method during culture. OURs are 
calculated as described in Sections 2.6.4. and 4.4. 
kLa (h-1) 
OUR (traditional 
dynamic gassing out) 
(mgO2L-1h-1) 
OUR (new method) 
(mgO2L-1h-1) 
34.0 ~80 190-220 
54.8 55-70 300-350 
82.7 50-70 400-530 
103.5 40-50 
600-650 
103.5 (at 1.75 gDCWL-1) 150-170 
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Figure 4.12. Example data (open symbols) and modelled (solid lines) biomass 
concentration profiles (A), and the corresponding biomass productivity (B). , ✕,  
represent high, medium and low OURs respectively. Experiments carried out as 
described in Section 2.6. Analysis as described in Section 2.6.4. and 4.4. 
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Figure 4.13. then shows the relationship during culture in microwell plates between 
growth and oxygen uptake. As has been seen previously (Section 3.2.5.), a sharp 
increase in OUR is followed shortly afterwards by the transition into exponential growth 
phase and the greatest rate of volumetric productivity. It is interesting to note the clear 
trend between greater available oxygen (shown here as greater kLa), greater OUR (as 
noted in Sections 4.2. and 4.3.) and a greater rate of biomass accumulation (dX/dt), 
as this helps to highlight the criticality of oxygen availability for microbial culture, 
particularly in small scale, high throughput systems. OUR peaks and then plateaus 
when volumetric productivity (dX/dt) reaches its maximum i.e. during the exponential 
growth phase. This is yet further evidence for the prioritization of growth in terms of 
oxygen utilization. OUR is then sustained, indicating that there is significant oxygen 
demand required for sustaining biomass concentration as suggested in Section 3.2.5. 
In summary, the method developed here for accurately quantifying and modelling 
the oxygen uptake rate of live microbial cells in culture appears to have been effective. 
The experimental method and analysis, though extensive, result in empirical models 
for kLa and OUR which can be easily reasoned and used with a high degree of 
confidence. In terms of the experimental method, little variance was seen between 
replicated profiles for DOT using the PreSens system, again providing a high degree 
of confidence in this technique, which hopefully is seen as an improvement on the 
traditional dynamic method as it accounts for the dynamic nature of a fermentation. 
In addition, this method has provided valuable insight into culture dynamics and 
the demands of a microbial expression system on the culture in terms of oxygen. It has 
also provided further support for the hypotheses in Section 3.2.5. on the prioritisation 
of oxygen utilisation. 
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Figure 4.13. Plots of OUR (solid line) and biomass volumetric productivity (☐) at 
differing oxygen availabilities (by kLa). kLa values represented are 34.0h-1 (A), 54.8h-1 
(B), 82.7h-1 (C) and 103.5h-1 (D). Profiles are a representative example of the trends 
seen in each of the different aeration environments across the experimental 
landscape.  Experiments performed as described in Section 2.6. Analysis as described 
in Sections 2.6.4. and 4.4. 
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4.5. Relationship Between Biomass Growth and Oxygen Availability 
Figure 4.13 highlights the relationship between oxygen availability, the rate of 
oxygen uptake and the dynamics of culture growth, as noted in Section 4.4. However, 
with oxygen widely regarded as the limiting substrate in microbial fermentation, the 
interrelationship between the availability of oxygen and the achievable biomass 
concentration was interrogated. The effects on biomass accumulation were modelled 
in each of the 24 and 96 deep square well plates. Figure 4.14. shows those factors 
from the design seen to have a statistically significant effect. It is shown in both cases 
that fill volume and shaker speed, the two main factors influencing kLa, are significant 
effects. In addition to this, Figure 4.17 again highlights that oxygen availability in 
microwells has a major influence on biomass accumulation, and that as previously 
suggested, it is likely to be limiting, with greater biomass concentrations seen with 
higher levels of available oxygen. 
Analysis of variance was undertaken on the models in order to ensure that these 
observations were statistically valid. The predicted against experimental plots (Figure 
4.15.) and ANOVA statistical diagnostics (Table 4.11.) show that the model of biomass 
concentration in 24 DSW fits well with the experimental data, and that it can be used 
with a high degree of confidence. An R-squared of 1.00 and close grouping of the data 
points around the predicted versus experimental parity line are good indicators. A good 
fit is also seen in the model for biomass accumulation in 96 DSW, though the R-
squared (0.83) and grouping of data points is not quite so good. 
 
Table 4.11. ANOVA statistical diagnostics to show confidence in the models for 
biomass accumulation as a result of oxygen availability in 24 and 96 DSW plates during 
culture. Models shown in Figure 4.14. and diagnostics on the model in Figure 4.15. 
 Model 
24 DSW 96 DSW 
R-squared 1.00 0.83 
p-value <0.0001 <0.0001 
Root Mean Square Error (RMSE) 0.19 0.68 
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Figure 4.14. Effect 
profiles for the factors of 
influence on the model 
for biomass 
accumulation 24 DSW 
culture (A) and 96 DSW 
culture (B). Fill Volume 
(i), shaking speed (ii), 
temperature (iii) and 
inoculum concentration 
(iv) are all seen to have 
a significant effect in 
both cases. Greater 
gradients indicate an 
effect of larger 
magnitude. Grey 
shaded areas indicate 
95% confidence 
intervals, while dashed 
red lines represent the 
value for biomass 
concentration at the 
centre point of the 
experimental range. 
Experiments carried out 
as described in Section 
2.6. Analysis as 
described in Section 
2.6.4. 
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Figure 4.15. Predicted versus experimental plots for the models of biomass accretion in 24 DSW (A) and 96 DSW (B) during culture. 
Black dots represent data points, the red line the line of parity (i.e. y=x) and the shaded red area the 95% confidence interval. Experiments 
carried out as described in Section 2.6. Analysis as described in Section 2.6.4.  
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4.6. Relationship Between Recombinant Protein Expression and Oxygen Availability 
Oxygen availability is highlighted as a potentially key factor in recombinant protein 
expression (Section 1.2.3. and 1.2.4.) and so the relationship between factors influencing 
oxygen mass transfer and the accumulation of protein are looked at in each of the microwell 
formats. The relationship between oxygen availability and recombinant protein expression 
appears to be a complex one, and one which is not extensively investigated in literature, which 
in some cases makes the cause behind responses more difficult to evaluate. 
As described in Section 2.5. sacrificial time point samples were taken from microwell 
cultures and measured for total fluorescence. Figure 4.16. shows representative examples of 
total fluorescence at different oxygen availabilities. Figure 4.18. shows that there are a number 
of significant effects on protein expression. Interestingly though, these do not appear to be 
directly linked to oxygen availability. Although shaking speed and fill volume are significant 
effects, they are small in magnitude, particularly when compared with the largest effect (time 
post inoculation). It is also interesting to note that the effect seen for shaking speed is a 
negative one in both plate formats, the opposite to kLa. Additionally, there is little effect seen 
as a result of changing inoculum concentration. Figure 4.17. also highlights that in the oxygen 
limited microwell plates, there is no direct correlation between increasing available oxygen 
and recombinant protein expression. 
The most significant positive effect after post inoculation time is temperature of the culture. 
It is hypothesised that this effect results from increasing biomass concentration and provision 
of sufficient energy for expression and fluorescence of the recombinant protein. Models for 
both the 24 and 96 DSW plate formats are similar, as indicated by the responses to factors in 
Figure 4.18. The effects, have similarly sized parameter coefficients and, as the statistical 
diagnostics demonstrate (Figure 4.19. and Table 4.12), the validity of the models are both 
good. The ANOVA undertaken on the models show low p-values and R-squared values in 
excess of 0.8, which, though not as high as other models seen in this work, are still acceptable 
for such a complex system and provide a high degree of confidence in the model. In addition, 
the predicted against experimental plots (Figure 4.19.) show a good agreement between the 
model and the experimental data, with limited scatter outside of the 95% confidence interval. 
As such it can be said that these models are a good representation of the system. 
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Figure 4.16. Representative examples of culture fluorescence profiles at low (), medium (X) 
and high (Δ) kLa. Experiments carried out as described in Section 2.6. Fluorescence measured 
as described in Section 2.8. 
Figure 4.17. Maximum biomass concentration (solid bars) and recombinant protein 
expression (striped bars) in conditions representative of high, medium and low oxygen 
availabilities in 24 and 96 DSW plates (grey and black respectively).  Experiments carried out 
as described in Section 2.6. Protein expression determined as described in Section 2.8.3.2. 
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Figure 4.18. Effect profiles for factors included in the multifactorial design evaluating the relationship between recombinant protein expression 
and oxygen availability in 24 DSW (A) and 96 DSW (B) plates. Fill volume (i), shaking speed (ii), post induction temperature (iii), inoculum 
concentration (iv) and log hour time post inoculation (v) are all shown. Solid black lines represent the model as a result of the contribution from 
the individual factor, grey shaded areas indicate 95% confidence intervals, while dashed red lines represent the value for GFP fluorescence at 
the centre point of the experimental range. Experiments and analysis performed as described in Section 2.6.  
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Figure 4.19. Predicted versus experimental parity plots for the models of recombinant 
GFP expression (by total fluorescence) in 24 DSW (A) and 96 DSW microwell plates 
(B) during culture. Black dots represent data points, the red line the line of parity (i.e. 
y=x) and the shaded red area the 95% confidence interval. Experiments performed as 
described in Section 2.6. Analysis as described in Section 2.6.4. 
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It is therefore interesting to observe that over this scale increase, 96 DSW plates 
should be a good mimic for the larger 24 DSWs as they give quantitatively similar titres 
and biomass concentrations, while responses to factors and levels are comparable in 
response to factors and levels investigated. These observations are needed to further 
scale up understanding between bioreactor systems and accelerate associated 
development timelines. It should be highlighted though that these are both oxygen 
limited environments, and so while this concurrence is good, it does not yet reflect 
performance in STRs or at commercial scale. 
In order to interrogate why there appeared not to be a direct relationship between 
oxygen availability and recombinant GFP expression. Figure 4.20. shows 
representative examples of the expression of GFP relative to the online DOT. This 
highlights that the timing of GFP accumulation, which follows the point at which DOT 
is minimum, and is approximately correlated with when the culture transitions from 
exponential growth to stationary phase. This indicates that protein is being produced 
but not folding completely until oxygen is available (oxygen is required for the 
maturation of GFP to the fluorescent state), and lends further weight to the argument 
that oxygen use is prioritised for growth and the generation (and maturation) of a 
recombinant protein product comes second.   
It is also noted that with greater kLa, there is an earlier start to product 
accumulation. In relation to the points previously made about the relationship between 
growth and productivity, it is likely that this is because with greater available oxygen 
the exponential phase begins and is exhausted earlier, allowing the culture to transition 
into stationary phase and protein generation. These plots also confirm that product 
generation is heavily impacted by culture temperature. 
Table 4.12. ANOVA statistical diagnostics to determine confidence in the models for 
recombinant GFP expression as a result of aeration environment in 24 and 96 DSW 
plates during culture. Analysis as described in Section 2.6. 
 Model 
24 DSW 96 DSW 
R-squared 0.81 0.88 
p-value <0.0001 <0.0001 
Root Mean Square Error (RMSE) 0.49 0.49 
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Figure 4.20. Representative examples of dissolved oxygen and protein expression 
profiles over time. Examples are taken from time courses with a kLa of ~104h-1. 
Examples are at 37°C and 250rpm, fill volumes of 1.6mL (A & C) and 3.2mL (B & D), 
and inoculum concentration of 1%v/v (A & B) and 5%v/v (C & D). Grey dots represent 
the DOT trace, while symbols (¢,☐,Δ,X) show the expression levels of the 
recombinant protein product by total GFP fluorescence. Experiments were performed 
as described in Section 2.6. Analysis as described in Section 2.6.4.
A B 
D C 
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It appears that, provided a sufficient threshold of available oxygen, reached when the 
culture is no longer in growth phase, there is no distinct advantage to increased levels of 
oxygen with respect to recombinant protein expression. Indeed, given sufficient oxygen the 
cell will prioritise growth rather than the generation of protein product, and therefore promoting 
a greater O2 mass transfer coefficient in microwells would seem to have the potential to be 
detrimental to productivity in the early stages of culture. This is highlighted in Figure 4.17. also. 
This is not to say that microwells are providing an ideal environment for microbial growth, but 
rather that utilisation of oxygen by the cells for protein expression is lower priority. This 
relationship is hypothesised and discussed also in Section 3. 
 
4.7. Modelling Overlaps in Aeration Environment Between 24 and 96 DSW Plates. 
One of the objectives of this work was to develop models for the overlap in aeration 
environment between 24 and 96 DSW plates using biomass accumulation and protein 
expression as key responses in each of the plate formats. This assumes oxygen limitation in 
microwell plates which as discussed in previous sections is a reasonable one. It should then 
be possible to estimate the set points required to achieve equivalent O2 mass transfer between 
plate geometries. 
In order to make the models generated in 96 and 24 well plates directly relatable, the 
parameters related to shaking speed in the orbital shakers have been converted into a linear 
velocity and a centripetal force. Additionally, to more appropriately correlate the volumes used 
in the different geometries, a ratio of fill volume to well volume has been calculated. 
For example, a 96DSW in an Eppendorf thermomixer comfort with a 3mm throw, running 
at 1100rpm with an 800μL fill volume and the density of culture assumed to be that of water: 
         ! = 					$%            Equation 4.6. 
    = 					0.003$ 
    = 					0.009425- 
Where C is the circumference and D the diameter of the orbital throw respectively. 																																								1100/0- = 1100 60⁄ = 18.33456 
                  789:;/	<:=>?8@A	 = 		!	 × 	C                                            Equation 4.7. 
   																																			< = 0.009425	 × 	18.33 = 		0.173-456 
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Where E is the angular velocity.  
!:9@/80:@;=	F>/?: = (H	.IJ)L                                                                  Equation 4.8.			
    = 0.0008		.		 0.173M 0.0015N 	
    = 0.015962 
    = 0.016	O 
 
Table 4.13. shows the calculated linear velocities and centripetal forces under each of the 
set of factor set points. There is an approximately 1.5 (with RPM) to 3 (with fill volume) times 
increase in linear velocity at the low and high ends of the ranges respectively. This translates 
to an almost 12 times increase from minimum to maximum centripetal force (2.37 to 27.4 x10-
3 N), providing a good breadth which it was expected would impact on oxygen availability and 
the resultant biomass and protein production. 
 
Table 4.13. Centripetal forces (x10-3 N) and linear velocities (ms-1 in parentheses) for the fill 
volumes and shaking speed investigated in the 24 and 96 DSW plates. Fill volumes of 400 
and 800μL pertain to the 96 DSW plates, while 1600 and 3200μL fill volumes were used in 24 
DSWs. Similarly, shaking speeds of 200 and 250rpm refer to set points used with 24DSW 
plates, and 600 and 1100rpm to 96 DSWs. Values calculated as described in Section 4.7. 
 Well Fill Volume (μL) 
400 800 1600 3200 
Shaking 
Speed 
(rpm) 
200 - - 
8.79 
(0.262) 
17.6 
(0.262) 
250 - - 
13.7 
(0.327) 
27.4 
(0.327) 
600 
2.37 
(0.094) 
4.74 
(0.094) 
- - 
1100 
7.98 
(0.173) 
16.0 
(0.173) 
- - 
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4.7.1. Equating O2 Mass Transfer Conditions in 24DSW to 96DSW Using Biomass 
Accretion 
Oxygen availability is assumed to be the factor which is limiting to growth in both 24 and 
96 DSW plates. This is based on the work in this thesis, as well as literature precedent. Thus 
a model can be built based on the measurements of oxygen availability, as well as the input 
parameters which have already been shown to affect this in 24 deep square well plates, to 
infer the availability of O2 in the smaller, 96 deep square wells which cannot be measured 
directly. 
4.7.1.1. Model Generation 
Models generated for maximum biomass concentration using JMP (Figure 4.14.) 
demonstrate that there is an overlap in the factors impacting on oxygen mass transfer in 
microwells. These include well fill volume, shaking speed (which for the purpose of developing 
this model has been converted to linear velocity of the well), an interaction between linear 
velocity and the temperature, and temperature for the 24 DSW plate. 
The equivalence is tested using the statistical models generated in this chapter. The 
models can be generalised as: OD96	=	A	+	BV96	+	CT	+	DF96	+	E(V96-V*96)(T-T*96)	 	 Equation 4.9.	OD24	=	A’	+	B’V24	+	C’T	+	D’F24	+	E’(V24-V*24)(T-T*24)		 	 Equation 4.10.	
Where V96 is the linear velocity of 96 deep square well plate (ms-1), V24 the linear velocity 
of 24 deep square well plate (ms-1), T the temperature (°C), F96 is the fill volume of 96 deep 
square well plate (μL) and F24 the fill volume of 24 deep square well plate (μL). The mean 
values of these variables, used for the interaction terms, are indicated using an asterisk (e.g. 
V*96) 
The constants and coefficients of these terms are defined as: OD96 is the maximum OD in 
96 deep square well plate using curve fitting; OD24 the maximum OD in 24 deep square well 
plate using curve fitting; A the constant term for 96 deep square well model; A’ the constant 
term for 24 deep square well model (this convention is used also for the following coefficients 
e.g. B’); B is the coefficient of velocity term; C the coefficient of temperature term; D is the 
coefficient of volume term and E the coefficient of velocity-temperature interaction. 
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Here the intention is to determine an equivalent linear velocity for the 96 and 24 well plates. 
Equating the two generalized models and rearranging so that V96 (the desired output) is the 
subject gives: 
]^ _ =	 `+Fa]24,cd+e(c)+ℎag96,g24dh(c)     Equation 4.11. 
Where: 
   ` = 	i’	– 	i	 + 	k’]∗Mmc∗Mm	– 	k]∗^_c∗^_	
   F(]Mm, c) = 	 (k’(c − c∗Mm) 	+ 	o’)]Mm]24	
   e(c) =	 (!’	– 	k’]∗Mm	–	(!	– 	k]∗Mm))c	
   (g^ _, gMm) = 	%’gMm	– 	%g^ _	
   h(c) = 	k(c	–	c∗^_) 	+ 	o	
Values for constants and coefficients from the models for OD in both 96 and 24 DSW 
plates can be introduced. The parameter values for each of the models are required. Values 
are shown in Table 4.14. 
From here, an example of equivalence can be considered using two cultures (one from 
the 96 well plates, one from the 24 wells), which resulted in similar maximum biomass 
concentrations, in order to demonstrate the intended application of the equivalence model with 
known data. The set points are as follows: 
T=37°C, F96 = 400µL, F24 = 3200µL, V96 = 0.173ms-1, V24 = 0.327ms-1 
Incorporating these into the model, gives: 
        α  = 161.22 
                f(V24,T) = 44.88 
    g(T) = -198.73 
       h(F96,F24)  = -5.2 
    d(T) = 96.36 
Giving a prediction that V96 should be 0.178 ms-1 in order to generate the same maximum 
biomass concentration, which is acceptably close to the actual value of 0.173 ms-1 used 
experimentally. Some error can be attributed to the small difference between actual and curve 
145 
fit biomass concentration values. Additionally, some to the fact that although good, the model 
is not a perfect fit.   
There are large areas of the design space which overlap in terms of biomass accumulation 
and therefore oxygen mass transfer in the two different plate geometries. Similar final biomass 
concentrations can be achieved, modelled and predicted between 96 and 24 deep square well 
plates using this method, and in turn be used to determine equivalent experimental parameter 
set points to achieve the same biomass concentration in each format. 
In turn, as O2 is assumed to be limiting, oxygen mass transfer in 96 well plates can be 
estimated i.e. the set points which achieve equivalent biomass concentrations are providing 
the same level of available oxygen and therefore have equivalent kLas. This is shown in the 
development of O2 mass transfer models in Sections 4.4. and 4.5., in which there is shown 
already to be a high degree of confidence. 
 
Table 4.14. Parameter coefficients from the models for oxygen mass transfer with respect to 
biomass accumulation in 24 and 96 DSW plates. 
Parameter 
Term in 24 
DSW Eqn. 
Value in 24 
DSW model 
Term in 96 
DSW Eqn. 
Value in 96 
DSW model 
Intercept A’ -16.12 A 17.22 
Coefficient of velocity B’ 66.90 B 28.44 
Coefficient of 
temperature  
C’ -0.10 C 0.38 
Coefficient of fill volume D’ -0.001 D -0.005 
Coefficient of velocity-
temperature interaction 
E’ 29.71 E 22.64 
Mean velocity V*24 0.295 V*96 0.128 
Mean temperature T*24 33.5 T*96 34.0 
This in turn acts as a proof of concept for establishing similar relationships at different 
stages of the scale up paradigm. 
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4.7.2. Equating O2 Mass Transfer Conditions in 24DSW to 96DSW Using Recombinant 
Protein Expression 
An initial aim of this section of work was to generate a model to equate recombinant protein 
expression in 24 and 96 DSW plate formats which would estimate the set points required to 
provide equal amounts of protein in each case, such as has been done in Section 4.7.1. for 
biomass accretion. 
Although some overlap is seen between the two plate geometries in terms of protein 
expression, it has also been demonstrated that oxygen does not appear to be the directly 
limiting factor for generation of this product (Section 4.6.). As such, any model generated in 
order to try and equate protein production as a result of the oxygen environment would be 
misleading, and likely unsuccessful. 
4.8. Summary 
The aim of this chapter was to develop a method to improve the precision of oxygen mass 
transfer quantification in commonly used microwell plate formats, using statistical models to 
demonstrate the usefulness of the method and equivalent culture performance in both 
geometries. Using recent developments in online dissolved oxygen measurement in microwell 
plates, a new method for quantification of OUR and mass transfer rates has been developed 
(Section 4.3.) which has a number of advantages compared with traditional gassing out or 
sulphite oxidation methods. As expected, influencing the physical parameters to which a 
microwell culture is subjected, impacts on both the available oxygen and the physiological 
response of the culture (Section 4.4.). Greater available oxygen results in increased biomass 
accumulation and reduced recombinant protein formation, lending further weigh to the 
hypothesis that oxygen utilisation prioritises growth (Section 3.5.).   
Multi-dimensional models for kLa (Figure 4.5. and Table 4.4.) and OUR (Figure 4.9. and 
Table 4.9.) were developed in 24 DSW plates based on the new method, improving the 
understanding of culture dynamics in microwells, mass transfer of oxygen into the culture and 
oxygen utilisation by the microbial expression system. 
Accumulation of biomass and a recombinant protein product (GFP) were evaluated in a 
multifactorial landscape (Sections 4.5. and 4.6.), and modelled to determine that oxygen does 
indeed appear to be the limiting factor in biomass accumulation in microwells but that 
additional significant factors influence on protein expression. 
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Similar models were observed in both plate geometries, indicating that 96 DSW plates are 
a good mimic for protein expression and growth in 24 DSW plates (Figures 4.14. and 4.18.). 
This allows users to switch between formats enabling flexibility for high throughput screening 
and expression studies. As many of the limitations of the two plate types are shared this would 
seem reasonable. This observation was only made available by the use of a DoE landscape 
in order to understand the influence of interacting factors on the system. 
A mathematical model was also built for estimation of equivalent biomass and parameter 
set points in 96 DSWs using overlaps with 24 DSW maximum biomass concentration and (due 
to oxygen being the limiting substrate) the aeration environment (Section 4.7.).  
In the next chapter the oxygen mass transfer capabilities of a number of commercially 
available single use bioreactors (SUBs) will be quantified and characterised. This will be used 
to determine the applicability of SUBs for culturing microbial expression systems, using the 
characterisation work undertaken in Section 3 as a reference point. 
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5. Oxygen Mass Transfer Characterisation of Laboratory Scale Single Use 
Bioreactors  
5.1. Context and Aim 
This work so far has reviewed the relevance of industrial biocatalysis, with a focus 
on oxidoreductive enzymes and oxygen utilisation by cytochrome P450 
monooxygenases (Section 3), and demonstrated the compatibility of scale down 
technologies (Section 4) in the form of microtiter plates for culturing microbial 
expression systems, and producing recombinant proteins of commercial interest. It is 
now interesting to consider the potential for scale up of microtiter plate results into 
single use bioreactors (SUBs). 
SUBs are increasingly used in industrial bioprocess development and 
manufacturing, with the largest reactor commercially available for microbial systems 
being 2m3 total volume. SUBs have a number of advantages including reduction in 
batch turnaround time and resource requirement for cleaning, but are not without their 
challenges (Section 1.2.7.). One of the biggest limitations is that SUBs typically have 
limited oxygen mass transfer capabilities (Table 1.13). Given the overall aim of this 
work, it is important to demonstrate which technologies are capable of supporting 
microbial fermentation and whole cell oxidative bioconversions.  
SUBs are available in a number of designs, from simple two-dimensional, pillow 
style bags which require rocking, to three-dimensional bags which require a support 
frame for stability, and rigid moulded designs which share many of the characteristics 
of a traditional stainless steel bioreactor. Each of these has differences in their 
geometry and configuration which will influence oxygen mass transfer capabilities. This 
was discussed in Section 1.2.7.4. 
5.1.1. Aims 
As discussed previously in Sections 1.2.9. and 4.1, current methods for 
characterisation of oxygen mass transfer have significant limitations, two of which are 
that an idealised liquid is often used (typically water) and that evaluations are done 
under a specific set of conditions and are not broadly applicable. As such, the 
objectives for this chapter will focus on evaluating the oxygen mass transfer 
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capabilities of commercially available SUBs and determining where they can be used 
for culturing microbial expression systems. Specific objectives are to: 
• Quantify oxygen mass transfer capabilities of two commercially available 
SUBs, and a traditional glass benchtop STR as a benchmark; 
• Establish a method for modelling oxygen mass transfer in multifactorial 
experimental space under a range of widely used experimental conditions. 
This will aid in understanding which factors interact with one and other, but 
also which of the factors that influence oxygen mass transfer are common 
to different reactor geometries, 
• Use this method to generate models for oxygen mass transfer in SUBs in 
order to establish where they can be applied to microbial fermentation. 
 
5.2. Oxygen Mass Transfer in a Conventional Stirred Tank Bioreactor (New 
Brunswick BioFlo 310) 
The New Brunswick BioFlo 310 is a glass, bench top, autoclavable, pilot scale, 
stirred tank bioreactor. It provides a model system with which to compare the SUBs, 
having similar total volume and aspect ratio to the XDR-10 (Section 2.3.1. and 2.7.3.) 
and the rigid construction and impeller type of the Ambr®250 (Section 2.3.1. and 
2.7.2.). Additional information on the BioFlo 310 can be found in Section 2.3.1, 2.7.1. 
and Table 2.1 including configuration and geometries. 
The BioFlo 310 uses a polarographic dissolved oxygen probe which must be 
calibrated outside of the reactor before a range check is undertaken once the probe is 
installed in the vessel. The data recording software provided has changing frequencies 
for data recording depending on the rate of change of the parameter (i.e. DOT). As a 
result, during rapid changes in DOT, data is recorded every five seconds, but this 
increases when the rate of change is reduced. Therefore, there is a concern over the 
consistency with which data points are logged.   
5.2.1. Building the Experimental Design  
The factors and ranges selected for investigation have been informed by prior 
knowledge of oxygen mass transfer in fermentation, and by evaluation of the available 
literature (Section 1.2.6.). Additional constraints were placed on the ranges by the 
limitations of the BioFlo 310 and the associated control software. A multifactorial 
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response surface methodology (RSM) was applied in order to generate a predictive 
model for kLa (Section 2.7.). This enables the identification of curvature in the response 
and a high degree of statistical confidence with respect to how the properties of the 
environment and process constraints affect mass transfer. 
Five factors were selected from a preliminary list of 11. A design containing 50 runs 
in an RSM framework was constructed. The experimental points were distributed 
across the range (at 0%, 25-30%, 50%, 70-75% and 100% of the range). The five 
factors chosen were aeration rate, agitation speed, temperature, viscosity as 
measured by media concentration of glycerol (henceforth referred to as viscosity) and 
supplementary antifoam concentration. Selection was of the factors deemed most 
likely to influence oxygen transfer. 
Factors and ranges are summarised in Table 5.1. In addition, the experimental 
design can be found in Appendix 4.1. Aeration rate is known to influence oxygen mass 
transfer. However, it has been shown that aeration rates in excess of 1.5vvm can flood 
the impeller region (Stanbury et al, 1995) and have a detrimental effect on mass 
transfer. As such 1.5vvm was set as the upper limit, while a preliminary experiment 
using water indicated that aeration rates less than 0.13 vvm result in the DOT not 
reaching above 70% of saturation, and so this was set as the minimum. A similar effect 
was seen for agitation speeds lower than 100rpm, and so this was set as the minimum 
for this factor. The maximum was dictated by the constraints of the BioFlo 310 motor 
and control software and was set at 1200rpm. 
As discussed in Section 1.2.6.4. temperature effects the solubility and diffusivity of 
oxygen, and so it was considered a potentially important factor to investigate. The 
temperature range was defined with a consideration for microbial fermentation which 
is unlikely to be performed below 15°C. In addition, diffusivity of oxygen dominates 
mass transfer in the range of 10-40°C (Doran, 1995) while outside of this range 
solubility of oxygen dominates. Thus, to test both of these mechanisms, a maximum 
temperature of 50°C was selected. With respect to viscosity, the established approach 
of using water and glycerol mixtures in order to modify viscosity in a predictable way 
was used (Sheely 1932; Segur & Oberstar 1951; Özbek & Gayik 2001; González et al. 
2011). The minimum would be close to that of water and so no addition of glycerol to 
the base media was used. 30mLL-1 was selected as the maximum concentration, with 
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fermentations unlikely to go this high due to a potential for carbon catabolite repression 
(CCR) and high cost at scale (Brückner & Titgemeyer 2002). 
Antifoam (poly-propylene glycol - PPG) concentrations were in the range of 0 to 
0.1% v/v, with a concentration of 0.02% v/v commented as being sufficient for 
suppression of foam in an aqueous media (Sigma-Aldrich 2015).  
Table 5.1. Factors and ranges for generating the model of oxygen mass transfer in a 
New Brunswick BioFlo 310 bench top STR. Experiments performed as described in 
Section 2.7. 
Factor Unit 
Set points 
Minimum Low Centre High Maximum 
Glycerol 
Concentration mL L
-1 0 8.69 15 21.31 30 
Aeration Rate vvm 0.125 0.43 0.75 1.07 1.50 
Agitation 
Speed rpm 100 419 650 881 1200 
Temperature °C 15 25.1 32.5 39.9 50 
Antifoam %v/v 0.0 0.036 0.055 0.074 0.100 
 
5.2.2. Fixed Factors 
In addition to highlighting what was changed, it is important to know what was fixed 
and why. Compressed air for example was used throughout rather than changing the 
composition of the inlet gas with respect to oxygen concentration. Although potentially 
impactful, beyond small pilot scale, pure oxygen is seldom used for microbial 
fermentation. This is due to cost, and because of the safety issues associated with 
storing large volumes of compressed oxygen. Instead, alternative means are used 
such as head pressure to increase the solubility of oxygen. 
It has been assumed that the hydrodynamics of the system are sufficient to provide 
a well-mixed environment (i.e. instantaneous dispersal of oxygen), and so there is no 
requirement to investigate probe height as a factor. The ionic content of the liquid 
phase has been shown to influence solubility of oxygen and therefore kLa, however 
this was deemed to be relatively minor, and would have likely required a switch to a 
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defined medium composition, and so the base media composition was fixed around 
that of terrific broth (TB).  
Finally, the static gassing out method was used (Section 2.7). Use of dynamic 
gassing out (as demonstrated in Chapter 4) would have been preferred, testing with a 
range of biomass concentrations. However, this would be impacted by the strain used, 
again distracting from the desired output of a widely applicable model. 
5.2.3. Run Ordering 
The order in which experimental runs were undertaken was a critical consideration 
dictated principally by media composition and temperature factors (Table 2.2.). Ideally, 
run order would be randomised to minimise the likelihood of any bias or introduction 
of experimental error into the data, however it was not practical to prepare fresh media 
for each run. As such, runs were grouped (no more than 6 runs in each group), 
accommodating increasing antifoam concentration, as it is a physical addition, and so 
cannot subsequently be removed. Furthermore, in order to avoid any potential adverse 
effects of high temperature on media properties (e.g. possible degradation of media 
components), if more than one temperature was grouped, then lower temperature runs 
were performed first. 
5.2.4. Modelling Oxygen Mass Transfer in a Pilot Scale Stirred Tank Bioreactor 
Prior to building a model for oxygen mass transfer, the kLa under each set of 
conditions must be quantified. The method for doing this and adjusting for the probe 
response time (PRT) is described in Section 2.7.1.2. A table of calculated kLa values 
for this investigation can be found in Appendix 4.2. The model equation can be found 
in Appendix 4.5. 
Building the multifactorial model after the initial data processing is a significant 
undertaking. Decisions regarding the application of particular model fits are required 
and must be based on the statistical evidence provided by analysis using the DoE 
software. 
The model built was quadratic. Since an RSM design was used and the design 
space was saturated, it was possible to look for curvature in the responses. The 
statistics behind the quadratic model were the strongest available (when compared 
with linear, two factor interaction and cubic options). A sequential p-value of <0.0001 
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and an R-squared of 0.88, as well as the lowest standard deviation value confirm the 
quadratic as the preferred choice. This is discussed in more detail in Section 5.2.4.3. 
In order to exclude those factors with an insignificant effect, a backward elimination 
was used, removing those factors and interactions with the smallest effects first and 
continuing until only significant terms remain as part of the model. The literature which 
describes the influence of factors investigated here on oxygen mass transfer is 
discussed in Section 1.2.6. In addition, comparison of the values determined here with 
those in the literature can be found in Table 5.14. 
5.2.4.1. Main Effects 
The model highlights three main effects on oxygen mass transfer. These are 
aeration rate, agitation speed and antifoam concentration. 
Figure 5.1A. shows the effect of aeration rate on kLa. Up to 1vvm there is a steady 
increase in kLa from 0.020 to 0.065s-1. Above 1vvm the kLa plateaus before beginning 
to decline. This is most likely due to flooding of the impeller resulting in ineffective 
dispersion of the gas into the liquid media. In addition, at higher aeration rates, with 
the fixed hole size of the sparger the bubbles formed become larger, resulting in a 
smaller surface area to volume ratio which has a negative impact on oxygen mass 
transfer. Aeration rate is the single greatest main effect. 
Agitation speed is the next most influential factor. The relationship between kLa 
and agitation speed is shown in Figure 5.1B, and again it is not a linear one. As 
agitation speed increases, bubbles are broken down, increasing the surface area to 
volume ratio. This larger interfacial surface area improves the efficiency of oxygen 
mass transfer into the media (Doran, 1995). Additionally, with increasing agitation 
speed, there is greater dispersion of the bubbles. These contribute to the increasing 
kLa (by ~0.03s-1) up to approximately 0.065s-1 at 800rpm, after which, there is a plateau 
and decline as with aeration rate. Above 800rpm, the decline in kLa is most likely due 
to flooding of the impeller region, in an interaction with aeration rate. This interaction 
will be discussed in Section 5.2.4.2. 
Aeration rate has a greater influence on oxygen mass transfer than agitation speed 
as a main effect (although they also interact). In Figures 5.1A and 5.1B it can be seen 
that changes in aeration rate are responsible for a more than three-fold increase in  
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Figure 5.1. Plots for the three main effects observed in the 
model of oxygen mass transfer coefficient in the BioFlo 310 
stainless steel stirred tank bioreactor. Effects of aeration rate 
(A), agitation speed (B) and antifoam concentration (C) are 
shown. Experiments and analysis performed as described in 
Section 2.7.  
 
 
B 
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kLa, from 0.02 to 0.065s-1, while the agitation speed causes an increase from 0.035 to 
0.065s-1 (a change of 0.03s-1). This is likely due to the aeration rate being responsible 
for increasing the volume of oxygen in the reactor, while agitation speed is responsible 
for the breaking down the bubbles. It appears therefore that there is a dependence, 
the contribution of agitation speed is restricted by aeration. It is reasonable also that 
these would have the greatest individual effects. 
Figure 5.1C shows the influence of antifoam on kLa, which also has a positive 
effect, increasing kLa from ~0.05 to ~0.065s-1. This positive correlation is contrary to 
much of the information available from the literature which suggests that, as antifoams 
are surfactants, they reduce the mobility of the gas-liquid interface and increase the 
coalescence which in turn adversely affects kLa (Stanbury et al. 1995; Hebrard et al. 
2009). However, there are a number of potential explanations for this effect. The first, 
put forth by Masutani and Stenstrom (1991), is that during unsteady state testing, with 
an increase in experimental number, there is deterioration in the performance of the 
antifoam as the same media is reused (Section 2.7.1.1.), resulting in increased kLa. 
Alternatively, oxygen may accumulate on the antifoam at the interface between the 
gaseous and liquid phases (Rols et al. 1990). This may result in increased 
concentrations of oxygen over time. The main effect is not as substantial as aeration 
or agitation speeds but is still a significant influence.  
5.2.4.2. Two Factor Interactions 
In addition to the main effects, there are six interactions between factors which 
have a statistically significant effect on oxygen mass transfer in the BioFlo 310 STR. 
These are aeration rate and agitation speed, viscosity and aeration rate, viscosity and 
temperature, aeration rate and temperature, agitation speed and antifoam 
concentration and antifoam concentration with temperature.  
The interaction between aeration rate and agitation speed is the greatest 
contributing interaction. Figure 5.2. shows a three-dimensional representation of the 
relationship, highlighting the complexity. There is an overall positive trend when 
increasing aeration rate and agitation speed, which would be expected as both are 
positive main effects. When aeration rate is low, the effect of changing agitation speed 
is small, however when aeration rate is high the effect of changing agitation speed is 
large and positive, rising from ~0.035 to 0.08s-1 across the experimental range. It is  
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Figure 5.2. Three-dimensional surface plot showing the impact on kLa of the 
interaction between agitation speed and aeration rate. Red dots represent 
experimental values at the centre point of the experimental design. Experiments and 
analysis performed as described in Section 2.7.  
Figure 5.3. Interaction plot to demonstrate the impact on oxygen mass transfer 
coefficient of the interaction between viscosity and aeration rate, when aeration rate is 
high (red) and low (black). Experiments and analysis performed as described in 
Section 2.7.  
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seen also that when both factors are high the interaction begins to plateau, 
indicating that a local optimum has either been reached or is close.  
This interaction is a result of increased oxygen flow due to greater aeration and the 
effective breakdown and dispersion of bubbles at high agitation speeds. As such there 
is an increased interfacial surface area for gas transfer, reduced coalescence of the 
bubbles and a thinning of the film at the gas-liquid interface (Stanbury et al, 1995). This 
results in the minimum distance and resistance to diffusion and maximisation of 
oxygen transfer.  
As with high agitation speeds and aeration rates individually, there is a point at 
which the oxygen mass transfer stops rising. This is likely a result of flooding the 
impeller region of the reactor meaning that dispersion becomes less effective and gas 
travels directly from the sparger to the surface of the liquid, minimising residence time 
and the opportunity for oxygen transfer. Additionally, bubbles of a small diameter 
(<3mm) resulting from greater agitation speeds become less proficient at mass transfer 
as they become rigid and surface tension regulates gas exchange (Doran, 1995).  
The interaction between aeration rate and viscosity is complex. Figure 5.3. shows 
that at a low aeration rate, increasing viscosity has a detrimental effect on oxygen 
transfer, whereas at a high aeration rate the impact of increasing viscosity is positive. 
It is probable that this is due to a trade-off between residence time and the thickness 
of the film formed around the bubbles, both of which increase with viscosity (Doran, 
1995). 
Figure 5.4. shows the interaction between viscosity and temperature, and the 
impact on kLa. It shows a relationship known as a saddle point which is a complicated 
interdependence of the two contributing factors, wherein the influence of changing one 
factor is reversed on the other side of the experimental range. For example, at low 
temperature the effect of increasing viscosity is positive and linear, rising from 0.035 
to 0.065, whereas at high temperature, the effect is reversed with increasing viscosity 
leading to a linear reduction in kLa of approximately the same magnitude. Similarly, at 
low viscosity, the impact of increasing temperature is positive but tapers off above 
35°C, while at high viscosity the opposite is observed, an increase in temperature 
results in a decrease in kLa of the same magnitude. In this interaction, the most stable 
area of the design space is in the centre of the two ranges. 
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Figure 5.4. Three-dimensional surface plot showing the interaction between viscosity 
and temperature and the effect on the oxygen mass transfer coefficient. Red dots 
represent experiments at the centre point of this interaction in two dimensions. 
Experiments and analysis performed as described in Section 2.7. 
Figure 5.5. Contour plot showing the relationship between temperature and aeration 
rate, and the effect on oxygen mass transfer. Dark blue represents the lowest observed 
kLa (~0.02s-1), ranging to dark green representing the highest kLa (~0.06s-1). 
Experiments and analysis performed as described in Section 2.7.  
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The likely cause of this phenomenon is that, as temperature increases, there is a 
reduction in surface tension leading to a decrease in the diameter of bubbles formed 
and therefore an increase in the interfacial area available for mass transfer (Doran, 
1995). In addition, greater temperatures result in improved diffusivity, particularly at 
low viscosity, and together these result in an increased capacity for oxygen mass 
transfer. However, at high temperatures, although diffusivity increases, solubility of 
oxygen decreases. This effect is then compounded at higher viscosities, as the 
thickness of the liquid film increases, adding resistance to gas-liquid mass transfer.  
Figure 5.5. shows a contour plot for the interaction between aeration rate and 
temperature. In comparison to those relationships seen previously it is relatively 
simple. With increased aeration and temperature, there is an increase in oxygen mass 
transfer across the range from 0.02 to 0.06s-1. As discussed in Section 1.2.6., 
temperature has an effect over the solubility and diffusivity of oxygen in the media, 
while aeration rate affects the available oxygen for mass transfer in the fluid and the 
form that the bubbles take in terms of their interfacial surface area and residence time. 
Operational ranges in which the oxygen mass transfer exceeds 0.06s-1 are seen at 
30°C and 0.8vvm and above.  
Antifoam concentration interacts with two other factors; agitation speed and 
temperature. When interacting with agitation speed, there is a more significant 
increase in the volumetric oxygen mass transfer coefficient when the antifoam 
concentration is greater (Figure 5.6), rising from 0.035 to 0.08s-1. A similar effect is 
seen when antifoam concentration interacts with temperature with higher 
concentrations seeing a rise between 0.05 and 0.065s-1, while the lower concentration 
shows a negative trend overall (Figure 5.7). 
In the case of the interaction with agitation speed, this is likely to be due to a 
relationship caused by the surfactant between the surface tension of the bubbles and 
the mobility of the gas-liquid interface. Although it is expected that the result will be an 
overall decrease in kLa due to the decrease in kL outweighing the increase in interfacial 
surface area (a), there are conflicting reports which suggest that size of the increase 
in the interfacial surface area may exceed the decrease in the kL and therefore the 
overall kLa would increase (Kawase & Moo-Young 1990).  
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Figure 5.6. Two factor interaction between antifoam concentration and agitation 
speed. The red line indicated high antifoam concentration (0.07% v/v), while the black 
line is low antifoam concentration (0.04% v/v). Experiments and analysis performed as 
described in Section 2.7.  
Figure 5.7. Two factor interaction between antifoam concentration and temperature. 
The red line represents high antifoam concentration (0.07% v/v), while the black line 
is low antifoam concentration (0.04% v/v). Experiments and analysis performed as 
described in Section 2.7.  
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This appears to be the effect seen here. It is likely that the interaction between 
antifoam concentration and temperature is due to increasing diffusivity of the gas in 
combination with the reduced effectiveness of the antifoam as more runs are executed 
at higher temperatures. 
5.2.4.3. Analysis of Variance (ANOVA) and Model Diagnostics  
Analysis of variance was used to evaluate both the model as a whole (Table 5.2.) 
and the individual terms within it (Table 5.3.). Four main statistics were used; model F-
value and its associated probability as a measure of the model significance, the 
adequacy of precision which is a measure of signal to noise and should be as great as 
possible, and the adjusted and predicted R-squared values which are a measure of 
how closely the model correlates with the experimentally determined data. These 
values are summarised in Table 5.2. 
Table 5.2. Summary of the ANOVA statistics for the model of oxygen mass transfer in 
a BioFlo 310 stirred tank bioreactor. 
R-squared 0.853 
Adjusted R-squared 0.805 
Predicted R-squared 0.703 
Adequacy of precision 18.4 
F-value 17.8 
Model P-value <0.0001 
 
The ANOVA indicates a good fit and a strong degree of statistical confidence in 
the model for kLa in the BioFlo310. The R-squared value is greater than 0.85 and the 
difference between the adjusted and predicted values is low (~0.1). Additionally, the 
adequacy of precision is in excess of 18, indicating that values obtained are unlikely 
to be as a result of systematic noise. 
The majority of the individual terms are also significant, with p-values less than 
0.0001. There are some terms however, including the interactions between viscosity 
and aeration rate, and temperature and antifoam concentration, which make a much 
less significant contribution to the model, however these terms are included in order to 
make the model hierarchical (Raudenbush & Bryk 2002). 
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Additional diagnostics were carried out on the model and are shown in Figure 5.8. 
The predicted versus actual plot (Figure 5.8A) shows that there is a generally good fit, 
with most points lying on, or close to the line of regression (y=x). The normal probability 
plot (Figure 5.8B) shows that the values and terms in the final model are included with 
a high degree of confidence. Figure 5.8C indicates that there is a random scatter to 
the data and so there appears to be no bias on kLa. 
Using the ANOVA evidence, it can be said that a high degree of confidence can 
be placed in this model and that interrogating it across the multidimensional 
experimental landscape is valid, and that observations made are genuine.  
It is worth noting also that the kLa values seen during this investigation were typical 
for an STR (Van’t Riet, 1979). 
Table 5.3. ANOVA for the terms contained within the quadratic model for oxygen 
mass transfer coefficient (kLa) in a BioFlo 310 stirred tank bioreactor. 
Term F value P-value, Prob. > F 
Model 17.84 < 0.0001 
Aeration rate 74.55 < 0.0001 
Agitation speed 24.96 < 0.0001 
Antifoam conc. 8.93 0.0050 
Viscosity-Aeration rate 3.51 0.0688 
Viscosity-Temperature 23.60 < 0.0001 
Aeration rate-Agitation 
speed 
9.18 0.0044 
Aeration-Temperature 8.24 0.0067 
Agitation-Antifoam 9.40 0.0040 
Temperature-Antifoam 
conc. 
3.05 0.0892 
Aeration rate2 38.77 < 0.0001 
Agitation speed2 18.81 0.0001 
Temperature2 12.44 0.0011 
 
5.3. Xcellerex Disposable Reactor-10 (XDR-10)  
The XDR-10 single use bioreactor is an example of a disposable bioreactor bag 
installed into a solid frame (Sections 1.2.7.4, 2.7.3. and Table 2.1). Though quite 
advanced there are limitations to the XDR-10. For example, temperature control 
requires heating an element in the frame, which heats the SUB bag before transferring 
energy to the culture itself, making it slow. Limitations on pressure due to the bag 
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construction, mean that the maximum volumetric airflow rate which can be applied to 
the system is restricted to 1.25 vvm.  
Similar to the BioFlo310, DOT probe calibration must be carried out prior to 
installation into the bag through a single use sheath. Also, software used in conjunction 
with this bioreactor was not capable of consistent logging of the online parameters, 
and so during each run, DOT had to be measured and recorded manually every 10 
seconds. This prevented software impacting on the frequency of the readings, but 
introduced a reliance on the operator and a significantly greater chance of human 
error. It is worth noting here that due to the design of the bag based SUBs, particular 
care must be taken with their installation and filling so as not to introduce creases or 
tears into the bag as this could in turn impact on hydrodynamics and mass transfer. 
 
5.3.1. Building the Experimental Design  
Factors selected were based on a refined list of those examined in the BioFlo 310. 
As there was little influence of the antifoam concentration and viscosity (Section 
5.2.4.), and with there being significant geometric and control differences between the 
two designs, it was decided that focusing on the engineering parameters of aeration 
rate, agitation speed and temperature would yield a more instructive data set and 
therefore descriptive and insightful model. Again, ranges were set in accordance with 
prior knowledge, literature information and the constraints of the system, as well as, in 
this case the previous experiments in the BioFlo 310. A summary of the factors and 
set points investigated can be seen in Table 5.4.  
Table 5.4. Factors and ranges for the investigation into oxygen mass transfer in a tank 
liner style SUB. 
Factor Unit 
Set points 
Minimum Low Centre High Maximum 
Aeration Rate vvm 0.25 0.58 0.75 0.92 1.25 
Agitation Speed rpm 120 200 240 280 360 
Temperature °C 15.0 26.7 32.5 38.3 50.0 
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Figure 5.8. Diagnostic plots for the model for oxygen mass transfer 
coefficient (kLa) in a bench top BioFlo 310 stirred tank bioreactor. 
Predicted vs actual plot (A), the normal distribution plot (B) and 
externally studentised residuals against run number are used to 
determine that the model is a good fit for the experimental data, that 
there is nothing biasing the model, and that it can be used with a high 
degree of statistical confidence. Analysis as described in Section 2.7. 
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Aeration rate is limited by the XDR-10 to 7.5 Lmin-1 (1.25 vvm), while the minimum 
value used (based on preliminary experiments) was set to 0.25 vvm (1.5 Lmin-1), 
allowing for even distribution of set points across the experimental range. The 
maximum agitation speed that the system is capable of is 360 rpm, significantly lower 
than either the STR or the Ambr®250, suggesting possible limitations in oxygen mass 
transfer capacity; particularly when considering the pitch blade design of the impeller 
(Karimi et al. 2013). The minimum value chosen was 120 rpm. The temperature range 
used was as close as feasible to that applied to the STR (maximum of 50°C), however 
the minimum value which could be used was 23.5°C as the element on the XDR-10 is 
not cooled and as such environmental temperature is the lowest value available. This 
was retrospectively incorporated into the DoE design. 
5.3.2. Fixed Factors 
In addition to the factors fixed during experiments with the BioFlo 310 (Section 
5.2.2.), both the viscosity of the media and the concentration of antifoam were fixed 
for experiments in the XDR-10. This was in part due to their relatively small effects on 
the oxygen mass transfer model in the STR (Section 5.2.4.) and the potential for 
convolution of the effect between viscosity and temperature. As with the BioFlo 310, 
the order and groups in which runs took place was an important consideration. The 
reasoning behind the run ordering is described in Section 5.2.3.  
The determination and analysis of kLa across the experimental landscape is as 
described in Section 2.7.1.2. This includes plotting and adjustment for probe response 
time. The only difference was in the recording of the data, which, as previously noted 
(Section 2.7.3.) was carried out manually due to a lack of online recording system. 
Good agreement is seen between the unadjusted data and those corrected for the 
probe response time. Several example data points from across the experimental range 
are shown in Table 5.5. A table of calculated kLa values for this investigation can be 
found in Appendix 4.3. 
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Table 5.5. Example kLa and PRT corrected kLa data from across the experimental 
design in an XDR-10 single use bioreactor bag. 
Aeration 
rate (vvm) 
Agitation 
speed (rpm) 
kLa (s-1) 
(x10-3) 
kLa corrected for 
PRT (s-1) (x10-3) 
0.58 200 7.90 8.26 
0.92 200 8.90 9.30 
0.58 280 12.2 13.5 
0.92 280 12.8 14.0 
 
5.3.3. Modelling Oxygen Mass Transfer Coefficient in a Single Use Bioreactor 
Bag (XDR-10) 
As with the BioFlo investigation (Section 5.2), a quadratic model was built. 
Although fewer factors and fewer experiments were performed, an RSM was used in 
order to ensure that the model could be interrogated for curvature. Additionally, the 
statistics supporting the use of a quadratic model when compared with the alternatives 
made it the preferred option. A p-value of 0.0078, an R-squared of 0.955 and the lowest 
standard deviation were all significantly better than the equivalent values for the cubic 
and linear model alternatives. A backward elimination was used, removing factors and 
interactions with the smallest effects first and continuing until only significant terms 
remain as part of the model. 
Once the model was built, it was essential to determine the validity using statistical 
diagnostics (Section 5.3.3.3). The model equation can be found in Appendix 4.6. 
5.3.3.1. Main Effects 
Two main effects were observed across the experimental landscape for the XDR-
10. These were agitation speed and temperature. Surprisingly, aeration rate was not 
seen to be a main effect, however this is most likely because the range over which 
aeration was varied on the XDR system was limited. In addition, the sparger is a frit 
type, and so bubbles delivered into the liquid are already very small regardless of 
aeration rate so the interfacial surface area is unlikely to change significantly as a result 
of this factor. 
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 Figure 5.9. Main effect plot for the observed impact on agitation speed on the model 
of oxygen mass transfer coefficient in the XDR-10 single use bioreactor. Experiments 
and analysis performed as described in Section 2.7.  
Figure 5.10. Main effect plot for the quadratic relationship observed as a result of 
temperature on the model of oxygen mass transfer coefficient in the XDR-10 single 
use bioreactor. Experiments and analysis performed as described in Section 2.7.  
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There is an almost linear positive correlation between agitation speed and oxygen 
mass transfer coefficient, with kLa doubling from 0.007s-1 to 0.014s-1 across the 
experimental range (Figure 5.9). This is a significantly smaller increase in kLa than 
seen when investigating the STR, where the maximum kLa measured in the XDR-10 
was 0.024s-1. Increased agitation speed commonly results in bubble breakdown. 
However, the design of the impeller (40° pitched blade) is likely to be responsible for 
generating a combination of axial and radial flow, resulting in greater mixing around 
the reactor (Mirro & Voll, 2009), greater bubble dispersion and therefore enhanced kLa. 
Figure 5.10 indicates a parabolic relationship between temperature and kLa. 
Fluctuations in solubility and diffusivity of oxygen as a result of changing temperature 
are as described in Section 1.2.6.4. Up to approximately 30°C the kLa decreases until 
the two effects reach equilibrium, after which diffusivity has the dominant effect on 
mass transfer. Again, the effect in the XDR is relatively small, with the influence on the 
model due to temperature changing kLa values by just 0.01s-1. Though a small 
increase, this is still significant in terms of the model.  
5.3.3.2. Two Factor Interaction 
A single two factor interaction was seen between the two main effects, temperature 
and agitation speed. The three-dimensional surface plot seen in Figure 5.11A. shows 
the interaction and the influence on kLa. At high or low temperature, increasing the 
agitation has a positive, linear effect on kLa although the effect is much greater at high 
temperature with kLa increasing from 0.007 to 0.015s-1. This can also be seen in the 
contour plot (Figure 5.11B.) with smaller gaps between contour lines along the high 
temperature edge of the plot. 
However, the effect of temperature at high or low agitation speeds is reversed. At 
low agitation speed, the effect of increasing temperature is small and negative (0.008 
to 0.007s-1), whereas at a high agitation speed, the effect of increasing temperature is 
larger and positive (0.012 to 0.015s-1). This is shown in Figure 5.11. This relationship 
is a result of the two main effects discussed in Section 5.3.3.1, with increasing agitation 
leading to greater breakdown and dispersion of bubbles, and the complex dynamic 
between solubility and diffusivity that results from changing temperature. At higher 
temperatures, the increased diffusivity combined with the better dispersion of bubbles 
results in higher kLa, with the effect driven by agitation (hence it remains linear). At low 
agitation speeds the detrimental effect of increasing temperature (a decrease in 
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oxygen solubility) appears to be dominant, while at greater agitation speeds the 
positive influence of increasing temperature (an increase in oxygen diffusivity) 
combined with the increased dispersion causes the inversion of this relationship. 
5.3.3.3. Analysis of Variance (ANOVA) and Model Diagnostics  
As with the BioFlo 310 model (Section 5.2.4.), four main diagnostic tests were used 
in order to evaluate the XDR-10 model (Table 5.6.) and the significant terms (Table 
5.7.). The reasoning for these four diagnostics are discussed in Section 5.2.4.3. The 
ANOVA indicates a good fit between the model and the experimental data and that a 
high degree of statistical confidence can be had in the model for kLa in the XDR-10. 
The R-squared value is around 0.94 and the difference between the adjusted and 
predicted values is relatively low (~0.07). Additionally, the adequacy of precision is 
approximately 26, indicating values obtained are not an artefact of system noise. 
Diagnostic values for the individual terms are shown in Table 5.7. The model itself 
and the major main effect (agitation speed) are seen to be highly significant, the 
statistics available for the additional terms, while not as good, are still significant. The 
(non-quadratic) temperature term is also included in order to make the model 
hierarchical. 
Table 5.6. Summary of the ANOVA statistics for the model of oxygen mass transfer 
in a XDR-10 disposable bioreactor. 
R-squared 0.94 
Adjusted R-squared 0.92 
Predicted R-squared 0.84 
Adequacy of precision 26.0 
F-value 39.3 
Model P-value <0.0001 
 
Additional diagnostics were carried out as with the STR (Section 5.2.4.3.) and are 
shown in Figure 5.12. Again, they highlight good agreement between the model and 
the experimental data (A), the terms for inclusion in the model (B) and that there is no 
systematic bias in the data (C). The ANOVA analysis demonstrates that the model is 
a good fit with the experimental data and that it can be used with a high degree of 
statistical confidence. 
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Figure 5.11. Three-dimensional surface plot (A) and contour plot (B) showing the 
interaction between temperature and agitation speed and its effect on oxygen mass 
transfer in an XDR-10 single use bioreactor. Increase in kLa is represented from dark 
blue to green. Experiments and analysis performed as described in Section 2.7.  
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A B 
C Figure 5.12. Diagnostic plots for the quadratic model built to 
describe kLa in an XDR-10 single use bioreactor bag. The 
predicted versus actual plot (A), the normal probability plot 
(B) and the residuals versus run number plot (C), all highlight 
a good agreement between the model generated and the 
experimental data. Analysis as described in Section 2.7. 
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Table 5.7. ANOVA for the terms contained within the quadratic model for oxygen 
mass transfer coefficient in a XDR-10 single use bioreactor. 
Term F value P-value, Prob. > F 
Model 39.3 < 0.0001 
Agitation speed 162.6 < 0.0001 
Temperature 1.99 0.183 
Agitation speed-Temperature 3.45 0.088 
Agitation speed2 14.6 0.002 
Temperature2 20.1 0.0008 
 
5.4. Ambr®250 Single Use Bioreactor 
The Ambr®250 parallel automated bioreactor system is geometrically similar to a 
conventional stainless-steel bioreactor and is constructed from moulded 
polycarbonate, removing potential issues of bag creasing and introduction of additional 
dead zones. In addition Ambr®250 reactors are fitted with online monitoring and control 
including for DO, temperature and off gas (Sections 1.2.7.4., 2.3.1. and 2.7.2.). 
Conditioning and calibration of the Ambr®250 and its probes differs significantly 
from the XDR10 and BioFlo310, particularly in terms of DOT. This is due to the 
Ambr®250 using an optical sensor as the measurement method for DOT (Rameez et 
al. 2014). This is provided pre-calibrated, but must undergo quenching and single point 
(100%) recalibration once the reactor is charged. The parameters of this calibration 
can be altered by the operator, and for these experiments an overnight calibration 
period with small variance (within 0.1% saturation for one hour) used in order to ensure 
the stability of the data stream. In addition, logging of data is through the Ambr’s 
proprietary ‘Pegasus’ software at consistent 12 second intervals. 
Using parallel bioreactors, it is possible to interrogate multifactorial landscapes in 
a single experiment. As such, a sub-objective of the Ambr®250 investigation is to 
establish an automated protocol for determining kLa in a high throughput manner such 
that it could run a large number of experimental determinations in a short time. This 
would then be used as a generic procedure for rapid determination of kLa under 
different conditions in the future. Additional considerations regarding set up and 
configuration of the Ambr®250 are discussed in Section 2.7.2. 
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5.4.1. Preliminary Determination of kLa  
A preliminary investigation to determine kLa in the Ambr®250 using water and a 
small number of experimental set points was carried out. This was undertaken in order 
to reproduce values reported in literature as a means of showing minimal system to 
system variance, and because the protocol developed here was automated and so 
differed from those used previously (e.g. Bareither et al, 2013). In addition, 
development of the automated protocol would require a number of iterative stages. 
Five independent experiments were executed to have as broad a range of 
conditions as possible within the limitations of the Ambr®250 bioreactor system. Three 
factors which had been seen previously (in literature and experimentally) to have a 
significant influence on oxygen mass transfer were selected: agitation speed, aeration 
rate and temperature. The set points were as shown in Table 5.8. 
Using the method of quantification described in Section 2.7.1, a range of kLa values 
were observed (from 0.002 to 0.19s-1) under the conditions outlined above. Agitation 
speed appears to be the greatest influencer on oxygen mass transfer, with aeration 
rate also significant and temperature of little effect. Figure 5.13. shows the size of the 
effects caused by the changing parameters. It should be noted that these are individual 
points and not evaluated using a multifactorial design, so these responses cannot be 
modelled or statistical analysis undertaken. 
 
 
Table 5.8. Set points for the preliminary investigation of kLa in Ambr®250 bioreactor. 
Experiments performed as described in Section 2.7. 
Condition Agitation speed 
(rpm) 
Aeration rate 
(vvm) 
Temperature 
(°C) 
1 1500 1.0 25 
2 500 0.5 25 
3 3000 2.0 25 
4 500 2.0 35 
5 3000 0.5 45 
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Figure 5.13. Oxygen mass transfer coefficient (kLa) as determined in Ambr®250 
bioreactors under a range of set conditions. Error bars represent one standard 
deviation about the mean (n=3). Experiments and analysis performed as described in 
Section 2.7.  
 
These values are in keeping with those determined in the literature during 
Ambr®250 prototype evaluation (Bareither et al, 2013), demonstrating minimal system 
to system variation. Differences seen can be attributed to the reduced manual 
intervention in this protocol. In addition, the protocol established in the Ambr®250 
software was successful in executing triplicate runs without mechanical or 
experimental difficulty and with low variability (Figure 5.13.). 
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5.4.2. Experimental Design for Modelling Oxygen Mass Transfer Coefficient (kLa) 
in an Ambr®250 SUB 
The Ambr®250 is a good geometric mimic of a traditional STR, and so it was 
decided that all five factors from the BioFlo 310 investigation (Section 5.2.) should be 
included, rather than just those with the greatest influence over the STR model. This 
would allow a much more inclusive and comprehensive model, which would relate as 
closely as possible the Ambr®250 and the BioFlo 310 STR. It will also highlight whether 
details in reactor geometry or materials of construction appear to be a strong influence 
on kLa. 
Ranges have been selected in consideration of the literature, prior knowledge, 
limitations of the system and the previous experiments. A summary of the factors and 
ranges is shown in Table 5.9. The ranges selected for the physical engineering 
parameters (agitation speed, aeration rate and temperature) were also influenced by 
the preliminary work carried out in the Ambr®250 (Section 5.4.1.). 
The ranges for temperature, viscosity and antifoam concentration were set to 
match those of the stirred tank bioreactor (Section 5.2.1.). Aeration rate though was 
set between zero and 2.0 vvm (0.0 and 0.3 Lmin-1), providing the maximum possible 
range. Agitation speed is limited to a maximum of 3000 rpm (~3 ms-1), while the lower 
limit was set at 100 rpm as this has been demonstrated on the Ambr system as the 
minimum set point capable of spanning sufficient dissolved oxygen tensions. 
 
Table 5.9. Factors and ranges for the investigation into oxygen mass transfer in an 
Ambr®250 bioreactor. 
Factor Unit 
Set points 
Minimum Low Centre High Maximum 
Aeration Rate vvm 0.5 1.0 1.5 2.0 2.5 
Agitation Speed rpm 100 825 1550 2275 3000 
Viscosity by [Gly] mLL-1 0.0 7.5 15.0 22.5 30.0 
Temperature °C 15.0 23.8 32.5 41.3 50.0 
Antifoam %v/v 0.0 0.025 0.05 0.075 0.10 
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Six parallel bioreactors were used to undertake an RSM design, executed over a 
short timeframe (compared with independent manual experiments). Once developed, 
the kLa protocol was capable of running a full RSM in triplicate in approximately a day 
and a half by a single operator. This included the system set up, filling, calibration of 
the bioreactors and running all 156 determinations. This is a significant resource 
saving when compared with the manual experiments in the STR and single use bags. 
The automated protocol can be seen in Appendix 4.8. 
Additionally, parallelisation enabled replication, which was useful for establishing 
that there was no bias in the bioreactor system as a result of bioreactor position, and 
no temporal drift in the experimental data. It was also important to the proof of concept. 
Complex systems will be evaluated using this protocol in future and so replication 
(even within a DoE landscape), will aid in providing the greatest possible statistical 
significance when used as part of a generic evaluation platform.  
As with the XDR-10 or the BioFlo 310 it was necessary to carefully consider the 
order in which the runs were executed. Here, the consideration was on the basis of 
what could be run in a single bioreactor. The restrictions though, are as outlined in 
Section 5.2.3. 
The quantification of kLa values across the experimental landscape is as described 
in Section 2.7.1.2. The subsequent analysis of the data though was done using JMP12 
software. The underlying mathematics in the software is very similar and so this will 
not affect the ability to compare the models generated for the different reactor types. 
A table of calculated kLa values for this investigation, can be found in Appendix 4.4. 
The model equation can be found in Appendix 4.7. 
5.4.3. Establishing a Protocol to Automate an O2 Mass Transfer Investigation in a 
SUB 
The protocol developed for automated kLa investigation on the Ambr®250 was 
based on the method described in Section 2.7. which was used to measure kLa in the 
BioFlo310 stirred tank bioreactor. The major challenge was programming explicitly 
each step of the experimental method. Instructions, set points, timings, limits and dead 
bands were all required and needed to be programmed in accordance with the 
limitations of the Ambr ‘Pegasus’ software. Each step of the method needed to be 
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incorporated in a form that the system can interpret and execute before the run 
commenced. 
A number of iterations were required in order to develop this, and to implement the 
protocol on six bioreactors in parallel. The final protocol, which ran the full method, can 
be seen in Appendix 4.8. Simple additions could be made to run a larger investigation 
into oxygen mass transfer in the Ambr®250.  
5.4.4. Modelling Oxygen Mass Transfer Coefficient in an Ambr®250 
Although a cubic model was offered by the JMP software, a quadratic model was 
again the most appropriate. The model coefficients are shown in Table 5.10. and the 
model equation in Appendix 4.7. As with the STR model there were five factors 
arranged in an RSM design, this time with runs in triplicate, and so the landscape could 
be interrogated for curvature. The quadratic model gave an R-squared value of 0.96, 
a p-value of <0.0001 and although there is no specific adequacy of precision statistic 
as with previous experiments, there is a root mean square error which can be used as 
a measure of noise, which is low at 0.021. Additionally, the standard deviation was 
significantly better than the equivalent values for the cubic and linear models. This is 
summarised in Table 5.11. Once the model was built, it was important to determine its 
validity using statistical diagnostics (see section 5.4.4.3). 
5.4.4.1. Main Effects 
Each of the factors included in this design demonstrated a significant effect on the 
oxygen mass transfer coefficient. Interestingly this was not the case in the bench-top 
STR, and so highlights the importance of investigating each bioreactor type thoroughly 
to understand the oxygen mass transfer capabilities. 
Agitation speed is the greatest contributing main effect. Figure 5.14B shows the 
dramatic rise in kLa from 0.08 to 0.135s-1 as agitation speed increases to approximately 
1850rpm. Above 1850rpm, kLa begins to decline. This is due to the impellers reaching 
the limit of their effectiveness and starting to flood the impeller region. In addition, there 
is an interaction between agitation speed and aeration rate (discussed in Section 
5.4.4.2.), which at high values of both factors results in a greater negative effect. The 
large impact agitation speed has on oxygen mass transfer (discussed also in Sections 
1.2.6.2. and 5.2.4.1.), this is a result of effective bubble breakdown and dispersion by 
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the two, six blade Rushton turbine impellers, thus the interfacial surface area (and 
therefore area available for mass transfer) is greater at higher agitation speeds.  
Figure 5.14A shows the impact of aeration rate, the next greatest main effect on 
kLa. Coefficients for the aeration terms in the model (Table 5.10) are high, with both 
the linear and quadratic terms within 0.005 of those for agitation speed. Once the 
aeration rate exceeds 1.2vvm, there is a reduction in the oxygen mass transfer. As 
previously noted (Sections 1.2.6.1. and 5.2.4.1.), is most likely due to the greater size 
of bubbles from the open tube sparger, combined with the reduced residence time of 
these bubbles and flooding of the impeller region at higher aeration rates.  
Viscosity only has a quadratic term in the model. There is no overall change in the 
kLa across the range and the maximum is positioned at the centre point. This is shown 
in Figure 5.14C. It appears that this is where there is a balance between encouraging 
stable bubble formation using a viscous component, and the detrimental thickening of 
the liquid film. 
Temperature is seen to have an overall positive effect, responsible for a rise in kLa 
from 0.114 to 0.133s-1. Interestingly, the peak is at approximately 37°C, the set point 
commonly used for a number of microbial expression systems, notably E. coli. After 
this point, a decline is seen as a result of reducing solubility of oxygen becoming 
dominant over the increasing diffusivity. The effect can be seen in Figure 5.14D. 
The overall effect of increasing antifoam concentration is a negative one, with the 
kLa decreasing from a peak of 0.132s-1 to 0.110s-1. As explained previously (Section 
5.2.4.1.), it has been hypothesised that an increase in antifoam concentration could 
cause an increase in oxygen mass transfer which may explain the small increase 
before the negative trend takes over and the primary function of the antifoam becomes 
dominant (Figure 5.14E). 
It is interesting to note that there are no linear relationships for any of the main 
effects. All either have a quadratic element or an interaction with another factor. This 
is indicative of a highly interdependent and dynamic system and speaks heavily both 
to the power of using multifactorial DoE for this type of work, and to the necessity for 
this kind of characterisation to be undertaken. Without it, it would be difficult to 
understand the oxygen mass transfer in a bioreactor under culture relevant conditions.  
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5.4.4.2. Two Factor Interactions 
There are two, two-factor interactions, one between aeration and agitation speed, 
and the other between temperature and antifoam concentration. Both of these were 
seen in the stirred tank bioreactor, where the effect of the latter was minimal, however 
this does not appear to be the case here.  
Figure 5.15. and Table 5.10. show how substantial the effect is of the interaction 
between agitation and aeration rates, with the minimum kLa almost zero and the 
maximum observed here almost 0.12s-1 depending on just these two factors. There is 
also a definitive peak in kLa, at around 1500rpm and 1.0vvm, with all conditions around 
this point quite detrimental. The cause of the decline in oxygen mass transfer has been 
discussed previously (Sections 1.2.6. and 5.2.4.2.), with flooding of the impeller region 
the cause of increasing aeration and agitation speeds having a negative effect on kLa. 
Interestingly, in the overall model the additional factors appear to have a stabilising 
effect on the oxygen mass transfer at higher values, as, although there is a decline in 
the oxygen mass transfer around the maximum, it is not so pronounced. 
The action of antifoams is temperature and time dependent. As such the two-factor 
interaction between antifoam concentration and temperature is due to temperature 
influencing the mechanism of the antifoam and diminishing the ability of the surfactant 
to reduce the surface tension of the gas-liquid interface. The effect is seen to be 
positive overall (Figure 5.16.), confirming that the increase in temperature is 
detrimental to the action of the antifoam. This is particularly evident at the high end of 
the temperature range (50°C), where the kLa is approximately quadruple the minima. 
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Figure 5.14. Profiles of kLa as a result of each of the factors in the model for oxygen mass transfer coefficient in the Ambr®250. (A) shows the 
effect of aeration rate, (B) of agitation rate, (C) of glycerol concentration (as a proxy for viscosity), (D) of temperature and (E) of antifoam 
concentration. Red lines represent the kLa value at the centre point of each of the factor ranges. Blue lines represent the confidence intervals for 
the model as influenced by each of the main effects. Experiments and analysis performed as described in Section 2.7.  
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Table 5.10. shows the parameter coefficients for each of the terms in the model, along 
with the standard error and the p statistic for each. Here, the standard error has been included, 
which is a measure of the accuracy of an estimated parameter coefficient. It is similar to the 
standard deviation in that it estimates the variability between the sample values (in this case 
kLa determined from each experimental run), and therefore the lower the value the more 
accurate the coefficient. 
This reiterates what has been stated previously, that the aeration and agitation speeds, as 
well as the interaction between the two, are the greatest contributors to influencing the oxygen 
mass transfer. Graphical representations of the overall model are shown in Figure 5.17. These 
show an area of maximal, and relatively stable kLa (>0.14s-1) at an aeration rate of around 1.1-
1.35 vvm and agitation speed of 1750-2250rpm. This is an important observation as it 
describes an area of suitable operation for the maximisation of oxygen mass transfer. 
  
Table 5.10. Coefficient values and statistical analysis for each of the terms in the model for 
oxygen mass transfer coefficient in the Ambr®250. The model expression can be found in 
Appendix 4.7.  
Term Parameter 
coefficient 
Standard 
error 
p-Value T-ratio 
Intercept 
Agitation  
0.1315 0.0038 <0.0001 27.80 
Agitation speed 
A 
0.0230 0.0019 <0.0001 22.69 
Aeration rate 0.0188 0.0019 <0.0001 8.67 
Temperature 0.0072 0.0019 0.0003 3.53 
Antifoam concentration -0.0029 0.0019 0.1312 36.32 
Agitation speed2 -0.0305 0.0021 <0.0001 19.00 
Agitation speed-Aeration rate 0.0176 0.0021 <0.0001 31.49 
Aeration rate2 -0.0272 0.0021 <0.0001 12.21 
Temperature2 -0.0101 0.0021 <0.0001 5.81 
Temperature-Antifoam 
concentration 
0.0054 0.0021 0.0134 18.84 
Antifoam concentration2 -0.0168 0.0021 <0.0001 11.46 
Viscosity2 -0.0104 0.0021 <0.0001 27.80 
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Figure 5.15. Contour (A) and three-dimensional response (B) plots for the two-factor 
interaction between agitation rate and aeration rate. Shading blue to red indicates an increase 
in kLa in both figures. kLa on the contour lines is represented in reciprocal seconds. 
Experiments and analysis performed as described in Section 2.7. 
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Figure 5.16. A contour plot showing the two-factor interaction between antifoam concentration 
and temperature and the effect on kLa in an Ambr®250 bioreactor. Contour lines are coloured 
blue to red with increasing kLa and are labelled with kLa in reciprocal seconds. Experiments 
and analysis as described in Section 2.7.  
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Figure 5.17. Three-dimensional response (A) and contour (B) plots for the overall model of 
kLa in an Ambr®250 bioreactor. Shading green to red indicates an increase in kLa. kLa on the 
contour lines is shown in reciprocal seconds. Experiments and analysis performed as 
described in Section 2.7.  
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5.4.4.3. Analysis of Variance (ANOVA) and Model Diagnostics 
As with previous models, analysis of variance was undertaken in order to ensure the 
validity of the model. Table 5.11. highlights that there is a good agreement between the model 
and the experimental data. Table 5.10. provides statistical diagnostic values for the individual 
terms, which also indicate good agreement with the model, with most p-values less than 
0.0001, and large t-values in all cases. A t-test is used here as a means of showing if single 
variables are significant. 
As additional diagnostics a parity plot of predicted versus actual data (Figure 5.18A) 
indicating some outlying data points but a broadly conformational correlation. The half normal 
plot (Figure 5.18B) is used to highlight the terms of greatest statistical significance, and 
therefore confirm those that are included in the model. The ANOVA indicates that the model 
is a good fit and can be used with a high degree of confidence for determining and predicting 
the oxygen mass transfer coefficient in an Ambr®250 bioreactor. 
 
Table 5.11. Summary of the statistical diagnostics for the overall model of kLa in an Ambr®250 
bioreactor system. 
R-squared 0.955 
Root mean square error (RMSE) 0.021 
p-value <0.0001 
Sequential p-value 0.078 
 
5.5. Comparison of Oxygen Mass Transfer in Different Bioreactor Types  
In addition to determining the oxygen mass transfer capabilities of each of the reactor 
types, it is important to compare these capabilities between bioreactors. How the models 
compare with traditional literature correlations is also necessary. Finally, comparing the 
oxygen mass transfer values with the reported oxygen demands for different expression 
systems which it may be desirable to cultivate. As such it is first important to compare the 
three bioreactors investigated here (BioFlo 310 STR, XDR-10 and Ambr®250) with respect to 
the factors which influence oxygen availability and mass transfer.  
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Figure 5.18. Diagnostic plots for the quadratic model built to describe kLa in an Ambr®250 
single use bioreactor system. The predicted versus actual plot (A) and the normal probability 
plot (B), all highlight a good agreement between the model generated and the experimental 
data. Analysis as described in Section 2.7.   
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5.5.1. Comparison of Models for Three Different Bioreactors 
Each of the models generated indicate similar factors are of significant influence on oxygen 
mass transfer (Table 5.12.), highlighting aeration rate as a main effect, and the Ambr®250 and 
BioFlo 310 also showing agitation speed to be important. It is useful to note these as common 
critical factors and that they agree with previously reported correlations. 
The Ambr®250 also demonstrates that temperature, antifoam concentration and viscosity 
are significant main effects, while the XDR-10 and BioFlo 310 have only one additional main 
effect each (temperature and antifoam concentration respectively). This indicates that each 
bioreactor configuration and set up has distinct contributors to oxygen mass transfer. Again, 
highlighting the necessity of this work on different bioreactor types to understand their 
suitability for specific applications. 
Multi factor interactions in the models do not demonstrate a particular trend, indicating that 
smaller influencers on oxygen mass transfer are highly system dependent. The Ambr®250 and 
the BioFlo 310 though do share a two-factor interaction between aeration and agitation 
speeds, further supporting the theory that these are the two most critical factors which 
influence oxygen mass transfer in stirred tank reactors. 
Table 5.12. includes the maximum observed kLa values for each of the bioreactor 
investigations. Values for the XDR-10 are an order of magnitude lower than those seen in the 
BioFlo 310 and Ambr®250 bioreactors, showing the negative effect of the pitch blade impeller, 
frit sparger and the operational constraints imposed by the engineering design of the system. 
The maximum kLa observed in the BioFlo 310 is more than 1.5 times that in the Ambr®250. 
Although the magnitude of the difference is surprising, this maximum is an outlying single 
point, with the next greatest value (0.193s-1), and a high degree of similarity between the rest 
of the two data sets. 
 
Table 5.12. Maximum kLa values and significant main effects observed in models of kLa for 
each bioreactor type investigated  
Bioreactor Max. kLa (s-1) Main Effects 
BioFlo 310 0.293 Aeration rate, Agitation speed, Antifoam concentration 
XDR-10 0.018 Agitation speed, Temperature 
Ambr®250 0.171 All (Aeration rate, Agitation speed, Temperature, Antifoam 
concentration, Viscosity 
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5.5.2. Comparison of kLa Models with Literature Correlations  
There are a number of correlations available for determining oxygen mass transfer 
coefficients in a stirred tank bioreactor (Section 1.2.8.). The major difficulty with their use is 
that these correlations are often empirical and very specific to the experimental set up. As yet 
there is no generically applicable relationship. As a result, it is often necessary to either 
compromise and select the correlation that most closely resembles the relevant culture set up, 
or determine a new empirical relationship. Although this is also the case to some extent for 
the DoE models produced by this work, a major insight is that the models, and therefore 
oxygen mass transfer capabilities are system specific. This goes for both the physical and 
environmental factors, and more information is gained into the effects of smaller factors.  
The most commonly applied correlation for calculation of kLa is: 
!"#	 = 	&. ()*/,)∝. ,/0          Equation. 5.1. 
Where Pg is the gassed power consumption in Watts, V is the volume of liquid in the vessel 
in m3, Vs is the superficial gas velocity in ms-1 and C, α and β are empirically determined 
coefficients specific to the system being investigated. 
Based on the geometries and set up of the BioFlo 310, the most appropriate relationship 
which could be found was determined by Linek et al (2004) and is shown in Equation 5.2. 
however, this was based on the use of air and water rather than culture relevant media. 
!"#	 = 	0.01()*/,)3.455,/3.678      Equation 5.2.  
Where the gassed power consumption, Pg is calculated using Equation 5.3. Where P is 
the power rating of the motor (in Watts), N is the impeller rotational speed in ms-1, Di is the 
diameter of the impeller in m, Q is the volumetric air flowrate in m3s-1 and K, a and b are 
empirical coefficients specific to the system. 
)* 	= 	9. ():. ;. <=/>?)@                  Equation 5.3. 
Equation 5.4. includes the appropriate coefficients (K, a and b) values for an STR with 2 
Rushton turbine impellers (such as the BioFlo310), as determined by Patrick and Kennedy 
(1995). 
)* 	= 	1.26():. ;. <=/>3.64)3.C6    Equation 5.4. 
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Figure 5.19. Parity plot of empirically determined kLa values and those predicted using the 
Van’t Riet equation (Equations 5.1 to 5.4) for a New Brunswick BioFlo 310 STR (A) and an 
Ambr®250 bioreactor (B). The dashed line highlights the correlation between experimental and 
predicted values across the majority of the experimental range. In the case of the Ambr®250, 
values are the mean of n=3 runs for each of the set points. Experiments and analysis 
performed as described in Section 2.7.   
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The calculated values of kLa for the BioFlo 310 using Equations 5.2. and 5.4. are plotted 
against the experimentally determined values in Figure 5.19A. This highlights a strong 
proportional correlation across the range. The experimentally determined kLa values are 
significantly lower than those calculated while the trend holds (~20%). This is most likely due 
to the increased solubility of air in water when compared with culture media, in addition to 
differences in the systems (e.g. motor power usage). However, the key observation is the 
correlation between the predicted (calculated) and experimental data.   
The same analysis was carried out for the Ambr®250. The bioreactor is of a similar 
geometrical configuration and so the main difference when calculating the predicted kLa using 
Equations 5.2 and 5.4 is to account for the change in gassed power input. This is due to the 
use of a lower power motor (RE-max, Maxon, Switzerland). The results are shown in Figure 
5.19B. Again it can be seen that there is a strong correlation between the values determined 
experimentally and through predictive calculation.  
5.6. Applicability of Single Use Bioreactors to Microbial Fermentation  
The overall aim of this chapter is to understand the applicability of single use bioreactor 
systems for microbial fermentation. Ideally, this would be done with a direct comparison of 
supply (i.e. kLa), and demand (i.e. OUR). However, it is difficult to directly compare the oxygen 
uptake rates, and therefore the direct demand of a culture system, with the volumetric mass 
transfer coefficients which have been determined here. Instead it is necessary to convert kLa 
to an oxygen transfer rate which can then be compared with OUR. 
5.6.1. Comparison of Oxygen Demands Determined in this Thesis and Oxygen Mass 
Transfer Capabilities of Three Different Bioreactors 
In order to calculate and compare oxygen transfer rates, it is first necessary to determine 
the solubility of oxygen, which changes based on the temperature and the composition of the 
medium, both of which are changed continuously throughout the experimental runs performed. 
As such, a number of assumptions are made in order to achieve the most appropriate 
comparison. 
Firstly, that the maximum solubility of oxygen in microbial liquid culture media is 8.181 
mgO2L-1 (calculated using Vendruscolo et al. 2012; Gros et al. 1999) for a model solution 
similar to fermentation media). Air is supplied at atmospheric pressure meaning that the partial 
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pressure of oxygen is 0.20946 atm. As there are no cells present during this kLa investigation, 
we can equate OTR and kLa using: DEF	 = 	 !"#	(&∗ 	− &")     Equation 5.5. 
Where CL is zero. The estimated oxygen transfer rate can then be calculated as follows 
(using the BioFlo 310 as an example): 
OTR = 17.58 x 8.181 
              = 143.82 mgO2L-1min-1 
               = 8.99 mmolL-1min-1 
Comparing this with the OURs determined in Section 3, where values between 5.68 and 
25.8 mmolL-1min-1 were seen (during culture in the same bioreactor investigated here), this 
would be capable of sustaining a non-induced batch culture with air alone. However, if the 
culture is fed and induced, which is where the higher peak OURs are seen, it would be 
necessary to work with oxygen enriched air or to increase the operating pressure. This is in 
agreement with what was observed during these experiments (Section 3). The system was 
configured to determine the highest achievable oxygen demand. This means that when 
required by the DOT control loop, pure oxygen was blended with air, raising the composition 
of the inlet gas, and therefore the potential achievable OTR to approximately five times what 
was observed here (around 45 mmolL-1min-1). This confirms that the BioFlo 310 can meet the 
oxygen demand of the fed batch microbial fermentation in Chapter 3.    
Based on these calculations, the Ambr®250 would be able to support batch cultures of E. 
coli at maximum demand. It would not however be able to support the maximum demands of 
the induced or fed-batch cultures. What this means is not that the culture and the 
bioconversion would not be able to be run, but rather that this would change the dynamics 
and potentially productivity of the culture, unless measures were taken to reconcile the 
shortfall in oxygen mass transfer (e.g. increased operating pressure or oxygen enriched air). 
OTRs in the XDR-10 would not be capable of supporting microbial fermentation under any 
of the three culturing strategies investigated in this thesis based on the maximum OURs 
observed. 
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5.6.2. Comparison of Oxygen Demands Determined in Industrial Microbial Fermentations 
and Oxygen Mass Transfer Capabilities of Three Different Bioreactors 
The oxygen mass transfer capabilities of the single use bioreactor systems investigated 
are also compared with industrial microbial fermentations carried out at Synthace Ltd. 
Figure 5.20. shows relevant on- and off-line profiles (OUR and biomass accretion) for a 
fermentation using an E. coli BL21 strain expressing a heterologous reductase, making it 
similar to the expression system used in Chapter 3 for evaluation of the maximum oxygen 
demand. The maximum OUR observed in this fermentation was 281 mmolL-1h-1. Here, 
maximum oxygen uptake rate occurs during the period of maximum volumetric productivity 
with respect to biomass accumulation (as was previously seen in Chapter 3). This was 
representative of the highest OURs seen from 26 Ambr®250 runs (300 fermentations) from 
which relevant data was available, supporting biomass concentrations up to 142 gWCWL-1. 
Using the calculations from Section 5.6.1. the maximum oxygen transfer rates seen in the 
Ambr®250 and the XDR-10 were 5.25 and 0.55 mmolL-1min-1 respectively (equating to 315 
and 33 mmolL-1h-1). This demonstrates that the Ambr®250 is suitable for industrial microbial 
fermentation, and that the XDR-10 is inappropriate for this use. 
Additional industrial fermentations have been summarised with respect to their peak 
oxygen uptake rates in Table 5.13. It is interesting to note the range of demands placed on 
the culture environment by the different expression systems, and the expressions or 
bioconversions that they are undertaking. Given the differences in growth rates and maximum 
biomass concentrations and titres this is to be expected. 
5.6.3. Comparison of Oxygen Mass Transfer Coefficients in SUBs and Microwell Plates 
It is important to compare the oxygen mass transfer capabilities of the two different 
bioreactor scales characterised in this thesis; microtitre plates and lab scale bioreactors. Table 
5.14. summarises the oxygen mass transfer coefficients of a number of commercially available 
single use bioreactors at a range of scales. With respect to the bioreactors characterised in 
this thesis, kLa values in 24 DSW plates are significantly lower than in the BioFlo 310 and 
Ambr®250 bioreactors. Maximum values observed were approximately 5 and 9 times greater 
in the Ambr®250 and BioFlo 310 respectively compared with 24 DSW. These significantly 
higher kLa values provide confidence that batch fermentation performance from the microtitre 
plates can be reproduced or improved on in the BioFlo 310 and Ambr®250.  
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Figure 5.20. Representative example traces of oxygen uptake and biomass concentration 
profiles from an industrial E. coli fermentation expressing a heterologous reductase. Solid line 
represents OUR, while the dashed line shows the biomass concentration in gWCWL-1. 
Experiments performed at Synthace using proprietary bioprocesses. 
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Although the OTR values determined in microtitre plates in Sections 4.2.3. and 4.3.3. were 
lower than the highest literature values found, the maximum oxygen transfer rates quantified 
in the lab scale bioreactors are still significantly higher. As such, significant confidence can be 
had with respect to reproducing the performance of a microtitre culture. 
5.7. Summary 
The aim of this chapter was to evaluate the oxygen mass transfer capabilities of a number 
of commercially available single use bioreactor systems and therefore their ability to undertake 
microbial fermentation. A method for developing multidimensional models for accurate 
determination and prediction of oxygen mass transfer rates in SUBs has been established. 
This was one of the key objectives for this chapter of work as typically, correlations for oxygen 
mass transfer have been limited to highly empirical characterisations using a limited number 
of experimental set points.  
Table 5.13. Observed oxygen uptake rates and maximum biomass concentrations for a 
number of industrial microbial fermentations using different expression systems under 
different modes of operation. Experiments carried out at Synthace Ltd. I-B denotes induced 
batch culture and I-FB, induced fed batch.  
Expression system Product or activity 
Mode of 
operation 
Maximum 
observed OURs 
(mmolL-1h-1) 
Maximum biomass 
concentration 
(gWCWL-1) 
E. coli BL21 
expressing 
heterologous 
reductase 
Heterologous 
reductase I-FB 
122.2 
278.2 
233.1 
187.3 
144.3 
283.8 
148.8 
74.0 
138.5 
113.9 
141.9 
142.2 
124.7 
82.3 
E. coli with 
membrane protein 
knockout  
Recombinant 
protein I-B 
302.8 
207.7 
30.4 
59.2 
Wild type 
filamentous fungus 
Oxidative 
bioconversion I-FB 
21.3 
16.8 
48.9 
29 
36.3 
15.7 
26.4 
17.2 
9.3 
23.1 
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This method has been applied to the generation of models for a classical, bench top stirred 
tank bioreactor (BioFlo 310), a tank liner type single use bioreactor (XDR-10) and a moulded 
polycarbonate single use bioreactor (Ambr®250). As anticipated, kLa was shown to be the 
greatest in the benchtop bioreactor (Section 5.5.) closely followed by the Ambr®250 which is 
geometrically and operationally similar to the traditional style reactor (around 0.29 and 0.17s-
1 respectively). The kLa in the XDR-10 was an order of magnitude lower (Table 5.12.). 
Additionally, a high degree of automation was incorporated into the investigation with the 
Ambr®250, making the process more robust and reproducible compared with a manual 
protocol, and meaning that the operation could be repeated if desired, or, with minimal 
adaptation expanded to include a wider range of potentially significant factors. 
When compared with data predicted by literature relationships (Figure 5.19), a proportional 
correlation is seen across the majority of the experimental space. This is the case for both the 
BioFlo 310, and the Ambr®250.  
Comparisons were also made with the maximum OURs determined for microbial 
fermentation and bioconversion in Chapter 3, approximately 26 mmolL-1min-1 (Section 5.6.1.). 
This highlighted that without additional measures to increase the solubility of oxygen in the 
culture media (e.g. oxygen blending or headspace pressure), it would be difficult to match the 
peak demands of the cultures, although it should be noted that for many fermentations the 
Ambr®250 and the BioFlo 310 would be able to meet the requirements without these additional 
measures. The XDR-10 would not.   
This work has highlighted that differences in reactor geometries and configurations 
influence the factors that impact on oxygen mass transfer and their contribution, further 
demonstrating the need for this level of characterisation in SUBs. Smaller influences on 
oxygen mass transfer are highly system dependent, insight that would be very difficult to gain 
without the use of multifactorial experimental methods. The methodology established in this 
chapter also represents an improvement in the way that oxygen mass transfer capabilities are 
characterised, although limitations are still seen when comparing reactor types due to 
differences in both hardware and software. 
In the next chapter, now that the potential for the Ambr®250 SUB system to culture 
microbial expression systems has been established from a scientific stand point, the suitability 
from an economic perspective will be investigated. A prototype computational tool capable of 
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estimating the cost of a run in the Ambr®250 will be developed and tested, and by the 
conclusion of the chapter, be suitable for internal deployment at Synthace. 
 
 
Table 5.14. kLa values and estimated equivalent oxygen transfer rates determined for a 
range of commercially available single use bioreactors, including those investigated as part 
of this thesis. 
 
Bioreactor Bioreactor Type 
Working 
Vol. (L) kLa* (s
-1) kLa* (min-1) 
Estimated 
equiv. OTR 
(mmolL-1min-1) 
BioFlo 310** Glass STR 2-6 0.293 17.58 8.99 
Ambr®250** Moulded PC STR 0.1-0.25 0.171 10.26 5.25 
XDR-10** Tankliner 2-7 0.018 1.08 0.55 
Wave 
Bioreactor™ Pillow 1-200 <0.003 <0.17 0.09 
Cell-tainer®20 Pillow or Square 0.2-25 >0.111 >6.67 3.41 
Cell-tainer®200 Pillow or Square 5-200 >0.111 >6.67 3.41 
BIOSTAT 
Cultibag Tankliner 50-200 >0.042 >2.50 1.29 
HyPerforma 
SUB Tankliner 30-300 >0.167 >10 5.12 
XDR SUB (up to 
2000L reported) Tankliner 10-2000 <0.006 <0.33 0.18 
Mobius® Cell 
Ready Tankliner 50-200 <0.019 <1.17 0.58 
Ambr®15 Moulded PC STR 
0.01-
0.015 <0.006 <0.33 0.18 
Ambr®250 
(reported) 
Moulded 
PC STR 0.1-0.25 ≤0.139 ≤8.33 4.26 
24DSW** Microwell Plate 
0.002-
0.006 0.033 2.0 1.01 
24DSW 
(reported) 
Microwell 
Plate 
0.002-
0.006 0.097 5.83 2.98 
Table adapted from Oosterhuis et al. 2013, Bareither et al. 2013, Nienow et al. 2013, Jones 
2015 and Kensy et al, 2009. *Values from this thesis or the maximum of those observed. 
**Bioreactors investigated as part of this work. DSW Deep Square Well Microtitre Plate, SS 
STR Stainless Steel Stirred Tank Bioreactor, PC STR Polycarbonate Stirred Tank Bioreactor.  
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6. An Economic Evaluation Tool for Bioprocess Development using the 
Ambr®250 System† 
6.1. Context & Aim  
The cost of experimentation during bioprocess development is a key issue in 
industry. There is a constant drive to bring down financial and resource requirements 
in order to reduce the overall development cost, reduce time to market and make a 
final process as commercially competitive as possible (Paul et al. 2010) This makes 
the economic evaluation of using single use technologies for fermentation a critical 
part of assessing their potential application (Shukla & Gottschalk 2013). In order to 
enable this, there is a need for tools which can accurately predict the economic burden 
of a bioprocess experiment using single-use equipment (termed a ‘run’ in this chapter) 
and a bioprocess development campaign (comprising multiple ‘runs’).  
The Ambr®250 system is a multi-bioreactor system for upstream bioprocess 
development as described in Section 2.3.1. and 2.7.2. Parallel fermentation with 
generation of large online data sets and automated liquid handling mean diverse 
bioprocesses can be investigated concurrently and available offline data captured as 
shown in Section 5.6.2.  
Use of parallel, single-use systems, even during the early stages of bioprocess 
development, needs to be balanced against the cost of doing so. In addition to the 
logistical challenge associated with planning, preparing, setting up and operating 12 
or 24 parallel fermentations, the cost of operating such a system in which many 
different components are single use, or need replacing on a regular basis, is complex 
to estimate. The number of different disposable components involved in a single 
bioreactor run is in double figures and all need to be considered in order to estimate a 
realistic run cost. As a confounding factor, the number, and in some instances the type 
of each consumable is influenced by the objective of an experiment (e.g. looking at 
process kinetics as opposed to final conversion yield) and design of an experiment 
(e.g. batch versus fed-batch operation) which can change considerably from run to 
run. A software tool capable of rapidly capturing this flexibility and is able to model  
cost of an individual run would be useful for application in an industrial context. 
                                                             
† This chapter is included as part of the requirement for award of the UCL EngD in Biochemical 
Engineering and Bioprocess Leadership. 
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6.1.1. Aims 
Chapters 4 and 5 have concluded that a number of single use bioreactor 
technologies commercially available are incapable of being used for experimental 
investigation of microbial expression systems. However, it was also shown that the 
Ambr®250 bioreactors can be used and so are a good model to evaluate here. 
The aim of this chapter is to build and develop a prototype computational tool 
capable of estimating the cost of a given bioprocess development run in the Ambr®250. 
A range of key inputs will be modelled which capture the complexity of a fermentation 
run, combined with the single use elements of the Ambr®250 system. As the tool will 
be used for evaluation of bioprocessing on the Ambr®250, for convenience it will 
henceforth be referred to as the ARC (Ambr Resourcing and Costing) tool. By the end 
of this work the goal is that the ARC tool should be suitable for deployment within 
Synthace Ltd for use on other projects with industrial partners. Specific objectives are 
therefore: 
• Initial development of a costing tool in Microsoft Excel in order to determine 
the validity of the approach, 
• Subsequent development of a more robust, accurate version of the ARC 
tool in Jupyter Notebooks using the Python programming language 
(selection of Jupyter and Python will be discussed in Section 6.3.), 
• Use of the improved tool for analysis of the major costs and how much they 
influence the overall cost of a single run. 
A diagrammatic representation of the proposed structure for calculating resource 
demand and cost is shown in Figure 6.1. Resource requirements will be determined 
taking inputs relating to a particular run such as number of samples, timings and tubing. 
These inputs can then be taken and passed through a prototype framework for 
calculating the operating resource demands (mainly consumables and time). The 
outputs of this first step then need to be used to approximate the total cost of a 
bioprocess run using unit costs. The calculations are based on experience with the 
Ambr®250 system, previous bioprocess development projects and prior knowledge on 
the costing and usage of Ambr®250 disposables. 
In calculating resource and cost requirements, the ARC tool will serve a dual 
purpose. First, it will be used for consumables projection (over a campaign or series 
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of projects), allowing negotiation of the best price for consumables with the supplier, 
and resulting in minimal overspend on unused materials. Also, it will be used for cost 
analysis of bioprocess development runs. This will allow tracking and projection of 
finances for a given bioprocess development run or project (necessary for accurate 
budgeting) and, where necessary, adapting a run strategy in order to improve the value 
of a run i.e. decrease cost to meet a target set of objectives.  
It will also be crucial to ensure that however the ARC tool is finally deployed, it 
should be as user friendly as possible to encourage adoption and use. Simplification 
of the bioprocess complexity for the end user will be critical.  
6.2. Ambr®250 Resourcing and Costing (ARC) Tool - Version 1.0 (Microsoft 
Excel). 
An initial User Requirement Specification (URS) was written, defining the input and 
output requirements for the ARC tool, as well as the requirements for usability. For 
example, simple information inputs such as dropdown lists or textboxes, rather than 
having to enter them using low level methods such as the command line, and 
refinement of the available inputs based on groupings such as experimental strategy.  
Once the user requirements were set out, Version 1.0 of the ARC tool was built in 
Microsoft Excel 2013. This made it relatively quick and simple to build, and meant that 
the focus could be on the calculations that would be used to take the input of process 
information and determine the consumables usage and resultant cost. The primary 
purpose of Version 1.0 of the ARC tool was to establish the validity of building this tool 
and whether the outputs yielded sufficient information and knowledge to justify the 
investment in building something more accurate and robust which could then be 
deployed within the company. 
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Figure 6.1. Basic structure for estimation of the resource demands for a given 
bioprocess development run in the Ambr®250 bioreactor. Arrows represent the flow of 
information. 
 
Building of the calculation framework (Figure 6.1) required determination of all of 
the steps that use consumables during an individual bioprocess run. This is shown 
diagrammatically in Appendix 5.1. It can be seen that there are a number of 
dependencies and that in a number of cases, there are multiple consumables options 
for fulfilling a task. This in turn needed to be considered during calculation and an 
element of prioritisation and logic embedded to ensure that the most appropriate 
consumable was selected and included. 
A simple example calculation for calculating the total number of samples taken 
(Equation 6.1) and basic Excel code are shown in Figure 6.2. to demonstrate the 
structure and information required. In addition, in order to process some of the inputs, 
fields are required to convert instructions into binary inputs for calculation. 
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Figure 6.2. Illustration of the inputs and code in Microsoft Excel cells in order to 
determine the output from Equation 6.1, calculating the total number of samples taken 
during a bioprocess run. 
 
 	Total	Samples	=	Primary	Samples	+	Secondary	Samples	+	Finals	Stage	Samples	
 Equation 6.1. 
 
Several options have been provided for insertion of information depending on what 
the input to the calculations require. Some information is inserted manually, but 
constrained by the calculation to be performed, others from a dropdown list of 
predefined options. 
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Figures 6.3. and 6.4. provide an example of a completed inputs page and outputs 
page respectively for this first iteration of the ARC tool. Where the inputs page indicates 
‘select’, there are drop down options, and where the page shows ‘enter’ as an 
instruction, input of an integer value is required. 
Although outwardly a simple example of what the ARC tool is intended to do, 
Version 1.0 has demonstrated that the principles under which it operates, and the 
means by which the resource and cost estimations are achieved are sufficient to justify 
further development. The real cost was determined by retrospectively calculating the 
cost incurred by individual bioprocess runs as part of client projects, and comparing 
these with the cost when the run was replicated in the ARC tool. It indicated that 
Version 1.0 of the ARC tool was estimating the cost of a run to within 10%. 
There are however a number of issues to be addressed. These include improving 
the accuracy of calculations by incorporating more comprehensive coverage of the 
potential variables, the ease of usability, access and updating of fixed values (e.g. 
costs) and protection of the calculation framework level from editing. These will need 
to be resolved in Version 2.0 of the tool. 
6.3. Ambr®250 Resourcing and Costing (ARC) Tool - Version 2.0 (Jupyter 
Notebooks). 
Taking into account the conclusions from Version 1.0 of the ARC tool in Microsoft 
Excel 2013 (Section 6.2), Version 2.0 of the ARC tool was constructed using the 
Python programming language in Jupyter Notebooks. 
Python was selected as it is a high level, open source programming language 
which is based on English language keywords rather than using more complex 
abbreviated structures in the syntax (Nagar 2017); this makes it relatively easy to self-
teach as a programmer with little previous experience. There is also a large community 
of Python users, which is constantly improving the code base, and its implementation. 
Deployment to a public server can be made relatively simple, enabling wider access 
and uptake. Therefore, successful construction of Version 2.0 of the ARC tool in 
Python would seem to overcome the majority of limitations seen from Version 1.0. 
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Figure 6.3. Example of the Inputs page from the Version 1.0 of the ARC tool in Microsoft Excel 2013, split into the top (A) and bottom (B) halves 
of the inputs page. Dropdown selection is indicated using a ‘Select’ instruction, while text inputs are required where ‘Enter’ is requested.  
A. B. 
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Figure 6.4. Example of the Outputs page from Version 1.0 of the ARC tool in Microsoft 
Excel 2013. Cost figures for the consumables are for illustrative purposes only. 
 
Figure 6.5. Basic structure for estimation of the resource demands for a given 
bioprocess development run in the Ambr®250 using Version 2.0 of the ARC tool in 
Python using Jupyter Notebooks. Arrows represent the flow of information. 
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The Jupyter Notebook is a web-based environment in which Python code can be 
scripted, saved and shared in a relatively simple format (Ragan-Kelley et al. 2014). 
There are also a large number of extensions and libraries available for the Jupyter 
Notebook including widgets (useful for simple, constrained information entry in real 
time e.g. slide bars and tick boxes), and graphing tools. For these reasons, Jupyter 
notebooks are commonly employed in end user laboratories for a wide range of 
applications including data handling, genetic sequencing and collaborative projects in 
areas such as bioinformatics (Shen 2014). 
The use of Python and Jupyter Notebooks also meant that separate parts of the 
ARC tool could be built in isolation, saved separately and imported to the final notebook 
to enable protection of the coded calculations and fixed data, and improve the ease 
with which updates could be implemented. This meant that the structure of the 
workflow was simplified slightly, with the calculations being built into a single notebook 
that would enable simultaneous calculation of the resources and costing. This is 
represented diagrammatically in Figure 6.5.  
Improved understanding of the Ambr®250 system was incorporated into the 
building of Version 2.0 of the ARC tool, but the same approach was used for the 
calculations i.e. using the process design inputs (Appendix 5.1.) to estimate resource 
demand. The increased knowledge of the system acquired between the building of the 
Version 1.0 and Version 2.0 meant that the algorithms used for calculation were 
improved, while the number of input variables was increased to include additional 
detail and try to ensure that different process-to-process options can be incorporated, 
thus improving the accuracy of the eventual estimations. An example of a calculation 
for the number of primary stage bioreactor samples (Equation 6.2.). The corresponding 
Python code is shown in Figure 6.6 to demonstrate the structure and information 
required. Unlike with the first iteration, to code the calculation for the total number of 
samples taken is extensive, and so here, the calculation for the number of primary 
seed stage samples only has been included to demonstrate the principle.  	No.	Primary	Samples	=	No.	Primary	Seed	Ambr®250s	x	No.	Samples	from	each	
Equation 6.2. 
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Figure 6.6. Illustration of the code in Jupyter Notebooks to determine the output from 
Equation 6.2, for calculating the number of samples taken during the primary seed 
stage of a bioprocess run in the Ambr®250 system. 
 
Further inputs were added during development of Version 2.0 as it was proposed 
that the original remit for the ARC tool could be extended beyond resource and cost 
estimation to include generation of process documentation from templates, media 
preparation recipes, and eventually, construction of the process run file for the 
Ambr®250 system. This is beyond the scope of this current work and will be discussed 
further in Section 6.6. 
The inputs notebook for Version 2.0 of the ARC tool therefore is thorough, but more 
extensive than would be necessary for many cases. As such, measures were taken to 
ensure that details which were not required based on already provided inputs were not 
included and hidden from the operator where appropriate, making the inputs notebook 
as comprehensive, but versatile as possible. Figure 6.7. shows a simple example of 
this for feed line allocation. 
One of the major improvements made between Version 1.0 and 2.0 of the ARC 
tool was greater functionality, making the tool easier to use and more difficult to 
misconstrue the required input information. Images of the user interface for the Inputs 
Notebook and Resource Estimates Notebook (representing calculations and outputs 
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respectively) are shown in Figures 6.8, 6.9 and 6.10. They highlight the aesthetic 
improvement from the initial version, but also the increased level of detail where 
relevant options have been selected. 
6.3.1. Summary of Developments  
Version 2.0 of the ARC tool has built upon the foundations of Version 1.0 by 
utilising a high-level programming language (Python) to improve functionality and 
usability as well as making the user interface much clearer. Additional knowledge 
gained on the Ambr®250 system has been incorporated in the form of added detail and 
inputs where relevant. These have subsequently been used in calculations to improve 
the accuracy of resource and costing estimations. Additionally, use of the Python 
programming language over Microsoft Excel for building this tool has resulted in the 
long term aim of the ARC tool being expanded to incorporate greater functionality 
including the generation of process documentation and run files for the Ambr®250 
system. To this end, Version 2.0 of the ARC tool has been built with consideration for 
this increased demand for information in the future, with additional data input options 
and the choice to include small data tables and predefined template text structures 
(e.g. introductory paragraphs of text for run documents).  
Importantly, Version 2.0 of the ARC tool also provides a much more extensive 
breakdown of where consumables are used in order to highlight major contributors to 
cost are and how this might be reduced. 
6.4. Case Studies 
Once the ARC tool was developed in the Jupyter Notebook (Section 6.3), a series 
of case studies were undertaken with respect to the cost of a bioprocess run in the 
Ambr®250. The purpose of this was two-fold. First, to test the robustness and usability 
of the ARC tool, but also to investigate where the greatest contributions to the cost of 
an Ambr®250 run are, and therefore where savings could be made. 
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Figure 6.7. Example of the dynamic properties of the ARC tool built in 
the Jupyter notebook. This example is for the use of feed lines for 
pumping of feeds and pH control titrants. Upon selection of the method 
of feed or titrant supply, the section expands to allow input of additional 
details. The expansion is reversed and any inputs contained within 
ignored should the selection be changed to not require pumping. 
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Figure 6.8. Example of the first part of the Inputs Notebook for the ARC tool built in Jupyter Notebooks using the Python programming language. 
This includes the input of experiment information and details of the bioprocess train. 
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Figure 6.9. Example of the second part of the Inputs Notebook for the ARC tool built in Jupyter Notebooks using the Python programming 
language. This includes the input of bioprocess train details, control strategy and a brief summary of outputs. 
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Figure 6.10. Example of the Resource Estimates Notebook for the ARC tool built in Jupyter Notebooks using the Python programming language. 
This includes a comprehensive summary of all of the required consumables and a resource and cost estimate for the whole run.
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The inputs tested were some of those commonly seen to change between runs and 
therefore appeared to constitute a good set of test cases. These were; the number of 
bioreactors used in total (Section 6.4.1.), the bioprocess run structure and duration (Section 
6.4.2.), the consumables discount from the supplier (Section 6.4.3.) and the sampling regime 
throughout the duration of the production stage culture (Section 6.4.4.). Each of these 
scenarios require assumptions which will be discussed individually throughout this section. 
It should be noted that cost figures for the consumables are for illustrative purposes only. 
6.4.1. Total Bioreactors 
Single use bioreactors are the most expensive individual consumable used during an 
Ambr®250 bioprocess. As such it is one of the key factors to look at in terms of an effect on 
the cost of the run as a whole. The run has been assumed to be a 48hr final stage process, 
and that this is the only stage at which the Ambr®250 vessels are used. A 16 hour primary and 
secondary seed stage (in shake flasks) are also assumed, in order to be factored into total run 
time and labour requirement. This was a simple first test of the output response of the ARC 
tool. 
Figure 6.11. shows that there is a linear trend in total costs and bioreactor cost. This is to 
be expected as the number of bioreactors used was changed equally each time. Interestingly, 
under these test conditions, reducing the number of final stage bioreactors, reduces total cost 
of run by approximately 2.9% per bioreactor, indicating that the contribution to run cost of the 
single use bioreactors is over a third (approximately 34.8%). It should also be noted that labour 
remains constant and is the largest contributor to overall cost. Labour is calculated using an 
approximate full time employee (FTE) salary, and estimating an hourly cost assuming a 37.5 
hour per week contract. 
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Figure 6.11. Effect of changing the number of production stage bioreactors used on the cost 
of a bioprocess run in the Ambr®250 system. Striped areas are the contribution to cost of 
labour, while solid grey is the cost due to consumables. Costs have been normalised to the 
highest total cost. 
 
 
 
 
 
 
 
 
 
 
Figure 6.12. Effect of changing the duration of each of the stages of the bioprocess run on 
the cost of a bioprocess run in the Ambr®250 system. Striped areas are the contribution to 
cost of labour, while solid grey is the cost due to consumables. Costs have been normalised 
to the highest total cost. 
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6.4.2. Bioprocess Run Structure and Duration  
The structure of the bioprocess train influences not only the number of bioreactors and 
other consumables used, but also the duration of a run and the required labour. As such, 
combinations of the structure and duration of the bioprocess train were tested for their 
influence on the overall cost, as well as the relative contributions to labour and consumables. 
It has been assumed that there were 10 final stage bioreactors, and a single primary and 
secondary seed stage (it was deemed unlikely that a bioprocess would run without the 
inclusion of seed stages). A four hourly sampling regime was also assumed. The combinations 
of bioprocess train structures and durations are shown in Table 6.1. 
The overall process cost changes by almost a third between a 38 hour run, and a 104 hour 
run (total for all stages). This demonstrates the proportional impact of the overheads for a run. 
There is understandably a relationship between the overall run cost and its duration, as was 
seen previously, since labour is a major contributor to the total cost of a bioprocess 
development run. Figure 6.12. highlights that by shortening the final stage by 24 hours resulted 
in the run cost reducing by approximately 11%; interestingly the cost of consumables changed 
very little (~1%) despite the decrease in tip and microtitre plate usage. In many cases the cost 
of labour exceeded half of the cost of the maximum normalized run. In 8 of the 12 examples, 
the cost of labour exceeds the cost of consumables. 
 
 
Table 6.1. Bioprocess train sequences and durations investigated for their effect on cost of a 
bioprocess run in the Ambr®250 system. All values are in hours. 
Primary Seed 
Duration 6 16 
Secondary Seed 
Duration 8 6 8 16 
Production Stage 
Duration 24 48 72 24 48 72 24 48 72 24 48 72 
Combination 6,8,24 
6,8,
48 
6,8,
72 
6,16,
24 
6,16,
48 
6,16,
72 
16,8,
24 
16,8,
48 
16,8,
72 
16,16,
24 
16,16,
48 
16,16,
72 
Total 38 62 86 46 70 94 48 72 96 56 80 104 
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6.4.3. Supplier Discount  
Discount provided by a consumables supplier could have a significant influence on the 
cost of each run, with greater discount often given for larger orders. However, use of a tool 
such as the ARC tool which would be capable of projecting consumables usage taking into 
account factors such as number of projects over a given period, their scheduled duration, and 
accurate prediction of demand could in turn lead to favourable costing. As such, a number of 
possible supplier discounts have been looked at (0%, 5%, 10%, 30% and 50%). Here, the 
cost of labour would not be impacted upon hence it is not included in the analysis. 
A simple process incorporating 12 bioreactors, including a secondary seed in the 
Ambr®250 and 11 final stage bioreactors, run for a total of 64 hours with a two hourly sampling 
regime has been used as the baseline experiment. Although there is a proportional decrease 
in the consumables cost due to an increase in supplier discount, the impact on the overall cost 
of undertaking a run is not so great, with the maximum difference (due to a 50% discount) 
resulting in a reduction of just over 20% in the total cost. This is shown in Figure 6.13. 
6.4.4. Sample Regime During Production Stage Culture 
The ability to use the liquid handling arm of the Ambr®250 to carry out time-dependent 
sampling and storage is a distinct advantage of the system. As such, there is value in 
attempting to understand what the impact on cost is of using different sampling regimes. 
Greater frequency sampling means a more complete data set and more information from 
which to draw conclusions and make process decisions. However, it also means a greater 
burden on analytics and an increase in consumables usage. 
In this analysis, ten production stage bioreactors were assumed to run for 48 hours, in 
addition to 16 hour primary and secondary seed stages in Ambr®250 vessels. Each of the 
seed stages would be sampled three times, and the sampling regime would be altered not 
only in terms of sample frequency, but for the inclusion of event-based sampling (e.g. pre-and 
post-induction). The timings included for this hypothetical run are not altered so again there is 
no impact on the cost of labour and it will not be discussed here. 
Figure 6.14 shows a 15% difference in the consumables cost that can be attributed to the 
choice of sampling regime in this bioprocess. The majority of this cost coming from the 
increase in tip and storage plate usage. This is a significant contribution to the cost of a run 
and so demonstrates the need to consider what the increase in sample frequency offers in 
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terms of the objective of an experiment. For instance, if a higher density data set is going to 
enhance understanding of a process e.g. if knowledge of accurate substrate utilization rates 
are considered likely to aid in the development of a process, then the additional cost may be 
justified. Furthermore, it is shown that an additional 3.5% is added to the consumables cost 
by adding event based sampling to the regime. This is relatively minor and could lead to 
valuable insights, and so would likely be retained within the experimental design. 
Sections 6.4.1 – 6.4.4 represent just a few examples of factors which could be investigated 
for their influence on the cost of the bioprocess. The comprehensive inclusion of potential 
inputs into the ARC tool means that a large number of combinations of parameters could be 
tested. This may be done with a view to understanding how to get the most value out of the 
bioprocess. In addition, it could also be used to understand the economic impact of, for 
example, a switch from complex to defined media, or changes to media component 
concentrations. These changes are highly convoluted, and understanding the impact on cost 
is an important part of decision making, and would be difficult to quantify by other means. 
It has also been observed through this demonstration of the ARC tool that for most run 
configurations the labour is the major contributor to cost. However, it is worth considering that 
this is likely to be significantly smaller than it would be for a traditional stainless steel 
fermentation systems, which would not benefit from the advantages of single use technology 
(e.g. removed need for cleaning), many of which require significant time and labour. 
 
6.5. Summary 
The primary objective of this chapter was to develop a prototype tool for cost estimation 
for upstream bioprocess development runs in the Ambr®250 system. This has been achieved. 
In doing this the potential for expansion of the objective to include a broader range of outputs 
(e.g. scheduling, process documentation) was realised and so Version 2.0 of the ARC tool is 
under further development to include these. 
In its current form, the ARC is a useful tool, currently implemented within Synthace for 
project costing and to provide insight into consumable resource demand. Progression from 
Version 1.0 to Version 2.0 of the ARC tool represents a significant improvement in functionality 
and usability. 
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Figure 6.13. Effect of increasing the supplier discount on consumables on the cost of a 
bioprocess run in the Ambr®250 system. Striped areas are the contribution to cost of labour, 
while solid grey was the cost due to consumables.  
 
 
 
 
 
 
 
 
 
Figure 6.14. Effect of changing sampling regime on the cost of a bioprocess run in the 
Ambr®250 system. Striped areas are the contribution to cost of changing the sampling regime, 
while solid grey was the cost which can be attributed to the inclusion of event based sampling. 
Costs have been normalised to the highest total cost.  
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The ARC tool has been designed to include most important potential factors in an 
upstream bioprocess. However, due to the complexity these will change from run to run, and 
some may not be captured. Currently, the majority of factors which contribute to the potential 
variability are included in the calculations for estimating bioprocess cost, meaning the values 
are a good approximation of the actual cost. As the ARC tool is expanded and refined, this 
accuracy will continue to improve. Undertaking each of the case studies described in Section 
6.4 has demonstrated the ease of use and functionality of this second iteration of the ARC 
tool.  
Operation of an Ambr®250 upstream process is expensive, and, although generally 
cheaper than a traditional stainless steel fermentation (especially when considering the high-
throughput, parallel processing capabilities), the cost must be justified. The first step in this is 
being able to accurately determine the cost of a run, and the ARC tool provides a means of 
achieving this and a method for tracking it.  
 
6.6. Future Developments 
In its current form, Version 2.0 of the ARC tool makes it useful as a costing and decision 
making tool for Ambr®250 bioprocess development runs. There are a number of areas in which 
the functionality or input variables of the model could be expanded with a view to making it a 
more inclusive and accurate resource. 
The ARC tool represents the early stages of a tool which, with additional development, 
could be a means of standardising the generation of bioprocess documentation and run files 
for bioprocess development on the Ambr®250 system. In order to achieve this, there are a 
number of areas that will need to be worked on. 
Improved functionality is necessary for the ARC tool to be most useful. One significant 
advancement which should be made is the ability to import a DoE design file e.g. from JMP 
or Design Expert software, to have this populate a number of the input parameters such as 
number of bioreactors, media compositions etc. This would improve the efficiency and 
accuracy of completing the inputs notebook. It would also likely provide a route to prioritising 
the most important factors to be included. 
This in turn may lead to a significant extension to functionality, by developing the ARC to 
 
 219 
be capable of generating process documentation and run files for the Ambr®250 system using 
template document structures and incorporating some additional key inputs. A considerable 
amount of the information included in process documentation is repeated from run to run. As 
such this is something that could be streamlined with the use of templates. There is a simple 
example of this included in the images from the ARC tool (Figure 6.8, 6.9 and 6.10). 
In order to increase the accuracy of resource demand projection, the ARC tool should be 
integrated with a scheduling tool. This will enable the projection of consumables usage at 
suitable intervals e.g. one, three, six and 12 months. This would aid risk mitigation ensuring 
consumable availability does not become a bottleneck, and conversely that excess 
consumables are not purchased. 
An additional improvement may come from developing input notebooks with constraints 
incorporated within them. For example, input notebooks could be constructed to allow for 
different organisms, and the process constraints that these impose. Alternatively input 
notebooks could be constrained by run objective e.g. seed train optimisation or production 
stage robustness testing. 
Another area which could be improved is in expanding the stages of the run which can be 
cost projected. Currently, the ARC tool is capable of estimating the cost of fermentation, but 
there is a significant resource burden associated with analytics. Current approximations 
suggest that these are around the same as the cost of the fermentation run, depending on the 
analytical methods used and sample numbers. A principal objective when undertaking a 
bioprocess development run is the generation and interpretation of data which informs the 
next stage of development until a robust, optimised, validated production process is 
formalised. To this end, analytics is vital. Additionally, the cost data itself will need to be 
expanded and updated on a periodic basis in order to ensure accuracy and relevance of the 
cost estimations.  
Finally, in order to integrate the ARC tool properly with Synthace’s software platform, in 
time it will need to be written in the Antha programming language. This will allow it to operate 
as an element within the wider design and execution of a bioprocess. 
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7. Conclusions and Future Work 
7.1. Conclusions 
Microbial fermentation and biocatalysis have long been applied in an industrial context for 
the generation of commercially valuable biomolecules (Section 1.2.1). Advancements in 
genetic engineering techniques provide routes to new or improved biomanufacturing 
processes, but there are limitations to the expansion of their use. The findings that can be 
translated from high throughput screening at microwell scales are limited due to the 
restrictions on oxygen mass transfer (Section 1.2.7), and the relative oxygen demands of 
microbial expression systems (Section 1.2.4). Scaling into single use bioreactors at pilot or 
production scale, which is the direction in which the industry is moving, comes with additional 
challenges. These include a lack of detailed engineering characterisation (Section 1.2.7.4), 
and the fact that many commercially available SUBs have been designed for mammalian 
expression systems, where the specific oxygen demand is significantly less (Dreher et al. 
2013). 
The aim of this thesis was to determine the applicability of commercially available single 
use bioreactor technologies for microbial fermentation; in particular microbial whole cell 
bioconversions. Specific objectives were: to optimise a whole cell P450 bioconversion in E.coli 
to provide a commercially relevant expression system with high oxygen demand for further 
investigation (Chapter 3); develop methods to improve the accuracy of oxygen mass transfer 
quantification in microwell plates (Chapter 4) and commercially relevant single use bioreactors 
(Chapter 5), use these to build models to characterise kLa and OUR in each bioreactor format; 
and finally, to build a tool to evaluate the economic feasibility and sensitivity of using a SUB 
system for performing microbial whole cell bioconversions (Chapter 6). 
In order to establish a foundation for investigations into the applicability of single use 
bioreactors for microbial cultivation, the oxygen demand of a whole cell P450 monooxygenase 
bioconversion in E.coli BL21 was characterised in Chapter 3. P450 systems often have low 
expression levels (Section 1.2.2) and so enhancement of the enzyme activity level was first 
explored using multifactorial experimental design (Section 1.2.10) in conjunction with 
microwell scale experiments (Section 2.5). Enzyme activity levels were enhanced by 
increasing shaking speed (Figure 3.2) and post induction temperature (Figure 3.6). The 
optimised culture conditions resulted in a 3.3-fold increase in bioconversion product titre 
(Table 3.4). The optimised conditions were subsequently scaled-up 3000-fold using three 
different fermentation strategies (Section 3.2): batch, induced batch and induced fed-batch. 
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This resulted in peak oxygen demands in the range of 5.7 to 25.8 mmolL-1min-1 depending 
on the fermentation strategy employed (Table 3.6). The inability of microwells to support these 
peak demands was demonstrated, and the identification of the relationship between the three 
main contributors to oxygen mass transfer (maintenance, growth and bioconversion) 
determined. This led to the identification of the mechanisms for oxygen utilisation, with 
biomass accumulation shown to be the priority over additional cellular activities such as 
bioconversion. The different demands for oxygen in whole cell oxidative bioconversions have 
not be thoroughly investigated, and so this finding improves understanding of whole cell 
oxidative bioconversions and how to improve their development for commercial application.  
Due to the main requirement for oxygen being associated with biomass growth (Table 
3.7) and the low productivity of the E.coli PQR368 strain, subsequent investigations focused 
on culture of an E.coli strain containing a fluorescent reporter (Section 2.6) in order to more 
readily measure the responses of the expression system in terms of productivity. Given the 
importance of oxygen mass transfer in microbial fermentation (Section 1.2.4), an improved 
methodology for determination of oxygen transfer values (including OUR, kLa and OTR) based 
on the dynamic gassing out method was developed in Chapter 4. This involved building a 
linear model for kLa in 24 DSW plates using the dynamic gassing out method (Section 4.2), 
before comparing online DOT profiles with the linear model in order to determine OUR values 
during culture.  
Using the improved method with multifactorial statistical analysis, models were built to 
characterise kLa and OUR in 24 DSW plates. Experiments showed that kLa increased as a 
function of shaking speed and reduced fill volume (Figure 4.9). The maximum value of kLa 
was 103.5 h-1 (Figure 4.3) while the maximum OUR observed was approximately 600 mgO2L-
1h-1 (Table 4.11). Additional models were constructed for biomass accretion and recombinant 
protein expression in E.coli, enabling the approximation of process parameter set points for 
matched oxygen mass transfer between 96 and 24 DSW plates. 
Since the overall aim of this work was to explore scale-up of microbial fermentation into 
single-use bioreactors the oxygen transfer capability of two representative single-use 
bioreactor designs was explored in Chapter 5. A tank liner style SUB, the Xcellerex XDR-10 
(Figure 2.2) and an Ambr®250 (Figure 2.3) of rigid construction were the single use bioreactors 
characterised. Using a BioFlo 310 traditional benchtop STR (Figure 2.1) as a reference 
standard, the bioreactors were characterised using DoE Response Surface Methodology 
(RSM) designs investigating process relevant parameters and conditions. Models were built 
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for the quantification of oxygen mass transfer coefficients in the BioFlo310 (Figure 5.1 to 5.7), 
the XDR-10 (Figure 5.9 to 5.11) and the Ambr®250 (Figure 5.14 to 5.17). Smaller influences 
on oxygen mass transfer were shown to be highly system dependent, a finding which would 
not have been possible without the use of a multifactorial DoE approach.   
The kLa in the Ambr®250 was shown to be similar to that of the traditional STR across the 
majority of the experimental landscape (Figure 5.19). Maximum kLa values observed were 
1054, 616 and 65 h-1 (Table 5.12) for the benchtop STR, the Ambr®250 and the XDR-10 
respectively. Analysis of the peak oxygen uptake rates determined in Chapter 3, and 
approximately 300 industrial microbial fermentations (carried out by the author) showed that 
the Ambr®250 is capable meeting the peak oxygen demands of microbial whole cell oxidative 
bioconversions, and that the XDR-10 is not. 
Once the applicability to industrial microbial fermentation of the Ambr®250 was shown 
(Section 5.6.2), the wider industrial utilisation of this type of single-use bioreactor was 
considered in Chapter 6. It was pertinent to investigate the resource demand of using a system 
in which many components are single use, and one run may change dramatically from the 
next. As such an Ambr resourcing and costing (ARC) tool has been developed in the Python 
programming language in order to rapidly capture the resource demands of a given bioprocess 
development run in the Ambr®250 system and aid in project costing and planning (Section 
6.3). The ARC tool was used to carry out sensitivity analyses on an Ambr®250 bioprocess run, 
highlighting that the number of bioreactors used could save up to 35% of the run cost (Figure 
6.11) and the length and number of stages of the bioprocess train approximately 32% (Figure 
6.12). Additional observations using this tool highlighted labour as the greatest contributor to 
cost, with replacement single use bioreactors the next most significant. This tool is now 
implemented within the industrial sponsor company for this research. 
Overall, the results presented in this thesis have shown the applicability of commercially 
available single use bioreactors for microbial whole cell bioconversions. The investigation has 
also yielded novel insights into the mechanism of oxygen utilisation (Section 3.2.7), the 
characterisation of oxygen mass transfer coefficients in scale down platforms (Section 4.2) 
and devised methodologies for the improved quantification of kLas in SUBs (Section 5.2 to 
5.4) and OURs in microwell systems (Section 4.3). In the following section options for future 
work are considered. 
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7.2. Future Work 
Now that the methodology has been established for optimisation and scaling of a 
microbial fermentations in small scale single-use systems (Section 3), this multifactorial 
optimisation and analysis should be undertaken with a wider range of microbial expression 
systems which carry out a diverse range of bioconversions or expression of different 
recombinant proteins. This should include industrially relevant P450 systems such as the one 
in this thesis, which are likely to have the highest oxygen demand. It will be critical to 
understand the oxygen demands of different expression systems in order to develop the most 
suitable processes and technologies. 
Something that has become clear throughout this work is that there is a need to develop 
new high throughput systems, including microwells, with higher oxygen transfer rates which 
match larger scale STRs. These systems should also be capable of carrying out different 
operating strategies such as fed batch and induced fermentations. It is important that there be 
a clearer definition of the optimum use of microwells in early stage microbial development, 
understanding what information can be reliably gained from microwell studies.  
Regarding the characterisation of microbial fermentations in microwell plates (specifically 
with respect to oxygen mass transfer), there are several additional pieces of work which should 
be undertaken in order to further this area and extend its practical application. These include 
development of a more detailed model to incorporate more factors, expand the ranges used 
and increase the number of experimental points in them to determine whether these also have 
an effect on microwell oxygen mass transfer. It would also be useful to investigate whether, 
even over this relatively small design space, the model is non-linear and a local optimum could 
be identified. Additionally, expanding the multifactorial design to include greater range of 
(particularly) agitation speeds and fill volumes may aid with this. 
Characterisation of O2 mass transfer for a greater number of relevant scale down 
bioreactor geometries is crucial, as many of the potentially influencing factors need to be taken 
into account. This will require accurate measurement of oxygen concentration in 96DSW to 
build and validate multifactorial models. Currently, the technology to do this across an entire 
plate geometry, is not available. As such an advancement in the available apparatus is 
required, either as a small probe (or set of probes) which could be used in a 96 DSW without 
influencing the hydrodynamics, or, a non-invasive technology similar to the PreSens SDR® 
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system which is used in this work with 24 DSW plates (Section 2.6). In turn, this would enable 
the investigation of overlaps in oxygen mass transfer values, all the way from microwells up 
to stirred tank bioreactors. 
It is important to note the increasing integration of mathematical and computational tools 
(such as DoE) into bioprocess development. The insight that these can help to provide, when 
considered in conjunction with the generation of increasingly large data sets generated by 
high throughput processing tools means that bioprocess development could be streamlined if 
these tools are harnessed effectively. In the context of this research, it would be beneficial to 
develop improved correlations and build a predictive tool which, based on literature 
correlations for kLa as well as ongoing research, would estimate oxygen mass transfer in a 
particular bioreactor geometry with the only experimental requirement being validation of the 
models. To that end, bioprocess validation runs should be undertaken to support the industrial 
data in the conclusion that the Ambr®250 is suitable for cultivation of microbial expression 
systems carrying out oxidative bioconversions. 
Now that the principle has been demonstrated for showing where single use bioreactors 
can be applied in the fermentation of an E.coli expression system, it is now important to 
interrogate single use bioreactors in addition to the Ambr®250 and the XDR-10 (investigated 
here). Multifactorial characterisation of larger scale systems such as the Xcellerex XDR MO 
from GE Healthcare and the Hyperforma SUF from ThermoFisher, designed for cultivation of 
microbial expression systems, will provide an insight into the current potential for fermentation 
of microbial whole cell bioconversions at a more manufacturing relevant scale. This will then 
need to be coupled with characterisation of additional expression systems and bioconversions 
in order to understand which microbial expression systems, fermentations and bioconversions 
can be undertaken in which commercially available technologies. Indeed, this will also inform 
on where the shortfalls lie and what the requirements are for the next generation of single use 
technologies. 
Finally, expansion of the Ambr®250 Resourcing and Costing (ARC) tool, will improve its 
usefulness and uptake within the Synthace organisation. This should include the ability to 
incorporate DoE design files from programs such as JMP and Design Expert such that this 
information would populate inputs for resource calculation. In addition, integration of a 
scheduling tool which would incorporate all planned runs in order to project consumables 
usage, resourcing and costing in one, three, six and 12 month intervals. This then aids risk 
mitigation, ensuring consumable availability does not become a resource bottleneck, and 
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conversely that excessive single use consumables (with defined shelf lives), are not 
unnecessarily purchased. In turn, this should lead to the most significant improvement in 
functionality, by having the ARC capable of generating process documentation and run files 
for the Ambr®250 using document templates, and prefabricated design file structures. 
In summary, a clear strategic priority for future work, is the expansion of single use 
bioreactor technologies and microbial expression systems that are comprehensively 
characterised using the methodologies developed or improved in this thesis. This will ensure 
a robust engineering understanding of both the demand and supply of oxygen to microbial 
fermentations and where commercially available SUBs can be applied in this area of 
bioprocess development.  
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Appendices 
 
Appendix 1.1. 9 factor, 64 run DoE design for screening bioconversion of 7-ethoxycoumarin 
to 7-hydroxycoumarin. 
 
 
Factor A B C D E F G H J   
Post Ind. 
Time 
[Subs] Post 
Ind. 
Vol. 
Pre 
Ind. 
Time 
Temp. 
(Post 
Ind.) 
Subs 
additio
n time 
[Yeast 
Extract] 
Buffer Shaker 
Speed 
Plate/Wel
l 
Std 
Order 
(hrs) (mM) (mL) (hrs) (°C) (hrs) (g/L)   (rpm) 
1/D3 1 8 0.1 0.5 2 25 0.167 10 Yes 300 
1/D4 2 65 0.1 0.5 2 25 1 30 Yes 300 
1/D5 3 8 1.0 0.5 2 25 1 30 No 300 
1/D6 4 65 1.0 0.5 2 25 0.167 10 No 300 
1/D7 5 8 0.1 1.0 2 25 1 10 No 300 
1/D8 6 65 0.1 1.0 2 25 0.167 30 No 300 
1/D9 7 8 1.0 1.0 2 25 0.167 30 Yes 300 
1/D10 8 65 1.0 1.0 2 25 1 10 Yes 300 
1/E3 9 8 0.1 0.5 5 25 0.167 30 No 300 
1/E4 10 65 0.1 0.5 5 25 1 10 No 300 
1/E5 11 8 1.0 0.5 5 25 1 10 Yes 300 
1/E6 12 65 1.0 0.5 5 25 0.167 30 Yes 300 
1/E7 13 8 0.1 1.0 5 25 1 30 Yes 300 
1/E8 14 65 0.1 1.0 5 25 0.167 10 Yes 300 
1/E9 15 8 1.0 1.0 5 25 0.167 10 No 300 
1/E10 16 65 1.0 1.0 5 25 1 30 No 300 
2/D3 17 8 0.1 0.5 2 37 0.167 10 Yes 300 
2/D4 18 65 0.1 0.5 2 37 1 30 Yes 300 
2/D5 19 8 1.0 0.5 2 37 1 30 No 300 
2/D6 20 65 1.0 0.5 2 37 0.167 10 No 300 
2/D7 21 8 0.1 1.0 2 37 1 10 No 300 
2/D8 22 65 0.1 1.0 2 37 0.167 30 No 300 
2/D9 23 8 1.0 1.0 2 37 0.167 30 Yes 300 
2/D10 24 65 1.0 1.0 2 37 1 10 Yes 300 
2/E3 25 8 0.1 0.5 5 37 0.167 30 No 300 
2/E4 26 65 0.1 0.5 5 37 1 10 No 300 
2/E5 27 8 1.0 0.5 5 37 1 10 Yes 300 
2/E6 28 65 1.0 0.5 5 37 0.167 30 Yes 300 
2/E7 29 8 0.1 1.0 5 37 1 30 Yes 300 
2/E8 30 65 0.1 1.0 5 37 0.167 10 Yes 300 
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2/E9 31 8 1.0 1.0 5 37 0.167 10 No 300 
2/E10 32 65 1.0 1.0 5 37 1 30 No 300 
3/D3 33 8 0.1 0.5 2 25 0.167 10 Yes 1100 
3/D4 34 65 0.1 0.5 2 25 1 30 Yes 1100 
3/D5 35 8 1.0 0.5 2 25 1 30 No 1100 
3/D6 36 65 1.0 0.5 2 25 0.167 10 No 1100 
3/D7 37 8 0.1 1.0 2 25 1 10 No 1100 
3/D8 38 65 0.1 1.0 2 25 0.167 30 No 1100 
3/D9 39 8 1.0 1.0 2 25 0.167 30 Yes 1100 
3/D10 40 65 1.0 1.0 2 25 1 10 Yes 1100 
3/E3 41 8 0.1 0.5 5 25 0.167 30 No 1100 
3/E4 42 65 0.1 0.5 5 25 1 10 No 1100 
3/E5 43 8 1.0 0.5 5 25 1 10 Yes 1100 
3/E6 44 65 1.0 0.5 5 25 0.167 30 Yes 1100 
3/E7 45 8 0.1 1.0 5 25 1 30 Yes 1100 
3/E8 46 65 0.1 1.0 5 25 0.167 10 Yes 1100 
3/E9 47 8 1.0 1.0 5 25 0.167 10 No 1100 
3/E10 48 65 1.0 1.0 5 25 1 30 No 1100 
4/D3 49 8 0.1 0.5 2 37 0.167 10 Yes 1100 
4/D4 50 65 0.1 0.5 2 37 1 30 Yes 1100 
4/D5 51 8 1.0 0.5 2 37 1 30 No 1100 
4/D6 52 65 1.0 0.5 2 37 0.167 10 No 1100 
4/D7 53 8 0.1 1.0 2 37 1 10 No 1100 
4/D8 54 65 0.1 1.0 2 37 0.167 30 No 1100 
4/D9 55 8 1.0 1.0 2 37 0.167 30 Yes 1100 
4/D10 56 65 1.0 1.0 2 37 1 10 Yes 1100 
4/E3 57 8 0.1 0.5 5 37 0.167 30 No 1100 
4/E4 58 65 0.1 0.5 5 37 1 10 No 1100 
4/E5 59 8 1.0 0.5 5 37 1 10 Yes 1100 
4/E6 60 65 1.0 0.5 5 37 0.167 30 Yes 1100 
4/E7 61 8 0.1 1.0 5 37 1 30 Yes 1100 
4/E8 62 65 0.1 1.0 5 37 0.167 10 Yes 1100 
4/E9 63 8 1.0 1.0 5 37 0.167 10 No 1100 
4/E10 64 65 1.0 1.0 5 37 1 30 No 1100 
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Appendix 1.2. Layout of factors and set points for execution of 9 factor, 64 run DoE design 
for screening bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. 
 
Included is the assignment of four different medias to wells (capital letters), the substrate 
addition concentration (concentration in mM in brackets) and the wells to 1mL working volume 
(arrows). Each plate is also labelled with post induction temperature and shaker frequency. 
NB. Grey wells contain sterilised water.  
Plate 1 (Post Induction Temperature 25°C, 300rpm)
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
A 
(0.1)
C 
(0.1)
D 
(1.0)
B 
(1.0)
B 
(0.1)
D 
(0.1)
C 
(1.0)
A 
(1.0)
E
D 
(0.1)
B 
(0.1)
A 
(1.0)
C 
(1.0)
C 
(0.1)
A 
(0.1)
B 
(1.0)
D 
(1.0)
F
B D C A
G
C A B D
H
Plate 2 (Post Induction Temperature 37°C, 300rpm)
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
B 
(0.1)
D 
(0.1)
C 
(1.0)
A 
(1.0)
A 
(0.1)
C 
(0.1)
D 
(1.0)
B 
(1.0)
E
C 
(0.1)
A 
(0.1)
B 
(1.0)
D 
(1.0)
D 
(0.1)
B 
(0.1)
A 
(1.0)
C 
(1.0)
F
A C D B
G
D B A C
H
Grey wells contain steril ised water.
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Included is the assignment of four different medias to wells (capital letters), the substrate 
addition concentration (concentration in mM in brackets) and the wells to 1mL working volume 
(arrows). Each plate is also labelled with post induction temperature and shaker frequency. 
NB. Grey wells contain sterilised water.  
 
 
Plate 3 (Post Induction Temperature 37°C, 1100rpm)
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
D 
(1.0)
B 
(1.0)
A 
(0.1)
C 
(0.1)
C 
(1.0)
A 
(1.0)
B 
(0.1)
D 
(0.1)
E
A 
(1.0)
C 
(1.0)
D 
(0.1)
B 
(0.1)
B 
(1.0)
D 
(1.0)
C 
(0.1)
A 
(0.1)
F
D B A C
G
A C D B
H
Plate 4 (Post Induction Temperature 25°C, 1100rpm)
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
C 
(1.0)
A 
(1.0)
B 
(0.1)
D 
(0.1)
D 
(1.0)
B 
(1.0)
A 
(0.1)
C 
(0.1)
E
B 
(1.0)
D 
(1.0)
C 
(0.1)
A 
(0.1)
A 
(1.0)
C 
(1.0)
D 
(0.1)
B 
(0.1)
F
C A B D
G
B D C A
H
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Appendix 1.3. 7 factor, 64 run DoE design for refinement stage of optimising bioconversion 
of 7-ethoxycoumarin to 7-hydroxycoumarin. 
 
 
Factor A B C D E F G   
Post 
Induction 
Time 
[Subs] Post 
Induction 
Vol. 
Pre 
Induction 
Time 
[Yeast 
Extract] 
Temp. (during 
bioconversion) 
Buffer 
Plate/Well Std 
Order 
(hrs) (mM) (mL) (hrs) (g/L) (°C) 
 
1/C3 1 50 0.75 0.5 2 10 22 Yes 
1/C4 2 75 0.75 0.5 2 30 22 No 
1/C5 3 50 1.25 0.5 2 30 22 No 
1/C6 4 75 1.25 0.5 2 10 22 Yes 
1/C7 5 50 0.75 1.0 2 10 22 No 
1/C8 6 75 0.75 1.0 2 30 22 Yes 
1/C9 7 50 1.25 1.0 2 30 22 Yes 
1/C10 8 75 1.25 1.0 2 10 22 No 
1/D3 9 50 0.75 0.5 5 30 22 No 
1/D4 10 75 0.75 0.5 5 10 22 Yes 
1/D5 11 50 1.25 0.5 5 10 22 Yes 
1/D6 12 75 1.25 0.5 5 30 22 No 
1/D7 13 50 0.75 1.0 5 30 22 Yes 
1/D8 14 75 0.75 1.0 5 10 22 No 
1/D9 15 50 1.25 1.0 5 10 22 No 
1/D10 16 75 1.25 1.0 5 30 22 Yes 
1/E3 17 50 0.75 0.5 2 10 22 Yes 
1/E4 18 75 0.75 0.5 2 30 22 No 
1/E5 19 50 1.25 0.5 2 30 22 No 
1/E6 20 75 1.25 0.5 2 10 22 Yes 
1/E7 21 50 0.75 1.0 2 10 22 No 
1/E8 22 75 0.75 1.0 2 30 22 Yes 
1/E9 23 50 1.25 1.0 2 30 22 Yes 
1/E10 24 75 1.25 1.0 2 10 22 No 
1/F3 25 50 0.75 0.5 5 30 22 No 
1/F4 26 75 0.75 0.5 5 10 22 Yes 
1/F5 27 50 1.25 0.5 5 10 22 Yes 
1/F6 28 75 1.25 0.5 5 30 22 No 
1/F7 29 50 0.75 1.0 5 30 22 Yes 
1/F8 30 75 0.75 1.0 5 10 22 No 
1/F9 31 50 1.25 1.0 5 10 22 No 
1/F10 32 75 1.25 1.0 5 30 22 Yes 
2/C3 33 50 0.75 0.5 2 10 30 Yes 
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2/C4 34 75 0.75 0.5 2 30 30 No 
2/C5 35 50 1.25 0.5 2 30 30 No 
2/C6 36 75 1.25 0.5 2 10 30 Yes 
2/C7 37 50 0.75 1.0 2 10 30 No 
2/C8 38 75 0.75 1.0 2 30 30 Yes 
2/C9 39 50 1.25 1.0 2 30 30 Yes 
2/C10 40 75 1.25 1.0 2 10 30 No 
2/D3 41 50 0.75 0.5 5 30 30 No 
2/D4 42 75 0.75 0.5 5 10 30 Yes 
2/D5 43 50 1.25 0.5 5 10 30 Yes 
2/D6 44 75 1.25 0.5 5 30 30 No 
2/D7 45 50 0.75 1.0 5 30 30 Yes 
2/D8 46 75 0.75 1.0 5 10 30 No 
2/D9 47 50 1.25 1.0 5 10 30 No 
2/D10 48 75 1.25 1.0 5 30 30 Yes 
2/E3 49 50 0.75 0.5 2 10 30 Yes 
2/E4 50 75 0.75 0.5 2 30 30 No 
2/E5 51 50 1.25 0.5 2 30 30 No 
2/E6 52 75 1.25 0.5 2 10 30 Yes 
2/E7 53 50 0.75 1.0 2 10 30 No 
2/E8 54 75 0.75 1.0 2 30 30 Yes 
2/E9 55 50 1.25 1.0 2 30 30 Yes 
2/E10 56 75 1.25 1.0 2 10 30 No 
2/F3 57 50 0.75 0.5 5 30 30 No 
2/F4 58 75 0.75 0.5 5 10 30 Yes 
2/F5 59 50 1.25 0.5 5 10 30 Yes 
2/F6 60 75 1.25 0.5 5 30 30 No 
2/F7 61 50 0.75 1.0 5 30 30 Yes 
2/F8 62 75 0.75 1.0 5 10 30 No 
2/F9 63 50 1.25 1.0 5 10 30 No 
2/F10 64 75 1.25 1.0 5 30 30 Yes 
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Appendix 1.4. 2 factor, 8 run Central Composite DoE design containing 4 centre points for an 
optimisation timecourse on the bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. 
Each of the eight ‘Std Order’ runs is cultured as a timecourse using the sacrificial well method 
(Section 2.5.3.) 
 
 
 
Factor A B   
[Subs] [Yeast 
Extract] 
Row Std 
Order 
(mM) (g/L) 
A 1 0.75 40 
B 2 1.00 40 
C 3 0.75 50 
D 4 1.00 50 
E 5 0.88 45 
F 6 0.88 45 
G 7 0.88 45 
H 8 0.88 45 
 
 
Appendix 1.5. Arrangement of factors for DoE optimisation timecourse experiment as 
described in Section 2.5.3. 
      Post Induction Time of Harvest (hr) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1.6.  
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Appendix 1.6a. Sample calibration curve for 7-Ethoxycoumarin (bioconversion substrate) 
concentration. Experiments carried out as described in Section 2.2.9.2. 
 
 
Appendix 1.6b. Sample calibration curve for 7-Hydroxycoumarin (bioconversion product) 
concentration. Experiments carried out as described in Section 2.8.3. 
 
 
 
y = 217.00x
R² = 0.998
0
50
100
150
200
250
0 0.3 0.6 0.9 1.2
Pe
ak
 A
re
a 
(m
AU
*m
in
)
Concentration (mM)
y = 328.69x
R² = 1.000
0
5
10
15
20
25
30
35
0 0.05 0.1 0.15
Pe
ak
 A
re
a 
(m
AU
*m
in
)
Concentration (mM)
 257 
Appendix 1.7. Determination of optimal absorbance of 7-Ethoxycoumarin by nanodrop 
measurement. 
 
 
 
Appendix 1.8. Sample calibration curve for quantification of free glycerol concentration. 
Experiments carried out as described in Section 2.8. 
325nm 
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Appendix 2.1. Design and raw data for 9 factor, 64 run DoE design for screening 
bioconversion of 7-ethoxycoumarin to 7-hydroxycoumarin. 
 
Factor  
 
A B C D E F G H J Response   
Post 
Ind. 
Time 
[Subs] Post 
Ind. 
Vol. 
Pre 
Ind. 
Time 
Temp. 
(Post 
Ind.) 
Subs 
addition 
time 
[Yeast 
Extract] 
Buffer Shaker 
Speed 
[7-
hydroxycoumarin] 
Std 
Order 
 
(hrs) (mM) (mL) (hrs) (°C) (hrs) (g/L) 
 
(rpm) 
 
1 Block 1 8 0.1 500 2 25 0.17 10 Yes 300 0.056 
2 Block 1 65 0.1 500 2 25 1 30 Yes 300 0.052 
3 Block 1 8 1 500 2 25 1 30 No 300 0.000 
4 Block 1 65 1 500 2 25 0.17 10 No 300 0.983 
5 Block 1 8 0.1 1000 2 25 1 10 No 300 0.123 
6 Block 1 65 0.1 1000 2 25 0.17 30 No 300 0.000 
7 Block 1 8 1 1000 2 25 0.17 30 Yes 300 0.000 
8 Block 1 65 1 1000 2 25 1 10 Yes 300 0.789 
9 Block 1 8 0.1 500 5 25 0.17 30 No 300 0.000 
10 Block 1 65 0.1 500 5 25 1 10 No 300 0.272 
11 Block 1 8 1 500 5 25 1 10 Yes 300 0.000 
12 Block 1 65 1 500 5 25 0.17 30 Yes 300 0.326 
13 Block 1 8 0.1 1000 5 25 1 30 Yes 300 0.000 
14 Block 1 65 0.1 1000 5 25 0.17 10 Yes 300 0.168 
15 Block 1 8 1 1000 5 25 0.17 10 No 300 0.000 
16 Block 1 65 1 1000 5 25 1 30 No 300 0.000 
17 Block 1 8 0.1 500 2 37 0.17 10 No 300 0.091 
18 Block 1 65 0.1 500 2 37 1 30 No 300 0.000 
19 Block 1 8 1 500 2 37 1 30 Yes 300 0.000 
20 Block 1 65 1 500 2 37 0.17 10 Yes 300 1.289 
21 Block 1 8 0.1 1000 2 37 1 10 Yes 300 0.000 
22 Block 1 65 0.1 1000 2 37 0.17 30 Yes 300 0.030 
23 Block 1 8 1 1000 2 37 0.17 30 No 300 0.000 
24 Block 1 65 1 1000 2 37 1 10 No 300 0.928 
25 Block 1 8 0.1 500 5 37 0.17 30 Yes 300 0.000 
26 Block 1 65 0.1 500 5 37 1 10 Yes 300 0.022 
27 Block 1 8 1 500 5 37 1 10 No 300 0.110 
28 Block 1 65 1 500 5 37 0.17 30 No 300 0.297 
29 Block 1 8 0.1 1000 5 37 1 30 No 300 0.000 
30 Block 1 65 0.1 1000 5 37 0.17 10 No 300 0.173 
31 Block 1 8 1 1000 5 37 0.17 10 Yes 300 0.047 
32 Block 1 65 1 1000 5 37 1 30 Yes 300 0.439 
33 Block 2 65 1 1000 5 37 1 30 No 1100 2.613 
34 Block 2 8 1 1000 5 37 0.17 10 No 1100 4.944 
35 Block 2 65 0.1 1000 5 37 0.17 10 Yes 1100 1.840 
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36 Block 2 8 0.1 1000 5 37 1 30 Yes 1100 1.197 
37 Block 2 65 1 500 5 37 0.17 30 Yes 1100 1.783 
38 Block 2 8 1 500 5 37 1 10 Yes 1100 1.829 
39 Block 2 65 0.1 500 5 37 1 10 No 1100 5.047 
40 Block 2 8 0.1 500 5 37 0.17 30 No 1100 1.954 
41 Block 2 65 1 1000 2 37 1 10 Yes 1100 2.458 
42 Block 2 8 1 1000 2 37 0.17 30 Yes 1100 1.409 
43 Block 2 65 0.1 1000 2 37 0.17 30 No 1100 2.160 
44 Block 2 8 0.1 1000 2 37 1 10 No 1100 3.964 
45 Block 2 65 1 500 2 37 0.17 10 No 1100 5.189 
46 Block 2 8 1 500 2 37 1 30 No 1100 2.012 
47 Block 2 65 0.1 500 2 37 1 30 Yes 1100 0.927 
48 Block 2 8 0.1 500 2 37 0.17 10 Yes 1100 1.677 
49 Block 2 65 1 1000 5 25 1 30 Yes 1100 4.473 
50 Block 2 8 1 1000 5 25 0.17 10 Yes 1100 2.507 
51 Block 2 65 0.1 1000 5 25 0.17 10 No 1100 3.989 
52 Block 2 8 0.1 1000 5 25 1 30 No 1100 2.223 
53 Block 2 65 1 500 5 25 0.17 30 No 1100 2.862 
54 Block 2 8 1 500 5 25 1 10 No 1100 4.777 
55 Block 2 65 0.1 500 5 25 1 10 Yes 1100 1.728 
56 Block 2 8 0.1 500 5 25 0.17 30 Yes 1100 1.252 
57 Block 2 65 1 1000 2 25 1 10 No 1100 4.267 
58 Block 2 8 1 1000 2 25 0.17 30 No 1100 2.073 
59 Block 2 65 0.1 1000 2 25 0.17 30 Yes 1100 1.005 
60 Block 2 8 0.1 1000 2 25 1 10 Yes 1100 1.580 
61 Block 2 65 1 500 2 25 0.17 10 Yes 1100 1.929 
62 Block 2 8 1 500 2 25 1 30 Yes 1100 1.420 
63 Block 2 65 0.1 500 2 25 1 30 No 1100 2.727 
64 Block 2 8 0.1 500 2 25 0.17 10 No 1100 3.916 
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Appendix 2.2. Example calculation for determining oxygen demand as a result of each of the 
major contributors during culture and whole cell bioconversion by simultaneous equations. 
 
Using the experimental data generated in Section 3, the following equations can be derived: 
 !"#$	&'()*+, = 	a	[!"#$	/012#33] + 	b	[!"#$	61782"9:0;	!:1<8;90=09>]  
Equation A1 !"#$	&'(*+, = 	a	[!"#$	/012#33] + 	b	[!"#$	61782"9:0;	!:1<8;90=09>] + 	g	[!"#$	!:1<8;9] 
Equation A2 !"#$	&'(*+?, = a	[!"#$	/012#33] + 	b	[!"#$	61782"9:0;	!:1<8;90=09>] + 	g	[!"#$	!:1<8;9] 
Equation A3 
 
Where, a is the oxygen demand for sustaining peak biomass concentration per unit 
biomass, b is the oxygen demand for growth per unit volumetric productivity with respect to 
biomass accumulation and g is the oxygen demand for bioconversion of 7-ethoxycoumarin to 
7-hydroxycoumarin per unit bioconversion product. 
 
Therefore, !"#$	&'()*+, = 	14.4a	 + 	2.31b	              Equation A4 !"#$	&'(*+, = 	4.1a	 + 	0.31b	 + 	1.36g	             Equation A5 !"#$	&'(*+?, = 26.2a	 + 	1.56b	 + 	0.66g             Equation A6 
 
Resulting in three simultaneous equations:  19.9 = 	14.4a	 + 	2.31b	               Equation A7 5.68 = 	4.1a	 + 	0.31b	 + 	1.36g	              Equation A8 25.8 = 26.2a	 + 	1.56b	 + 	0.66g              Equation A9 
 
Which can be solved to give: 
a = 0.71 
b = 4.23 
g = 1.69 
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Appendix 3.1. DoE design and raw data for the linear screening experiment to model 
oxygen mass transfer values in 24DSW plates. 
 
Temperature Shaker Speed 
Fill 
Volume 
Biomass 
Concentration kLa OUR 
(°C) (RPM) (mL) (gDCW/L) (1/h) (mgO2/L/hr) 
30 250 1600 0.35 121.47 58.34 
   0.35 80.03 43.30 
  3200 0.35 58.28 68.66 
   0.35 52.97 73.46 
  1600 1.75 105.45 172.79 
   1.75 85.49 163.67 
30 200 1600 0.35 65.94 43.88 
   0.35 65.07 58.42 
  3200 0.35 32.52 77.62 
   0.35 30.12 82.89 
37 250 1600 0.35 107.82 42.54 
   0.35 100.28 32.47 
  3200 0.35 39.68 53.55 
   0.35 52.54 57.07 
  1600 1.75 122.25 156.57 
   1.75 120.87 140.64 
37 200 1600 0.35 103.05 87.64 
   0.35 80.83 57.12 
  3200 0.35 31.89 78.04 
   0.35 57.07 82.95 
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Appendix 3.2a. DoE design and raw data for modelling oxygen mass transfer values in 24DSW plates using the new dynamic gassing method 
in Section 4.  
 
 
Fill 
Volume 
Shaking 
Speed 
Post 
Induction 
Temp. 
% 
Inoculum 
Log 
Hour 
Time 
Max 
Biomass 
Conc. 
GFP 
Fluorescence  
Max 
Specific 
Growth 
Rate 
kLa OUR  
(uL) (RPM) (°C)   (hr) (gDCW/L) (x10^6 RFUs)  (hr-1) (mgO2/L/h) 
1600 200 30 1 0 5.36 1.488 10.22 82.66 518.0 
1600 200 30 1 8 5.36 1.441 10.22 82.66 518.0 
1600 200 30 5 0 4.79 1.376 0.63 82.66 545.3 
1600 200 30 5 8 4.79 1.380 0.63 82.66 545.3 
1600 200 37 1 0 4.90 1.659 16.16 82.66 508.2 
1600 200 37 1 8 4.90 1.407 16.16 82.66 508.2 
1600 200 37 5 0 3.40 1.511 18.89 82.66 507.9 
1600 200 37 5 8 3.40 1.842 18.89 82.66 507.9 
1600 250 30 1 8 4.33 1.260 0.83 103.5 739.5 
1600 250 30 5 8 3.91 1.385 0.77 103.5 684.5 
1600 250 37 1 0 8.15 1.348 0.81 103.5 741.2 
1600 250 37 1 8 8.15 1.244 0.81 103.5 741.2 
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1600 250 37 5 0 7.70 1.632 0.72 103.5 736.6 
1600 250 37 5 8 7.70 1.381 0.72 103.5 736.6 
3200 200 30 1 0 4.31 1.375 5.06 33.97 304.5 
3200 200 30 1 8 4.31 1.510 5.06 33.97 304.5 
3200 200 30 5 0 3.93 1.332 0.91 33.97 227.7 
3200 200 30 5 8 3.93 1.447 0.91 33.97 227.7 
3200 200 37 1 0 3.29 1.609 20.45 33.97 197.0 
3200 200 37 1 8 3.29 2.146 20.45 33.97 197.0 
3200 200 37 5 0 2.32 1.522 7.45 33.97 210.4 
3200 200 37 5 8 2.32 1.769 7.45 33.97 210.4 
3200 250 30 1 8 3.94 1.265 0.80 54.8 361.7 
3200 250 30 5 8 3.81 1.413 1.04 54.8 350.7 
3200 250 37 1 0 7.10 1.291 2.62 54.8 415.4 
3200 250 37 1 8 7.10 1.213 2.62 54.8 415.4 
3200 250 37 5 8 7.02 1.170 2.73 54.8 346.4 
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Appendix 3.2b. DoE design and raw data for modelling oxygen mass transfer values in 
96DSW plates using the new dynamic gassing method in Section 4.  
Fill 
Volume 
Shaking 
Speed 
Post 
Induction 
Temp. 
% 
Inoculum 
Log Hour 
Time 
Max 
Biomass 
Conc. 
GFP 
Fluorescence  
Max 
Specific 
Growth 
Rate 
(uL) (RPM) (°C)   (hr) (gDCW/L) (x10^6 RFUs)   
400 600 30 1 8 2.69 1.67 8.18 
400 600 30 1 24 6.14 2.77 8.18 
400 600 30 1 32 6.02 2.92 8.18 
400 600 30 1 48 6.92 3.10 8.18 
400 600 30 1 56 6.04 3.26 8.18 
400 600 30 5 8 3.85 1.56 1.64 
400 600 30 5 24 5.88 2.81 1.64 
400 600 30 5 32 5.87 3.07 1.64 
400 600 30 5 48 5.97 3.26 1.64 
400 600 30 5 56 5.88 3.35 1.64 
400 600 37 1 8 3.21 1.89 14.61 
400 600 37 1 24 3.74 4.65 14.61 
400 600 37 1 32 4.45 6.55 14.61 
400 600 37 1 48 3.41 8.69 14.61 
400 600 37 1 56 2.62 4.43 14.61 
400 600 37 5 8 2.89 1.95 8.22 
400 600 37 5 24 3.90 5.54 8.22 
400 600 37 5 32 3.29 4.86 8.22 
400 600 37 5 48 1.48 3.22 8.22 
400 600 37 5 56 4.63 6.98 8.22 
400 1100 30 1 8 0.07 1.28 35.93 
400 1100 30 1 24 4.71 2.46 35.93 
400 1100 30 1 32 3.73 2.50 35.93 
400 1100 30 1 48 1.54 3.29 35.93 
400 1100 30 1 56 14.44 1.14 35.93 
400 1100 30 5 8 0.28 1.24 8.11 
400 1100 30 5 24 4.40 2.64 8.11 
400 1100 30 5 32 4.02 2.92 8.11 
400 1100 30 5 48 2.65 3.13 8.11 
400 1100 30 5 56 8.35 1.72 8.11 
400 1100 37 1 8 5.42 1.65 0.86 
400 1100 37 1 24 5.94 3.52 0.86 
400 1100 37 1 32 7.48 3.41 0.86 
400 1100 37 1 48 7.31 4.05 0.86 
400 1100 37 1 56 6.24 7.35 0.86 
400 1100 37 5 8 6.07 1.91 1.01 
400 1100 37 5 24 6.01 2.99 1.01 
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400 1100 37 5 32 7.62 3.41 1.01 
400 1100 37 5 48 7.35 4.19 1.01 
400 1100 37 5 56 5.31 8.38 1.01 
800 600 30 1 8 2.51 1.57 0.86 
800 600 30 1 24 5.17 2.12 0.86 
800 600 30 1 32 5.02 2.51 0.86 
800 600 30 1 48 5.59 3.18 0.86 
800 600 30 1 56 3.99 3.39 0.86 
800 600 30 5 8 2.95 1.56 4.08 
800 600 30 5 24 4.79 2.19 4.08 
800 600 30 5 32 5.30 2.60 4.08 
800 600 30 5 48 5.31 3.15 4.08 
800 600 37 1 8 0.32 0.11 0.56 
800 600 37 1 24 8.36 2.84 0.56 
800 600 37 1 32 8.00 2.72 0.56 
800 600 37 1 48 5.87 2.00 0.56 
800 600 37 1 56 10.71 3.64 0.56 
800 600 37 5 8 5.56 1.89 2.91 
800 600 37 5 24 7.99 2.72 2.91 
800 600 37 5 32 9.43 3.21 2.91 
800 600 37 5 48 10.02 3.41 2.91 
800 600 37 5 56 10.56 3.59 2.91 
800 1100 30 1 8 -0.06 -0.02 6.22 
800 1100 30 1 24 1.90 0.65 6.22 
800 1100 30 1 32 12.95 4.40 6.22 
800 1100 30 1 48 39.29 13.36 6.22 
800 1100 30 1 56 11.31 3.85 6.22 
800 1100 30 5 8 0.67 0.23 4.45 
800 1100 30 5 24 1.47 0.50 4.45 
800 1100 30 5 32 9.44 3.21 4.45 
800 1100 30 5 48 9.23 3.14 4.45 
800 1100 30 5 56 8.73 2.97 4.45 
800 1100 37 1 8 12.37 4.21 4.04 
800 1100 37 1 24 17.41 5.92 4.04 
800 1100 37 1 32 18.01 6.12 4.04 
800 1100 37 1 48 18.70 6.36 4.04 
800 1100 37 1 56 17.87 6.08 4.04 
800 1100 37 5 8 12.28 4.18 4.61 
800 1100 37 5 24 17.43 5.93 4.61 
800 1100 37 5 32 17.01 5.78 4.61 
800 1100 37 5 48 18.47 6.28 4.61 
800 1100 37 5 56 12.91 4.39 4.61 
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Appendix 4.1. Experimental designs for oxygen mass transfer characterisation of single use 
bioreactors. 
 
Bioreactor 
Study Factor Unit 
Range set points 
Minimu
m Low Centre High Maximum 
BioFlo 310 
(STR) 
A Viscosity by [Gly] mL/L 0 8.69 15 21.31 30 
B Aeration Rate vvm 0.125 0.43 0.75 1.07 1.5 
C Agitation Rate rpm 100 418.8 650 881.2 1200 
D Temperature °C 15 25.14 32.5 39.86 50 
E Antifoam %v/v 0.0 0.036 0.055 0.074 0.10 
XDR-10 
(Tank liner) 
A Aeration Rate vvm 0.25 0.58 0.75 0.92 1.25 
B Agitation Rate rpm 120 200 240 280 360 
C Temperature °C 15.0 26.7 32.5 38.3 50.0 
Ambr®250 
A Aeration Rate vvm 0.5 1.0 1.5 2.0 2.5 
B Agitation Rate rpm 100 825 1550 2275 3000 
C Viscosity by [Gly] mL/L 0.0 7.5 15.0 22.5 30.0 
D Temperature °C 15.0 23.8 32.5 41.3 50.0 
E Antifoam %v/v 0.0 0.025 0.05 0.075 0.10 
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Appendix 4.2. Pilot Scale STR DoE design and raw data table. 
 
  
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Response 
Std Run A:Viscosity by 
[Gly] (ml/L) 
B:Aeration 
(vvm) 
C:Agitation 
(rpm) 
D:Temperature 
(°C) 
E:Antifoam 
(%v/v PPG) 
kLa (PRT) 
(s-1)         
1 12 8.69 0.43 418.8 25.14 0.0361 0.0112 
2 39 21.31 0.43 418.8 25.14 0.0361 0.0195 
3 26 8.69 1.07 418.8 25.14 0.0361 0.0199 
4 41 21.31 1.07 418.8 25.14 0.0361 0.0373 
5 11 8.69 0.43 881.2 25.14 0.0361 0.0087 
6 49 21.31 0.43 881.2 25.14 0.0361 0.0167 
7 44 8.69 1.07 881.2 25.14 0.0361 0.0112 
8 1 21.31 1.07 881.2 25.14 0.0361 0.0887 
9 2 8.69 0.43 418.8 39.86 0.0361 0.0219 
10 24 21.31 0.43 418.8 39.86 0.0361 0.0000201 
11 37 8.69 1.07 418.8 39.86 0.0361 0.0327 
12 35 21.31 1.07 418.8 39.86 0.0361 0.0518 
13 34 8.69 0.43 881.2 39.86 0.0361 0.017 
14 3 21.31 0.43 881.2 39.86 0.0361 0.0000228 
15 50 8.69 1.07 881.2 39.86 0.0361 0.0907 
16 8 21.31 1.07 881.2 39.86 0.0361 0.293 
17 16 8.69 0.43 418.8 25.14 0.0739 0.0024 
18 5 21.31 0.43 418.8 25.14 0.0739 0.0156 
19 6 8.69 1.07 418.8 25.14 0.0739 0.0006 
20 20 21.31 1.07 418.8 25.14 0.0739 0.0405 
21 36 8.69 0.43 881.2 25.14 0.0739 0.0219 
22 7 21.31 0.43 881.2 25.14 0.0739 0.0243 
23 48 8.69 1.07 881.2 25.14 0.0739 0.0737 
24 43 21.31 1.07 881.2 25.14 0.0739 0.0746 
25 38 8.69 0.43 418.8 39.86 0.0739 0.0152 
26 40 21.31 0.43 418.8 39.86 0.0739 0.0159 
27 29 8.69 1.07 418.8 39.86 0.0739 0.0479 
28 28 21.31 1.07 418.8 39.86 0.0739 0.0325 
29 18 8.69 0.43 881.2 39.86 0.0739 0.0161 
30 19 21.31 0.43 881.2 39.86 0.0739 0.0168 
31 30 8.69 1.07 881.2 39.86 0.0739 0.119 
32 27 21.31 1.07 881.2 39.86 0.0739 0.1 
33 15 0 0.75 650 32.5 0.055 0.0518 
34 4 30 0.75 650 32.5 0.055 0.0518 
35 45 15 0.125 650 32.5 0.055 0.0035 
36 23 15 1.5 650 32.5 0.055 0.193 
37 32 15 0.75 100 32.5 0.055 0.0024 
38 25 15 0.75 1200 32.5 0.055 0.0426 
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39 13 15 0.75 650 15 0.055 0.0256 
40 46 15 0.75 650 50 0.055 0.193 
41 9 15 0.75 650 32.5 0 0.0297 
42 17 15 0.75 650 32.5 0.1 0.0787 
43 10 15 0.75 650 32.5 0.055 0.0587 
44 22 15 0.75 650 32.5 0.055 0.0621 
45 21 15 0.75 650 32.5 0.055 0.0734 
46 14 15 0.75 650 32.5 0.055 0.0533 
47 33 15 0.75 650 32.5 0.055 0.0495 
48 31 15 0.75 650 32.5 0.055 0.0605 
49 47 15 0.75 650 32.5 0.055 0.0608 
50 42 15 0.75 650 32.5 0.055 0.0564 
 
 
Appendix 4.3. XDR-10 SUB DoE design and raw data table. 
 
  
Factor 1 Factor 2 Factor 3 Response  
Std Run A:Aeration B:Agitation C:Temp kLa (PRT)   
vvm rpm DegC s-1 
1 2 0.58 200 26.67 0.0083 
2 8 0.92 200 26.67 0.0093 
3 12 0.58 280 26.67 0.0135 
4 3 0.92 280 26.67 0.0140 
5 4 0.58 200 38.33 0.0067 
6 17 0.92 200 38.33 0.0083 
7 7 0.58 280 38.33 0.0144 
8 18 0.92 280 38.33 0.0178 
9 11 0.25 240 32.50 0.0085 
10 1 1.25 240 32.50 0.0088 
11 5 0.75 120 32.50 0.0032 
12 16 0.75 360 32.50 0.0235 
13 13 0.75 240 15.00 0.0128 
14 9 0.75 240 50.00 0.0153 
15 14 0.75 240 32.50 0.0093 
16 10 0.75 240 32.50 0.0082 
17 6 0.75 240 32.50 0.0083 
18 15 0.75 240 32.50 0.0089 
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Appendix 4.4. Ambr®250 SUB DoE design and raw data table. 
 
  
Factor 
1 
Factor 
2 
Factor 
3 
Factor 
4 
Factor 
5 
kLa (s-1) 
Run BR 
Position 
vvm rpm [Gly] Temp AF % Repeat 
1 
Repeat 
2 
Repeat 
3 
Mean 
1 2 0.5 825 7.5 23.8 0.025 0.0059 0.0055 0.0056 0.0057 
2 6 0.5 825 7.5 23.8 0.075 0.0050 0.0049 0.0050 0.0050 
3 2 0.5 825 7.5 41.3 0.025 0.0056 0.0056 0.0057 0.0056 
4 6 0.5 825 7.5 41.3 0.075 0.0055 0.0056 0.0056 0.0056 
5 4 0.5 825 22.5 23.8 0.025 0.0051 0.0051 0.0052 0.0051 
6 8 0.5 825 22.5 23.8 0.075 0.0048 0.0048 0.0048 0.0048 
7 4 0.5 825 22.5 41.3 0.025 0.0054 0.0055 0.0055 0.0055 
8 8 0.5 825 22.5 41.3 0.075 0.0053 0.0053 0.0054 0.0054 
9 2 0.5 2275 7.5 23.8 0.025 0.0185 0.0191 0.0189 0.0188 
10 6 0.5 2275 7.5 23.8 0.075 0.0249 0.0244 0.0236 0.0243 
11 2 0.5 2275 7.5 41.3 0.025 0.0238 0.0241 0.0233 0.0237 
12 6 0.5 2275 7.5 41.3 0.075 0.0357 0.0370 0.0348 0.0359 
13 4 0.5 2275 22.5 23.8 0.025 0.0191 0.0190 0.0190 0.0190 
14 8 0.5 2275 22.5 23.8 0.075 0.0215 0.0208 0.0206 0.0210 
15 4 0.5 2275 22.5 41.3 0.025 0.0236 0.0241 0.0236 0.0237 
16 8 0.5 2275 22.5 41.3 0.075 0.0290 0.0282 0.0282 0.0285 
17 2 1.5 825 7.5 23.8 0.025 0.0091 0.0096 0.0100 0.0096 
18 6 1.5 825 7.5 23.8 0.075 0.0091 0.0095 0.0096 0.0094 
19 2 1.5 825 7.5 41.3 0.025 0.0101 0.0117 0.0125 0.0115 
20 6 1.5 825 7.5 41.3 0.075 0.0114 0.0120 0.0125 0.0120 
21 4 1.5 825 22.5 23.8 0.025 0.0083 0.0088 0.0090 0.0087 
22 8 1.5 825 22.5 23.8 0.075 0.0088 0.0090 0.0091 0.0089 
23 4 1.5 825 22.5 41.3 0.025 0.0103 0.0111 0.0114 0.0109 
24 8 1.5 825 22.5 41.3 0.075 0.0118 0.0123 0.0124 0.0121 
25 2 1.5 2275 7.5 23.8 0.025 0.1502 0.1348 0.1531 0.1460 
26 6 1.5 2275 7.5 23.8 0.075 0.0601 0.0661 0.0602 0.0621 
27 2 1.5 2275 7.5 41.3 0.025 0.0765 0.0769 0.0703 0.0746 
28 6 1.5 2275 7.5 41.3 0.075 0.1295 0.1404 0.1295 0.1332 
29 4 1.5 2275 22.5 23.8 0.025 0.1126 0.1182 0.1048 0.1119 
30 8 1.5 2275 22.5 23.8 0.075 0.1029 0.1048 0.1051 0.1043 
31 4 1.5 2275 22.5 41.3 0.025 0.0786 0.0781 0.0765 0.0778 
32 8 1.5 2275 22.5 41.3 0.075 0.0844 0.0876 0.0905 0.0875 
33 3 0.0 1550 15.0 32.5 0.050 0.0016 0.0016 0.0016 0.0016 
34 3 2.0 1550 15.0 32.5 0.050 0.0505 0.0493 0.0660 0.0553 
35 3 1.0 100 15.0 32.5 0.050 0.0021 0.0021 0.0021 0.0021 
36 3 1.0 3000 15.0 32.5 0.050 0.0282 0.0283 0.0284 0.0283 
37 1 1.0 1550 0.0 32.5 0.050 0.0980 0.0984 0.0980 0.0982 
38 5 1.0 1550 30.0 32.5 0.050 0.0955 0.0910 0.0934 0.0933 
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39 3 1.0 1550 15.0 15.0 0.050 0.0229 0.0220 0.0220 0.0223 
40 3 1.0 1550 15.0 50.0 0.050 0.1737 0.1772 0.1629 0.1713 
41 3 1.0 1550 15.0 32.5 0.000 0.1048 0.1026 0.0924 0.0999 
42 3 1.0 1550 15.0 32.5 0.100 0.0418 0.0391 0.0413 0.0407 
43 7 1.0 1550 15.0 32.5 0.050 0.1279 0.1442 0.1222 0.1314 
44 7 1.0 1550 15.0 32.5 0.050 0.1387 0.1126 0.1348 0.1287 
45 7 1.0 1550 15.0 32.5 0.050 0.1281 0.1422 0.1463 0.1389 
46 7 1.0 1550 15.0 32.5 0.050 0.1387 0.1412 0.1540 0.1447 
47 7 1.0 1550 15.0 32.5 0.050 0.1447 0.1464 0.1446 0.1452 
48 7 1.0 1550 15.0 32.5 0.050 0.1182 0.1287 0.1093 0.1187 
49 7 1.0 1550 15.0 32.5 0.050 0.1236 0.1123 0.1248 0.1202 
50 7 1.0 1550 15.0 32.5 0.050 0.1117 0.1255 0.1300 0.1224 
51 7 1.0 1550 15.0 32.5 0.050 0.1048 0.1410 0.1273 0.1244 
52 7 1.0 1550 15.0 32.5 0.050 0.1311 0.1400 0.1150 0.1287 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 271 
Appendix 4.5. Model expression for oxygen mass transfer in the New Brunswick BioFlo 310 
 
 
 
Appendix 4.6. Model expression for oxygen mass transfer in the Xcellerex XDR-10 
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Appendix 4.7. Model expression for oxygen mass transfer in the Ambr®250 
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Appendix 4.8. Examples sections of Ambr®250 automated DoE Protocol 
 
 274 
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Appendix 5.1. Process design inputs and dependencies for consumables calculation in the 
ARC tool. 
 
 
